Page last updated: 2024-08-23

daunorubicin and Acute Lymphoid Leukemia

daunorubicin has been researched along with Acute Lymphoid Leukemia in 507 studies

Research

Studies (507)

TimeframeStudies, this research(%)All Research%
pre-199024 (4.73)18.7374
1990's180 (35.50)18.2507
2000's158 (31.16)29.6817
2010's124 (24.46)24.3611
2020's21 (4.14)2.80

Authors

AuthorsStudies
Hama, A; Hara, J; Hasegawa, D; Hiramatsu, H; Horibe, K; Imamura, T; Ishida, H; Kaino, A; Katayama, S; Kitazawa, H; Moriya, K; Moriya-Saito, A; Okamoto, K; Sasahara, Y; Sato, A; Sekimizu, M; Suenobu, S; Uemura, S; Usami, I; Yokoyama, N1
Bojalil-Álvarez, L; Cortés, JE; Fernández-Gutiérrez, JA; García-Villaseñor, E; Murrieta-Álvarez, I; Reyes-Cisneros, OA; Ruiz-Argüelles, GJ; Ruiz-Delgado, GJ; Sánchez-Bonilla, D1
Cui, L; Li, W; Li, Z; Liu, S; Liu, W; Wang, C; Zhang, R; Zhao, X1
Benesch, M; Egger, M; Flaschberger, S; Gorkiewicz, G; Karastaneva, A; Kohlmaier, B; Lackner, H; Marterer, R; Seidel, M; Sperl, D; Strenger, V; Trobisch, A; Urban, C1
Aguiar, M; Akarca, A; Aref, S; Bailey, K; Burt, R; Cheuk Yan Ng, K; Day, W; Dey, A; Fielding, AK; Hooper, S; Kirkwood, A; Kirschner, K; Lee, SW; Lo Celso, C; Manji, J; Mansour, MR; Marafioti, T; Mitchell, RJ; Muirhead, RC; Pospori, C; Puccio, I; Sahai, E; Zuborne-Alapi, K1
Al-Aamri, HM; Bradley, C; Irving, HR; Meehan-Andrews, T1
Abolghasemi, H; Akbari, ME; Mehrvar, A; Mehrvar, N; Movafagh, A; Rezvany, MR; Saberynejad, J1
Attarbaschi, A; Bader, P; Barisone, E; Basso, G; Biondi, A; Cario, G; Caterina Putti, M; Cazzaniga, G; Colombini, A; Conter, V; Flotho, C; Kuhlen, M; Lang, P; Lauten, M; Linderkamp, C; Lo Nigro, L; Locatelli, F; Mann, G; Möricke, A; Niggli, F; Panzer-Grümayer, R; Parasole, R; Peters, C; Rizzari, C; Schrappe, M; Suttorp, M; Valsecchi, MG; Zimmermann, M1
Tidwell, C; Willman, A1
Huang, LL; Lu, YY; Sun, JB; Tu, SJ; Xie, ZW; Yu, QQ1
Campana, D; Cheng, C; Coustan-Smith, E; Lins, MM; Lucena-Silva, N; Pedrosa, A; Pedrosa, F; Pedrosa, M; Ramos, AML; Ribeiro, RC; Rivera, GK; Vinhas, E; Zhou, Y1
Alten, J; Behrens, YL; Bergmann, AK; Buchmann, S; Cario, G; Cazzaniga, G; Davenport, CF; Ebersold, J; Fazio, G; Göhring, G; Hagedorn, M; Hofmann, W; Lentes, J; Möricke, A; Schieck, M; Schlegelberger, B; Schrappe, M; Stanulla, M; Steinemann, D; Thomay, K1
Itani, K; Kohno, K; Nakayama, T; Ogata, M; Saburi, M; Soga, Y1
Anwar, S; Faizan, M; Farooq, A; Khan, S; Latif, MF1
Chen, ZP; Gao, C; Li, ZG; Liu, SG; Lu, WT; Xing, TY; Yue, ZX; Zhao, XX; Zheng, HY1
Hori, D; Kobayashi, K; Kobayashi, R; Kodama, K; Matsushima, S; Sano, H; Suzuki, D; Yanagi, M1
Młynarski, W; Proc, P; Szczepańska, J; Wyka, K; Zubowska, M1
Adamkiewicz-Drożyńska, E; Balwierz, W; Ćwiklińska, M; Derwich, K; Karolczyk, G; Kazanowska, B; Kowalczyk, J; Kołtan, A; Krawczuk-Rybak, M; Lejman, M; Machnik, K; Matysiak, M; Mizia-Malarz, A; Młynarski, W; Niedźwiecki, M; Ociepa, T; Owoc-Lempach, J; Płonowski, M; Romiszewski, M; Sobol-Milejska, G; Szczepański, T; Tomaszewska, R; Trelińska, J; Urasiński, T; Urbańska-Rakus, J; Wachowiak, J; Wysocki, M; Zawitkowska, J1
Abdelhafiz, A; Elfishawi, S; Gameel, A; Ibraheem, D; Kamel, A; Madney, Y; Osman, R; Radwan, E; Rasekh, EO1
Chen, HQ; Fang, JP; Li, CG; Li, CK; Li, JQ; Li, XY; Lin, YD; Liu, RY; Luo, XQ; Sun, X; Sun, XF; Wu, XD; Xu, HG1
Gopakumar, KG; Guruprasad, CS; Jacob, PM; Jagathnath Krishna, KM; Nair, M; Nair, RA; Prasanth, VR; Rajeswari, B; Seetharam, S; Thankamony, P1
Andarsini, MR; Cahyadi, A; Hidayat, T; Larasati, MCS; Ontoseno, T; Rahman, MA; Samosir, SM; Ugrasena, IDG; Utamayasa, IKA1
Cao, W; Jiang, Z; Li, L; Li, X; Li, Y; Wan, D; Yu, J; Zhang, S1
Wang, D; Wang, ZD; Zhang, CH; Zhang, Q1
Alten, J; Bens, S; Bleckmann, K; Cario, G; Dagdan, E; Fedders, B; Fischer, S; Moericke, A; Panzer-Grümayer, R; Schewe, D; Schmäh, J; Schrappe, M; Siebert, R; Stanulla, M; Zimmermann, M1
Chen, M; Huang, Z; Li, Y; Qian, J; Tong, H; Wang, J; Xu, Z1
Cario, G; Conter, V; Dagdan, E; Hinze, L; Junk, S; Kratz, CP; Möricke, A; Schrappe, M; Stanulla, M; Zimmermann, M1
Adams, G; Apperley, JF; Brannigan, E; Davies, F; Fernando, F; Innes, AJ; Marchesi, JR; Mullish, BH; Pavlů, J1
Avgeris, M; Baka, M; Doganis, D; Gourgiotis, D; Kossiva, L; Marmarinos, A; Piatopoulou, D; Scorilas, A; Xagorari, M1
Cortez-Toledo, O; Dieli-Conwright, CM; Louie, SG; Mittelman, SD; Neely, M; Oberley, MJ; Orgel, E; Parmentier, JH; Pei, H; Sheng, X; Tucci, J1
Fujita, H; Hori, T; Iesato, K; Igarashi, K; Kikuchi, N; Miyanishi, K; Saito, M; Tsutsumi, H; Yamamoto, M1
Basso, G; Buldini, B; Cazzaniga, G; Ceppi, F; Colombini, A; Conter, V; Douyon, L; Gagné, V; Krajinovic, M; Parasole, R; Quintin, CJ1
Cho, YH; Kim, SY; Lee, MH; Park, JH; Yoon, SY1
Adly, AAM; Ebeid, FSE; El-Ghoroury, E; Mostafa, M; Tantawy, AAG1
Haider, G; Kumar, D; Raja, W; Vallacha, A1
Avgeris, M; Baka, M; Drakaki, I; Gourgiotis, D; Kossiva, L; Marmarinos, A; Piatopoulou, D; Pourtsidis, A; Scorilas, A; Xagorari, M1
Kearns, P; Stankovic, T; Wei, W; Weston, VJ1
Garg, B; Jain, S; Kapoor, G; Malhotra, P1
Agrawal, V; Bali Singh, T; Gupta, V; Kumar Singh, S1
Wang, Y; Zeng, HM; Zhang, LP1
Appanraj, P; Chandar, R; Cs, G; Gopakumar, KG; Nair, M; Rajeswari, B; Seetharam, S; Thankamony, P1
Fu, Y; Lu, F; Meng, J; Miao, H; Qian, X; Wang, H; Yu, Y; Zhai, X; Zhu, X1
Chen, C; Chen, YR; Lin, SF; Tang, XK; Wang, J; Xu, HG; Xue, HM1
Al-Aamri, HM; Bradley, C; Irving, HR; Ku, H; Meehan-Andrews, T; Tucci, J1
Borowitz, MJ; Campana, D; Carroll, WL; Cheng, C; Choi, JK; Devidas, M; Fulton, RS; Gastier-Foster, J; Hunger, SP; Jay, D; Jeha, S; Karol, SE; Kornegay, N; Larsen, EC; Loh, ML; Mardis, ER; Pui, CH; Raetz, EA; Relling, MV; Robinson, KM; Winick, N; Wood, B; Yang, W1
Celkan, T; Çifçi Sunamak, E; Özdemir, N1
Madjidyar, J; Peters, S; Zhang, XD1
Cai, X; Chen, X; Li, C; Liang, Y; Wang, H; Xia, Z1
Alvaro, F; Bierings, MB; Cross, S; Dalla Pozza, L; de Bont, ES; de Groot-Kruseman, HA; de Haas, V; Haber, M; Hoogerbrugge, PM; Kaspers, GJ; Law, T; Maarten Egeler, R; Marshall, GM; Mueller, H; Ng, A; Norris, MD; Pieters, R; Révész, T; Suppiah, R; Sutton, R; van den Berg, H; van der Schoot, E; van der Velden, VH; van Dongen, J; Venn, NC1
Burakgazi-Dalkilic, E; Esmer, O; Karadag, R; Oner, AF; Soylu, E1
Alizadeh, H; Bernsen, R; Hassan, IB; Kristensen, J1
Bartram, CR; Koehler, R1
Gaynon, P1
Attarbaschi, A; Beier, R; Lauten, M; Möricke, A; Niggli, F; Odenwald, E; Schrappe, M; Stanulla, M; Zimmermann, M1
Beier, R; Cario, G; Debatin, KM; Gadner, H; Gruhn, B; Harbott, J; Henze, G; Klingebiel, T; Kremens, B; Ludwig, WD; Mann, G; Möricke, A; Niemeyer, C; Niggli, F; Ratei, R; Reiter, A; Ritter, J; Schrappe, M; Schrauder, A; Stanulla, M; Welte, K; Zimmermann, M1
Eckert, C; Henze, G; v Stackelberg, A1
Bourquin, JP; Creutzig, U; Dworzak, MN; Fleischhack, G; Graf, N; Klingebiel, T; Kremens, B; Lehrnbecher, T; Reinhardt, D; Ritter, J; Sander, A; Schrauder, A; Starý, J; von Neuhoff, C; von Stackelberg, A; Zimmermann, M1
Chen, X; Dai, H; Dong, X; Jin, Y; Li, X; Shi, J; Wang, J; Zhang, X; Zhou, J1
Cui, L; Gao, C; Jiang, J; Li, WJ; Li, ZG; Ma, XL; Mei, YY; Shi, HW; Wang, B; Wang, KL; Wu, MY; Xie, J; Zhang, RD; Zhang, YH; Zhao, W; Zhao, XX; Zhou, X1
Erdlenbruch, B; Güttel, C; Härtel, C; Lauten, M1
Bao, L; Chen, H; Huang, XJ; Jiang, B; Jiang, H; Jiang, Q; Liu, DH; Lu, J; Lu, XJ; Wang, J; Xu, LP; Zhu, HH1
Bergsagel, J; Cooper, T; Daves, M; Keller, F; Lew, G; Nickel, RS; Sabnis, H1
Jamil, K; Jayaraman, A1
Hatta, Y1
McElligott, F; O'Marcaigh, A; O'Rafferty, C; Smith, O; Storey, L1
Freyer, DR; Gaynon, PS; Ladas, E; Malvar, J; Orgel, E; Seibel, NL; Sposto, R1
Cui, L; Deng, G; Ding, W; Gao, C; Jia, H; Li, W; Li, Z; Liu, F; Mei, Y; Wang, K; Wu, M; Zhao, X1
Baytan, B; Bengoa, SY; Evim, MS; Gözmen, S; Güneş, AM; Irken, G; Karapınar, TH; Oren, H; Tüfekçi, O1
Cai, YJ; Chen, GQ; Chen, J; Duan, CW; Enver, T; Hong, DL; Li, LH; Li, ZQ; Mi, JQ; Qin, X; Shi, J; Tao, Y; Wang, B; Yin, MZ; Yu, YH; Zhang, F; Zhou, XC1
Bacigalupo, A; Ballerini, F; Clavio, M; Cruciani, F; De Astis, E; Di Grazia, C; Galaverna, F; Ghiggi, C; Ghiso, A; Gobbi, M; Guolo, F; Lemoli, RM; Lovera, D; Marani, C; Miglino, M; Minetto, P; Mitscheunig, L; Pastori, G; Raiola, AM; Varaldo, R1
Borthakur, G; Cardenas-Turanzas, M; Cortes, JE; Daver, NG; Ferrajoli, A; Franklin, AR; Garcia-Manero, G; Garris, R; Jabbour, EJ; Jorgensen, JL; Kadia, TM; Kantarjian, HM; Konopleva, MY; Kornblau, SM; O'Brien, SM; Pemmaraju, N; Ravandi-Kashani, F; Rytting, ME; Schroeder, K; Thomas, DA1
Anderson, D; Beesley, AH; Cole, CH; Kees, UR; Lock, RB; Marshall, GM; Papa, RA; Samuels, AL; Sutton, R; Yadav, BD1
Boehm, I; Carol, H; Fan, MM; Harasym, TO; Houghton, P; Lock, RB; Mayer, LD; Smith, MA1
Arnoux, I; Asnafi, V; Baruchel, A; Béné, MC; Brouzes, C; Dombret, H; Fossat, C; Garand, R; Garnache-Ottou, F; Ifrah, N; Jacob, MC; Kuhlein, E; Macintyre-Davi, E; Plesa, A; Robillard, N; Roussel, M; Tkaczuk, J1
Lukawska, M; Mazur, L; Opydo-Chanek, M; Oszczapowicz, I; Stojak, M2
Gong, Y; Naren, D; Shi, F; Shi, R; Wu, J; Yang, X1
Chen, Y; Gao, P; He, X; Li, J; Niu, C; Wang, C; Wang, Y; Zhang, H1
Cai, R; Chen, Y; Guo, X; Li, P; Lu, S; Sun, F; Sun, X; Wang, J; Xia, Y; Zhang, F; Zhen, Z; Zhu, J1
Chai, YH; Liang, Y; Pan, J; Pang, L; Wang, JR; Zhao, WL1
Chen, YB; Jiang, J; Li, SD; Li, ZG; Ma, XL; Qin, MQ; Wang, B; Wu, MY; Wu, RH; Wu, Y; Xie, J; Zhang, R; Zhang, RD; Zheng, HY; Zhou, X1
Acar, C; Alacacioglu, I; Demirkan, F; Katgi, A; Medeni, SS; Ozcan, MA; Ozdemirkan, F; Ozsan, GH; Payzin, B; Piskin, O; Sevindik, OG; Undar, B1
Anastasiou, T; Avgeris, M; Baka, M; Gourgiotis, D; Kosmidis, H; Piatopoulou, D; Scorilas, A; Stamati, L1
Blažek, B; Černá, Z; Domanský, J; Hak, J; Houdková, A; Hrušák, O; Jabali, Y; Janotová, I; Jarošová, M; Mejstříková, E; Mihál, V; Novák, Z; Procházková, D; Ptoszková, H; Sedláček, P; Smíšek, P; Starý, J; Štěrba, J; Timr, P; Trka, J; Zdráhalová, K; Zemanová, Z; Zuna, J1
Ding, C; Jiao, W; Li, X; Liu, L; Qu, Q; Wu, D; Zhang, Y1
Ahn, JS; Chi, HS; Cho, YU; Chung, JS; Eom, HS; Hyun, MS; Jang, S; Joo, YD; Jung, CW; Kim, DH; Kim, DY; Kim, H; Kim, I; Kim, K; Kim, KH; Kim, SD; Kim, YS; Lee, GW; Lee, H; Lee, HS; Lee, JH; Lee, JJ; Lee, KH; Lee, SM; Lee, WS; Lim, SN; Moon, JH; Mun, YC; Park, CJ; Park, J; Park, JH; Park, S; Shin, HJ; Sohn, SK; Won, JH; Yang, DH; Yoon, SS1
Chen, S; Li, H; Li, S; Liu, S; Rao, Q; Tang, K; Tian, Z; Wang, J; Wang, M; Xing, H; Yu, J1
Bae, SH; Chi, HS; Eom, HS; Hyun, MS; Jang, DY; Joo, YD; Jung, CW; Kim, DY; Kim, H; Kim, HJ; Kim, I; Kim, MK; Lee, GW; Lee, JH; Lee, KH; Lee, SM; Lee, WS; Lim, SN; Moon, JH; Park, S; Ryoo, HM; Shin, HJ; Sohn, SK; Won, JH; Yang, DH; Yun, SC1
Bierings, MB; de Vries, MC; Dekking, SA; Kodish, E; Lantos, JD; van Delden, JJ; van der Graaf, R1
Goulden, N; Hough, R; Mitchell, C; Moorman, A; Rowntree, C; Vora, A; Wade, R1
Bi, L; Han, Y; Wu, J; Ye, A; Yu, K; Zhang, S1
Ashraf, MS; Belgaumi, AF; Iftikhar, S; Jabeen, K1
Bednarski, W; Dettlaff, K; Jelińska, A; Kaczmarek, A; Oszczapowicz, I; Paszel-Jaworska, A; Rybczyńska, M; Totoń, E1
Anderson, D; Beesley, AH; Bendak, K; Cole, CH; Kees, UR; Lock, RB; Marshall, GM; Samuels, AL; Sutton, R; Venn, NC; Wells, JE; Yadav, BD1
Antillón, FG; Blanco, JG; Borrayo, DA; Castellanos, M; Conter, V; Garrido, CP; Girón, V; Letona, TR; Lorenzana, R; Mack, RA; Melgar, MA; Metzger, M; Osorio, EJ; Ribeiro, RC; Rossi, E; Valsecchi, MG; Valverde, PD1
Behan, JW; Heisterkamp, N; Ji, L; Mittelman, SD; Parmentier, JH; Sheng, X; Tucci, J1
Guo, Q; Han, J; Jin, R; Zhang, M; Zhou, F1
Attarbaschi, A; Dworzak, M; Haas, OA; König, M; Mann, G; Meister, B; Pichler, H; Pötschger, U; Reismüller, B; Schmitt, K; Steiner, M; Urban, C1
Narayanan, G; Soman, LV1
Bazarbachi, A; Charafeddine, M; El Dika, I; El-Cheikh, J; Kharfan-Dabaja, MA; Mahfouz, R; Massoud, R1
Gordon, MJ; Kovacsovics, T; Loriaux, MM; Mayer, LD; Spurgeon, SE; Tardi, P; Traer, E; Tyner, JW1
Dujua, AC; Hernandez, FG1
Campana, D; Pui, CH1
Bretscher, C; Cario, G; Fetz, A; Möricke, A; Schrappe, M; Schrauder, A; Stanulla, M1
Bink-Boelkens, MT; Brouwer, CA; Elzenga, NJ; Gietema, JA; Haaksma, J; Kamps, WA; Postma, A; van den Berg, MP; Vonk, JM1
Basso, G; Biondi, A; Fabbri, G; Locatelli, F; Paganin, M; Polato, K; Rizzari, C; Zecca, M1
Figliolia, SL; Lauris, JR; Maurício, AR; Mello de Andrea, ML; Oliveira, DT; Pereira, MC1
Abe, A; Hayasaka, K; Kawakami, K; Kawano, Y; Kumamoto, T; Nishikawa, T; Okamoto, Y; Tonooka, S1
Diamantidis, MD; Girtovitis, F; Hatzitolios, A; Kaiafa, G; Kontoninas, Z; Ntaios, G; Papadopoulos, A; Saouli, Z; Savopoulos, C1
Gibson, B; Pizer, B; Selwood, K; Skinner, R1
Broekhuis, MJ; Den Boer, ML; Evans, WE; Holleman, A; Hulleman, E; Kazemier, KM; Pieters, R; Rudin, CM; VanderWeele, DJ1
Chang, JE; Esterberg, E; Juckett, MB; Kahl, BS; Kim, J; Kim, K; Lionberger, J; Longo, WL; Medlin, SC; Williams, EC1
Mori, N; Motoji, T; Shiseki, M; Takanashi, M; Tanaka, N; Tsuji, K; Wang, YH1
Behm, FG; Campana, D; Hijiya, N; Hudson, MM; Onciu, M; Pui, CH; Razzouk, BI; Ribeiro, RC; Sandlund, JT; Zhou, Y1
Li, Y; Mi, Y; Qiu, L; Wang, J; Zhao, Y; Zou, D1
Bonney, D; Razali, H; Turner, A; Will, A1
Haymond, MW; Margolin, JF; McKay, SV; Okcu, MF; Sonabend, RY; Yan, J1
Darzynkiewicz, Z; Halicka, HD; Jayabose, S; Kajstura, M; Levendoglu-Tugal, O; Ozkaynak, MF; Sandoval, C; Seiter, K; Traganos, F1
Cario, G; Coulthard, SA; Dördelmann, M; Eichelbaum, M; Kaatsch, P; Möricke, A; Reiter, A; Riehm, H; Schaeffeler, E; Schrappe, M; Schrauder, A; Schwab, M; Stanulla, M; Welte, K; Zimmermann, M1
Bayles, A; Bowman, WP; Boyett, JM; Campana, D; Cheng, C; Coustan-Smith, E; Downing, JR; Evans, WE; Handgretinger, R; Howard, SC; Jeha, S; Kaste, SC; Kun, LE; Leung, W; Metzger, ML; Onciu, M; Pei, D; Pui, CH; Raimondi, SC; Relling, MV; Ribeiro, RC; Rubnitz, JE; Sandlund, JT; Simmons, V1
Cai, Y; Lin, L; Ling, JY; Sun, XF; Tong, GL; Xia, Y; Zhen, ZJ1
Heyman, M; Kristinsson, J; Mogensen, UB; Rosthøj, S; Saarinen-Pihkala, U; Schmiegelow, K; Vettenranta, K; Wesenberg, F1
Hawks, RG; Meza, JL; Post-White, JE; Sacks, N; Seibel, NL; Smith, LM; Withycombe, JS1
Barisone, E; Boos, J; De Lorenzo, P; de Rossi, G; Hempel, G; Pieters, R; Relling, MV; Stary, J; Valsecchi, MG1
Hsia, SH; Jaing, TH; Lin, JJ; Lin, JL; Lin, YP; Yang, SH1
Abdulghaffar, EE; Abou El Asrar, M; Adly, AA; El-Bostany, EA; El-Ghouroury, EA; Tantawy, AA1
Altomare, M; Crescenzio, N; De Mattia, D; Del Vecchio, GC; Falanga, A; Giordano, P; Marchetti, M; Molinari, AC; Perutelli, P; Russo, G; Santoro, N; Saracco, P1
Buffardi, S; Cianciulli, E; Mangione, A; Marchese, L; Menna, G; Misuraca, A; Nastro, A; Parasole, R; Petruzziello, F; Poggi, V1
Akyay, A; Bçakç, Z; Cetin, II; Olcay, L; Oztürkmen, S; Paç, A; Polat, TB; Senayl, A1
Cortes, J; Faderl, S; Jabbour, E; Kantarjian, H; O'Brien, S; Pierce, S; Ravandi, F; Thomas, D1
Fujita, K; Hidaka, Y; Hotta, N; Inada, H; Itonaga, N; Kawakami, K; Kawano, Y; Matsuzaki, A; Moritake, H; Nagatoshi, Y; Nakayama, H; Okamura, J; Suminoe, A; Ueda, K; Yamanaka, T; Yanai, F1
Cai, X; Liu, X; Sun, Z; Wu, J; Zheng, C; Zhu, W1
Akcan, M; Hazar, V; Karasu, GT; Küpesiz, A; Uygun, V; Yesilipek, A1
Al-Tonbary, Y; Fouda, A; Kandil, SM; Mansour, A; Zalata, K1
Abnous, K; Lavaee, P; Ramezani, M; Taghdisi, SM1
Akbari Moqadam, F; Chen, C; De Menezes, RX; Den Boer, ML; Khankahdani, LM; Lange-Turenhout, E; Pieters, R; Schotte, D1
Gong, YP; Yang, X; Zheng, BH; Zhou, RQ1
Chang, H; Gong, YP; Xing, HY; Yang, L; Yang, X; Zheng, BH; Zhou, RQ1
Balcerska, A; Balwierz, W; Chybicka, A; Derwich, K; Dobaczewski, G; Kowalczyk, JR; Kwiecińska, K; Matysiak, M; Moryl-Bujakowska, A; Pawelec, K; Płoszyńska, A; Sońta-Jakimczyk, D; Styczyński, J; Szczepański, T; Tomaszewska, R; Wachowiak, J; Wiśniewska-Slusarz, H; Wysocki, M1
Blach, L; Borowitz, MJ; Bowman, WP; Camitta, BM; Carroll, AJ; Carroll, WL; Devidas, M; Hunger, SP; Larsen, EL; Linda, SB; Pullen, DJ; Shuster, J; Willman, CL; Winick, N1
Alfaro, EM; Alonso, CN; Felice, MS; Fraquelli, LE; Gallego, MS; Guitter, MR; Rossi, JG; Scopinaro, MJ; Zubizarreta, PA1
Baila, L; Benoit, Y; Bertrand, Y; Boutard, P; Ferster, A; Lescoeur, B; Mazingue, F; Mechinaud, F; Millot, F; Munzer, M; Philippet, P; Plouvier, E; Renard, M; Robert, A; Suciu, S; Uyttebroeck, A; van der Werff Ten Bosch, J; Vandecruys, E1
Alfaro, EM; Alonso, CN; Bernasconi, AR; Felice, MS; Gallego, MS; Guitter, MR; Rossi, JG; Rubio, PL; Zubizarreta, PA1
Ariffin, H; Kwok, CS; Quah, TC; Tay, SK; Yeoh, AE1
Balwierz, W; Bik-Multanowski, M; Galicka-Latala, D; Gozdzik, J; Pietrzyk, JJ; Strojny, W; Surmiak, M; Szymon, S1
Gong, Y; Guo, Y; He, G; Lin, J; Ma, H; Shan, Q; Shuai, X; Yang, X; Zhou, R1
Boos, J; Franke, D; Gerss, J; Henze, G; König, T; Kühnel, HJ; Lanvers-Kaminsky, C; Möricke, A; Schrappe, M; von Stackelberg, A; Willer, A1
Abe, A; Akahori, Y; Akatsuka, Y; Emi, N; Inaguma, Y; Kurosawa, Y; Murayama, Y; Sumitomo, M; Tokuda, M; Tsuzuki, S; Ukai, Y; Yamamoto, K; Yamamoto, Y1
Iseki, T; Kawaguchi, T; Kawajiri, C; Muto, T; Nagao, Y; Nakaseko, C; Ohwada, C; Sakai, S; Sakaida, E; Shimizu, N; Sugita, Y; Takeda, Y; Takeuchi, M; Tanaka, S; Tsukamoto, S; Yamazaki, A; Yokote, K1
Attarbaschi, A; Dworzak, MN; Haas, OA; Hochreiter, D; Hutter, C; Kasper, DC; Kornmüller, R; Mann, G; Pichler, H; Pötschger, U; Steiner, M1
Barnard, MR; Chang, H; Chuang, WY; Sun, CF1
Camitta, B; Carroll, WL; Devidas, M; Dreyer, ZE; Hilden, JM; Hunger, S; Jones, TL; Salzer, WL; Winick, N1
Abromowitch, M; Finlay, JL; Gross, TG; Lones, M; Perkins, SL; Smith, LM; Termuhlen, AM; Weinstein, H1
Andreeff, M; Benito, JM; Chen, C; Fuentes-Mattei, E; Jin, Y; Konopleva, M; Lee, MH; Pan, J; Velazquez-Tores, G; Yeung, SC1
Bloomfield, CD; DeAngelo, DJ; Johnson, JL; Kolitz, JE; Larson, RA; Marcucci, G; McDonnell, D; Mrózek, K; Powell, BL; Stock, W; Stone, RM; Vardiman, JW; Westervelt, P; Wetzler, M1
Abella, E; Amigo, ML; Barrios, M; Bravo, P; Brunet, S; García, O; González-Campos, J; Hernández-Rivas, JM; Montesinos, P; Ribera, JM1
Devidas, M; Gaynon, PS; Hunger, SP; Mattano, LA; Nachman, JB; Sather, HN; Seibel, NL; Steinherz, PG1
Escherich, G; Janka-Schaub, G; Zimmermann, M1
Gardner, RA; Hawkins, DS; Thomson, B1
Lee, CS; Lee, SC; Shim, JW; Yoon, JS1
Czyzewski, K; Debski, R; Jaworska-Posadzy, A; Kolodziej, B; Kubicka, M; Kurylo-Rafinska, B; Piatkowska, M; Pogorzala, M; Styczynski, J; Wysocki, M1
Heisterkamp, N; Ichihara, B; Mittelman, SD; Pramanik, R; Sheng, X1
Çankal, A; Gözmen, S; Irken, G; Ören, H; Tüfekçi, Ö; Vergin, C; Yüksel, F1
Fujisawa, S; Hattori, Y; Ishigatsubo, Y; Kitagawa, M; Kuwabara, H; Nakajima, Y; Ohshima, R; Sakai, R; Tomita, N1
Liedtke, M; Medeiros, BC; Ngo, D; Patel, S1
Chiba, P; Ecker, GF; Jabeen, I; Pastor, M; Wetwitayaklung, P1
Aricò, M; Benigno, V; Locatelli, F; Orlando, MA; Russo, D; Ziino, O1
Balogh, E; Jakab, Z; Kappelmayer, J; Karászi, E; Kiss, C; Oláh, E1
Apak, H; Celkan, T; Kuruoglu, S; Ozkan, A; Yildiz, I; Yuksel, L1
Balcerska, A; Balwierz, W; Chybicka, A; Debski, R; Kowalczyk, J; Kurylak, A; Matysiak, M; Rokicka-Milewska, R; Sońta-Jakimczyk, D; Styczyński, J; Wachowiak, J; Wysocki, M1
Handa, H; Isozumi, K; Komatsumoto, S; Motohashi, S; Nara, M1
Ghosh, K; Gupta, M; Jijina, F; Madkaikar, M; Mohanty, D; Rajpurkar, M1
Nakaseko, C; Nishimura, M; Saito, Y; Uehara, T; Yokota, A1
Baccarani, M; Bonini, A; Fanin, R; Gobbi, M; Gugliotta, L; Michelutti, T; Michieli, M; Piccaluga, PP; Piccolrovazzi, S; Pierri, I; Russo, D; Tiribelli, M; Visani, G1
Bonetti, F; Conter, V; Fagioli, F; Favre, C; Giorgiani, G; Lanino, E; Locatelli, F; Messina, C; Pession, A; Porta, F; Rondelli, R; Sacchi, N; Uderzo, C; Zecca, M1
Dabadghao, S; Gupta, M; Kumar, A1
Dudkin, SD; Dyshlevaia, ZM; Fechina, LG; Hartmann, R; Henze, H; Karachunskiĭ, AI; Lebedev, VV; Miakova, NV; Rudneva, AE; Rumiantsev, AG; Shamardina, AV; Timakov, AM; Timofeeva, VN; Trubina, NM; Varfolomeeva, SR1
Andersson, PO; Brune, M; Gustavsson, B; Stockelberg, D; Wadenvik, H; Wernstedt, P1
Ahlke, E; Fleischhack, G; Junker, R; Nowak-Göttl, U; Schobess, R; Schumann, C; Schwabe, D1
Alvarez, Y; Bastida, P; Caballín, MR; Coll, MD; Ortega, JJ1
English, MW; Karandikar, SS; Sastry, J1
Ali, R; Kimya, Y; Ozan, U; Ozçelik, T; Ozkalemkaş, F; Ozkocaman, V; Tunali, A1
Hirano, T; Hu, XM; Oka, K1
Bull, C; Dorup, I; Levitt, GA; Sorensen, K; Sullivan, ID1
Cetin, M; Yetgin, S1
Altman, A; Halpern, S; Heath, JA; Jhanwar, S; Pieters, R; Sather, H; Shah, N; Steinherz, L; Steinherz, PG; Tannous, R; Terry, W; Trigg, ME1
Brandwein, J; Gupta, V; Kamel-Reid, S; Lipton, JH; Messner, HA; Minden, MD1
Bogdanović, A; Colović, M; Janković, G; Kraguljac, N; Suvajdzić, N1
Kaliszewski, J; Kitszel, A; Krawczuk-Rybak, M; Wołczyński, S1
Kaliszewski, J; Kitszel, A; Krawczuk-Rybak, M1
Becker, CM; Chitambar, CR; Drexler, HG; Efferth, T; Gebhart, E; Humeny, A; Miyachi, H; Sauerbrey, A; Steinbach, D; Zintl, F1
Baccarani, M; Damiani, D; Fanin, R; Furlanut, M; Michelutti, A; Michelutti, T; Michieli, M; Pea, F; Piccolrovazzi, S; Russo, D1
den Boer, ML; Holleman, A; Janka-Schaub, GE; Kazemier, KM; Pieters, R1
Filippa, DA; Mora, J; Qin, J; Wollner, N1
Blazek, B; Cerná, Z; Dembická, D; Gajdos, P; Hak, J; Hrstková, H; Hrusák, O; Jabali, Y; Kopecná, L; Mihál, V; Mydlil, J; Pospísilová, D; Procházková, D; Ptoszková, H; Slavík, Z; Starý, J; Timr, P; Trka, J; Vávra, V; Zahálka, F1
Bennett, JM; Cassileth, PA; Hoagland, HC; Leong, T; Oken, MM; Paietta, E; Wiernik, PH1
Asgedom, G; Cario, G; Lauten, M; Schrappe, M; Welte, K1
Fu, RY; Jia, CS; Liao, QK1
Bresciani, P; Ferrari, A; Luppi, M; Morselli, M; Potenza, L; Riva, G; Saviola, A; Torelli, G1
Dorup, I; Levitt, GA; Sorensen, K; Sullivan, I1
Audhuy, B; Baranger, L; Béné, MC; Berthou, C; Blanchet, O; Cahn, JY; Caillot, D; Casassus, P; Delain, M; Garidi, R; Guyotat, D; Harousseau, JL; Hunault, M; Ifrah, N; Jouet, JP; Lamy, T; Lioure, B; Pignon, B; Sadoun, A; Solal-Celigny, P; Sotto, JJ; Stalnikiewicz, L; Truchan-Graczyk, M; Witz, F1
Ascari, E; Benatti, C; Gnocchi, M; Invernizzi, R; Travaglino, E1
Cheng, C; Cheok, MH; den Boer, ML; Evans, WE; Holleman, A; Janka-Schaub, GE; Kazemier, KM; Pei, D; Pieters, R; Pui, CH; Relling, MV; Veerman, AJ; Yang, W1
Balleari, E; Ballerini, F; Balocco, M; Canepa, L; Clavio, M; Garrone, A; Gobbi, M; Michelis, GL; Miglino, M; Pierri, I; Venturino, C1
Boiron, JM; Boulat, O; Espinouse, D; Fiere, D; Garban, F; Gardin, C; Huguet, F; Lhéritier, V; Reman, O; Sutton, L; Thomas, X; Turlure, P1
Blazek, B; Hajduch, M; Janostakova, A; Kouzmina, G; Mihal, V; Noskova, V; Orel, M; Pospisilova, D; Safarova, M; Stary, J1
Braszko, JJ; Holownia, A; Jakubow, P; Kaliszewski, J; Krawczuk-Rybak, M; Muszynska-Roslan, K; Trofimiuk, E1
Sun, XF; Wang, ZH; Wang, ZQ; Xia, Y; Zhang, CQ; Zhen, ZJ1
Hato, A; Ito, M; Matsui, T; Minagawa, K; Okamura, A; Sada, A; Urahama, N; Yakushijin, K; Yamamoto, K1
Guan, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Liu, DG; Sun, XF; Xia, Y; Xia, ZJ; Zhang, L; Zhen, ZJ; Zhou, ZM1
Dokmanović, L; Janić, D; Jovanović, N; Lazić, J; Skorić, D1
Abdall, N; Ballerini, F; Balocco, M; Canepa, L; Clavio, M; Garrone, A; Gatto, S; Gobbi, M; Michelis, GL; Miglino, M; Pierri, I; Varaldo, R; Venturino, C1
Catarini, M; Centurioni, R; Corvatta, L; Leoni, F; Leoni, P; Malerba, L; Marconi, M; Masia, MC; Offidani, M; Scortechini, AR1
Krawczuk-Rybak, M; Luczyński, W; Stasiak-Barmuta, A; Zak, J1
Balcerska, A; Balwierz, W; Chełmecka-Hanuszewicz, L; Chybicka, A; Cwiklińska, M; Derwich, K; Jackowska, T; Kaczmarek-Kanold, M; Kowalczyk, JR; Kołtan, A; Matysiak, M; Odój, T; Płoszyńska, A; Sońta-Jakimczyk, D; Steczowicz, M; Wachowiak, J; Wojciechowska, V; Wójtowicz, A; Wysocki, M1
Bartyik, K; Békési, A; Galántai, I; Jakab, Z; Kajtár, P; Kiss, C; Kovács, G; Magyarosy, E; Masát, P; Müller, J; Nagy, K; Rényi, I1
Camera, A; Cimino, G; Cuneo, A; Foà, R; Izzo, B; Mancini, M; Mandelli, F; Martinelli, G; Mecucci, C; Pane, F; Picardi, M; Quintarelli, C; Rotoli, B; Saglio, G; Salvatore, F; Specchia, G; Vitale, A1
Baggetto, LG; Barakat, S; Cogne, S; Coleman, AW; Dayan, G; Gayet, L; Labialle, S; Mazane, A; Michaud, M; Rigal, D1
Bradburn, M; Burrett, J; Eden, T; Hann, I; Kinsey, SE; Lilleyman, JS; Love, S; Mitchell, C; Moorman, AV; Roy, A; Saha, V; Vora, A1
Cheng, C; Cheok, MH; den Boer, ML; Evans, WE; Holleman, A; Janka-Schaub, GE; Lugthart, S; Pieters, R; Pui, CH; Relling, MV; Yang, W1
Bonagura, VR; Brodtman, DH; Lanzkowsky, P; Redner, A; Rosenthal, DW1
Aleskog, A; Barbany, G; Björnberg, A; Hallböök, H; Larsson, R; Lindhagen, E; Sundström, C1
Asselin, B; Buck, S; Hamre, M; Ozdemir, O; Pullen, J; Ravindranath, Y; Savaşan, S1
Bubała, H; Karpe, J; Mazur, B; Sońta-Jakimczyk, D; Szczepański, T; Torbus, M1
Codeluppi, M; Ferrari, A; Guaraldi, G; Imovilli, A; Luppi, M; Morselli, M; Potenza, L; Riva, G; Rossi, G; Torelli, G; Volzone, F1
Aricò, M; Barisone, E; Basso, G; Boccalatte, MF; Conter, V; De Rossi, G; Lo Nigro, L; Locatelli, F; Messina, C; Micalizzi, C; Pession, A; Rizzari, C; Valsecchi, MG1
Acar, K; Guzel, O; Haznedar, R; Kalkanci, A; Kokturk, N; Kustimur, S; Sancak, B; Senol, E1
Androutsos, G; Athanassiadou, F; Papadhimitriou, SI; Paterakis, GS; Polychronopoulou, S; Tsakiridou, AA1
Burkhardt, B; Doerffel, W; Henze, G; Janssen, D; Kontny, U; Ludwig, WD; Mann, G; Niggli, F; Reiter, A; Riehm, H; Schrappe, M; Vormoor, J; Woessmann, W; Zimmermann, M1
Goldstone, A; Hann, I; Mitchell, C; Ramanujachar, R; Richards, S; Rowe, J; Vora, A; Webb, D1
Appel, IM; Hop, WC; Pieters, R1
Aricò, M; Basso, G; Biondi, A; De Lorenzo, P; De Rossi, G; Lo Nigro, L; Locatelli, F; Masera, G; Rizzari, C; Valsecchi, MG1
Hou, Y; Hu, Q; Liu, AG; Liu, SY; Zhang, LQ1
Breit, S; Flohr, T; Happich, M; Kulozik, AE; Ludwig, WD; Muckenthaler, MU; Schrappe, M; Stanulla, M; Tolle, G1
Boesen, AM; Gregersen, H; Gustafsson, G; Heyman, M; Johnsen, HE; Kjeldahl, M; Nielsen, OJ; Schmidt, K; Schrøder, H1
Colson, YL; Marty, FM; Paul, S1
Boesen, AM; Gregersen, H; Gustafsson, G; Johnsen, HE; Kjeldstad, M; Nielsen, OJ; Schmidt, KG; Schrøder, H1
Baccarani, M; Candoni, A; Damiani, D; Fanin, R; Michelutti, A; Simeone, E1
Balcerska, A; Balwierz, W; Chybicka, A; Derwich, K; Dobaczewski, G; Juszczak, K; Kowalczyk, J; Krauze, A; Luszczyńska, A; Matysiak, M; Moryl-Bujakowska, A; Pawelec, K; Pawińska, K; Płoszyńska, A; Skoczeń, S; Sońta-Jakimczyk, D; Styczyńskii, J; Swiatkiewicz, V; Tomaszewska, R; Wachowiak, J; Wiśniewska-Slusarz, H; Wysocki, M1
Salonen, JH1
Alonso Ojembarrena, A; Contra Gómez, T; Díaz Pérez, MA; García Castro, J; González-Vicent, M; Madero López, L; Pérez Martínez, A; Ramírez Orellana, M1
Kajdas, L; Krawczuk-Rybak, M; Muszynska-Roslan, K; Sawicka-Zukowska, M; Sonta-Jakimczyk, D; Szczepanski, T1
Abella, E; Bethencourt, C; Brunet, S; Debén, G; del Potro, E; Feliu, E; Hernández-Rivas, JM; López, R; Morgades, M; Novo, A; Oriol, A; Ortega-Rivas, F; Ortín, X; Ribera, JM; Sancho, JM; Sanz, MA; Tormo, M; Xicoy, B1
Avramis, VI; Cohen, LJ; Douer, D; Levine, AM; Periclou, AP; Watkins, K; Yampolsky, H1
Fletcher, DA; Lam, WA; Rosenbluth, MJ1
Berbić-Fazlagić, J; Sakić, M1
Ariola, C; De Gregoris, C; Foà, R; Guarini, A; Mandelli, F; Meloni, G; Mettivier, V; Pastorini, A; Perbellini, O; Pizzolo, G; Pizzuti, M; Vignetti, M; Vitale, A1
Kroczka, S; Romaniszyn, A; Steczkowska-Klucznik, M1
Ainoon, O; Cheong, SK; Fazlina, N; Hamidah, H; Hamidah, NH; Jamal, R; Maha, A; Zarina, AL; Zulkifli, SZ1
Beck, JD; Ittner, E; Janka, G; Krappmann, P; Lackner, H; Langer, T; Nickel, P; Paulides, M; Plattig, B; Schrappe, M; Stöhr, W1
Guan, ZZ; Huang, HQ; Li, YH; Ling, JY; Liu, DG; Sun, XF; Xia, Y; Xia, ZJ; Zhang, L; Zhen, ZJ; Zhou, ZM1
Ahluwalia, J; Das, R; Jain, S; Kumari, S; Mahi, S; Malhotra, P; Radhika, S; Sharma, SC; Varma, N; Varma, S1
Campos, T; Franco-Macías, E; Gómez-Aranda, F; González Pérez, P; Montes-Latorre, E; Serrano-Pozo, A1
Atasever, T; Bakkaloglu, SA; Gursel, T; Kaya, Z; Kocak, U; Oktar, SO1
Andler, W; Menke, T; Niklowitz, P; Wiesel, T1
Chen, XH; Gao, L; Li, ZJ; Liu, Y; Peng, XG; Si, YJ; Wang, JG; Zeng, DF; Zhang, C; Zhang, X1
Dudkin, SA; Fechina, LG; Henze, G; Herold, R; Karachunskiĭ, AI; Lebedev, VV; Makhortykh, TZh; Miakova, NV; Rumiantsev, AG; Rumiantseva, IuV; Shamardina, AV; Stakelberg, A; Timakov, AM; Timofeeva, VN; Varfolomeeva, SR1
Bárdi, E; Bobok, I; Kappelmayer, J; Kiss, C; V Oláh, A1
Attarbaschi, A; Dworzak, MN; Gadner, H; Haas, OA; Kager, L; Koenig, M; Lion, T; Mann, G; Schrappe, M; Strehl, S1
Bartels, DB; Claviez, A; Dördelmann, M; Dynybil, C; Löning, L; Schrappe, M; Stanulla, M1
Chi, HS; Choi, SJ; Im, HJ; Jang, S; Jun, KR; Lee, JH; Lee, KH; Moon, HN; Park, CJ; Seo, JJ1
Aricò, M; Barisone, E; Basso, G; Biondi, A; Casale, F; Conter, V; Lo Nigro, L; Locatelli, F; Luciani, M; Masera, G; Messina, C; Micalizzi, C; Parasole, R; Pession, A; Rizzari, C; Santoro, N; Silvestri, D; Testi, AM; Valsecchi, MG1
Chen, J; Gu, LJ; Li, J; Pan, C; Tang, JY; Xue, HL; Ye, H; Zhao, HJ1
Bajdun, L; Chipsanova, N; Dudkin, S; Fechina, L; Henze, G; Herold, R; Karachunskiy, A; Lebedev, V; Mahortih, T; Maschan, A; Miakova, N; Roumiantseva, J; Rumjanzew, A; Shamardina, A; Timakow, A; Timofeeva, V; Varfolomeeva, S; von Stackelberg, A1
Abella, E; Bastida, P; Bethencourt, C; Bueno, J; del Potro, E; Feliu, E; Fernández-Abellán, P; Grande, C; Heras, I; Oriol, A; Ortega, JJ; Parody, R; Ribera, JM; Sanz, MA; Tormo, M1
Ahn, JS; Han, AR; Jang, JH; Jung, CW; Kang, WK; Kim, K; Kim, WS; Lee, MH1
Erdodi, F; Hajas, G; Kiss, A; Lontay, B; Márkász, L; Oláh, E; Rajnavölgyi, E1
Eguchi, H; Inoue, T; Ishihara, T; Ishii, E; Matsuzaki, A; Miyake, K; Okamura, J; Tsuboi, C; Yanai, F; Yoshida, N1
Heinze, F; Henze, G; Holtgrave, EA1
Berman, E; Lin, S; McBride, M; Menedez-Botet, C; Tong, W1
Annino, L; Crescenzi, S; Ferrari, A; Mandelli, F; Romani, C1
Broekema, G; Giaccone, G; Kaspers, GJ; Klumper, E; Pieters, R; van Ark-Otte, J; van Wering, ER; Veerman, AJ1
Behm, FG; Boyett, JM; Hancock, ML; Krance, RA; Mahmoud, HH; Pui, CH; Raimondi, SC; Relling, MV; Ribeiro, RC; Sandlund, JT1
Aricò, M; Basso, G; Colella, R; Conter, V; Messina, C; Miniero, R; Mori, PG; Rizzari, C; Testi, AM; Valsecchi, MG1
Davies, HA; Didcock, E; Didi, M; Ogilvy Stuart, AL; Shalet, SM; Wales, JK1
Bosco, I; Teh, A1
Eviatar, L; Grossman, R; Karayalycin, G; Lanzkowsky, P; Maytal, J; Schaul, N; Shende, AC; Yusuf, FH1
Lizard, G; Lizard-Nacol, S; Maynadié, M; Poupon, MF; Roignot, P1
Aster, JC; Inhorn, RC; Roach, SA; Slapak, CA; Soiffer, R; Stone, RM; Tantravahi, R1
Abe, T; Hirao, A; Kawano, Y; Okamoto, Y; Saito, S; Sato, J; Shimizu, T; Suzue, T; Takaue, Y; Watanabe, T1
de Stefano, V; Gugliotta, L; Leone, G; Mandelli, F; Mazzucconi, MG1
Eden, OB; Eynaud, P; Perry, P; Slavotinek, A; Steel, CM; Thomson, A1
Hählen, K; Kaspers, GJ; Pieters, R; Van Wering, ER; Van Zantwijk, I; Veerman, AJ1
Fujisawa, S; Fukawa, H; Kodama, F; Maruta, A; Murata, T; Ogawa, K; Sakai, R; Sasaki, S; Taguchi, J; Tomita, N1
Burns, CP; Davey, FR; Dodge, RK; Duggan, D; Frankel, SR; Larson, RA; Lee, EJ; Schulman, P; Sobol, RE; Stone, RM1
Fydryk, J; Kamieńska, E; Krygier-Stojałowska, A; Peregud-Pogorzelski, J; Urasiński, T1
Bailey, CC; Duggal, MS; O'Sullivan, EA1
Agretto, A; Auricchio, U; Casale, F; Giuliano, M; Iacono, A; Iarussi, D; Indolfi, P; Murano, A1
den Boer, ML; Huismans, DR; Klumper, E; Loonen, AH; Pieters, R; Veerman, AJ1
Artaza, M; Burgos, R; Cavero, MA; Maicas, C; Oteo, JF; Pulpón, LA; Rubio, JA; Serrano-Fiz, S; Silva, L; Téllez, G1
Andolina, M; Arrighini, A; Barisone, E; Brach del Prever, A; Leone, L; Madon, E; Massara, FM; Miniero, R; Saroglia, EM; Soldano, S1
Cianfriglia, M; Eisterer, W; Gotwald, M; Hilbe, W; Hofmann, J; Ludescher, C; Thaler, J; Zabernigg, A1
Bach, QK; Bastion, Y; Bosly, A; Christian, B; Corront, B; Danaïla, C; Dufour, P; Gratecos, N; Leblay, R; Thomas, X1
Büssing, A; Mertens, R; Rubbert, F1
Ohno, R1
Boutagy, J; Galettis, P; Ma, DD1
Bettelheim, P; Geissler, K; Jäger, U; Knöbl, P; Kyrle, PA; Laczika, K; Mitterbauer, G; Neumann, E; Scherrer, R; Schneider, B1
Advani, IM; Gopal, R; Nadkarni, K; Pai, S; Pai, V; Parikh, P; Raje, N; Saikia, T; Vaidya, S1
Andreeff, M; Godfrey, L; Hegewisch-Becker, S; Maslak, P1
Bhushan, V; Chandy, M; Dennison, D; Kudva, GC; Srivastava, A1
Chan, LC; Chan, TK; Chiu, EK; Kwong, YL; Liang, R; Lie, A; Todd, D1
Djaldetti, M; Floru, S; Mittelman, M1
Ambrosetti, A; Cassibba, V; Meneghini, V; Nadali, G; Perona, G; Pizzolo, G; Tecchio, C; Todeschini, G; Veneri, D; Zanotti, R1
Gururangan, S; Horner, M; Marina, NM; Rodman, JH1
Bessho, F; Hayashi, Y; Kamoshita, S; Kinumaki, H; Kobayashi, M; Yokota, S1
Akashi, K; Eto, T; Harada, M; Harada, N; Inaba, S; Niho, Y; Okamura, T; Takamatsu, Y; Teshima, T1
Heller, G; Meyers, P; Redner, A; Steinherz, L; Steinherz, PG; Tan, C1
Berman, E1
Durrant, IJ; Richards, SM1
Armata, J; Balwierz, W; Bogusławska-Jaworska, J; Chybicka, A; Jackowska, T; Jakowicka, M; Kulus, M; Matysiak, M; Michalewska, D; Ochocka, M1
Breneman, JC; Cherlow, JM; Gaynon, PS; Grossman, NJ; Hammond, GD; Johnstone, HS; Kersey, JH; Sather, HN; Steinherz, PG; Trigg, ME1
de Waal, FC; Hählen, K; Kaspers, GL; Klumper, E; Pieters, R; van Wering, ER; van Zantwijk, I; Veerman, AJ1
Chen, LM; Huang, SH; Hwang, WS; Tseng, MT; Wang, CC1
Büchner, T; Freund, M; Heil, G; Hiddemann, W; Hoelzer, D; Löffler, H; Ludwig, WD; Maschmeyer, G; Thiel, E; Völkers, B1
Andrea, M; Aranega, V; Brandalise, S; Odone, V; Pereira, W; Zanichelli, M1
Bailey, CC; Curzon, ME; Duggal, MS; Hart, P; O'Sullivan, EA1
Goldman, J; Morleda, J; Mughal, T1
Fujioka, K; Funabiki, T; Hanzawa, N; Ikuta, K; Kai, S; Kajigaya, Y; Okuyama, T; Sekiguchi, H; Sumita, H; Takahashi, H1
Akutsu, M; Furukawa, Y; Imagawa, S; Iwama, A; Komatsu, N; Kurata, H; Suzuki, T; Tsunoda, J; Tsunoda, S; Yoshida, M1
Falletta, JM; Hvizdala, E; Katz, JA; Murphy, SB; Schwenn, M; Shuster, J1
Hählen, K; Huismans, DR; Kaspers, GJ; Loonen, AH; Pieters, R; van Wering, ER; Veerman, AJ1
Adair, S; Camitta, BM; Casper, JT; Civin, CI; Graham, M; Kiefer, G; Lauer, SJ; Leventhal, BG; Mahoney, DH; Shuster, JJ1
Ohyashiki, JH; Ohyashiki, K; Toyama, K1
Ikeda, K; Kubota, Y; Murata, M; Nagai, M; Ohnishi, H; Sasaki, K; Takahara, J; Tanaka, T; Taoka, T; Tasaka, T1
Andresen, SW; Bergfeld, WF; Thorisdottir, K; Tomecki, KJ1
Dunphy, CH; Kitchen, S; Saravia, O; Velasquez, WS1
Mempel, K; Pfetsch, M; Reiter, A; Riehm, H; Schrappe, M; Schwab, G; Welte, K1
Amley, J; Chan, PK; Koller, CA; Qi, Y1
Bleyer, WA; Breneman, JC; Chappell, R; Cherlow, JM; Gaynon, PS; Grossman, NJ; Hammond, D; Johnstone, HS; Kersey, JH; Sather, HN; Steinherz, PG; Trigg, ME1
Broxterman, HJ; Eekman, CA; Feller, N; Lankelma, J; Löwenberg, B; Ossenkoppele, GJ; Pinedo, HM; Schoester, M; Schuurhuis, GJ; Sonneveld, P; Währer, DC1
Cleary, ML; Davis, RE; Kamel, OW; Soslow, RA; Warnke, RA1
Bradstock, K; Brisco, J; Enno, A; Hughes, E; McCaul, K; Morley, AA; Neoh, SH; Sykes, PJ; Szer, J1
Grander, D; Heyman, M; Jeddi-Tehrani, M; Johansson, B; Liu, Y; Nordgren, A; Ost, A; Rasool, O; Wallberg, B1
Bartram, CR; Borkhardt, A; Harbott, J; Janka-Schaub, G; Janssen, JW; Kabisch, H; Lampert, F; Ludwig, WD; Ratei, R; Reinisch, I; Repp, R; Riehm, H; Ritterbach, J; Schlieben, S; Schrappe, M; Zimmermann, M1
Tomaszewska, B; Zoch-Zwierz, WM1
Barbui, T; Bassan, R; Lerede, T; Rambaldi, A1
Okamura, J; Tsuruchi, N1
Corden, TE; Morgan, ER1
Morland, BJ; Shaw, PJ1
Sauerbrey, A; Stammler, G; Volm, M; Zintl, F2
Aumann, V; Blum, WF; Kluba, U; Mittler, U; Mohnike, KL; Vorwerk, P1
Ames, MM; Bleyer, WA; Feig, SA; Gerber, M; Harris, RE; Leonard, M; Pendergrass, TW; Reid, JM; Sather, HN; Steinherz, L; Trigg, M; Warkentin, P1
Aziz, Z; Mahmood, R; Maqbool, S; Zahid, M1
Buendia, MT; Lozano, JM; Terselich, G; Viscaino, MP1
Bull, C; Chessells, J; Levitt, G; Sorensen, K; Sullivan, I1
Arai, Y; Masuda, M; Mizoguchi, H; Motoji, T; Okamura, T; Wada, M1
Burke, PJ; Gore, SD; Karp, JE; Kaufmann, SH1
Flexner, JM; Goodman, S; Greer, JP; Stein, RS; Wolff, SN1
Abenhardt, W; Diem, H; Gieseler, F; Gullis, E; Kolb, HJ; Langenmayer, I; Nüssler, V; Pelka-Fleischer, R; Schmitt, R; Wilmanns, W; Wohlrab, A; Zwierzina, H1
Hanada, R; Hongo, T; Horikoshi, Y; Sakurai, M; Yajima, S1
Gaynon, PS; Lukens, JN; Nachman, J; Sather, HN; Trigg, ME; Wolff, L1
Gibson, BE; Hann, IM; Hill, FG; Lilleyman, JS; Richards, SM; Stevens, RF; Will, AM1
Geissler, D; Geissler, K; Heinz, R; Hinterberger, W; Hubmann, E; Jaeger, U; Knöbl, P; Koller, E; Kyrle, P; Lechner, K; Linkesch, W; Mannhalter, C; Niederwieser, D; Pabinger, I; Schwarzinger, I; Thalhammer, R1
Fujimoto, T1
Aricó, M; Basso, G; Conter, V; Dördelmann, M; Ludwig, WD; Masera, G; Reiter, A; Riehm, H; Rizzari, C; Schrappe, M; Valsecchi, MG; Zimmermann, M1
Beck, JD; Berger-Jones, K; Hertzberg, H; Huk, WJ; Korinthenberg, R; Langer, T; Meier, W; Skirl, G; Strassburg, HM; Ueberall, MA; Wenzel, D1
Bouabdallah, R; Broustet, A; Cahn, JY; Cazin, B; Cony-Makhoul, P; Cordonnier, C; Delannoy, A; Dreyfus, F; Fière, D; Gay, C; Michaux, JL; Sadoun, A; Sebban, C; Vernant, JP1
Bradley, SJ; Gosriwitana, I; Hider, RC; Porter, JB; Srichairatanakool, S1
April, F; Meneghini, V; Perona, G; Pizzolo, G; Ricetti, MM; Solero, P; Tecchio, C; Todeschini, G; Veneri, D; Zanotti, R1
Amemiya, Y; Furukawa, Y; Hoshino, M; Imagawa, S; Izumi, T; Kawano, C; Kirito, K; Komatsu, N; Kuribara, R; Miura, Y; Miyazato, A; Muroi, K; Omine, K; Otsuki, T; Shimizu, R; Suzuki, T; Tabata, M; Takahashi, H; Takatoku, M; Terui, Y; Tomizuka, H; Toshima, M; Tsunoda, J; Uchida, M; Yoshida, M1
Li, S; Wang, C; Yao, C1
den Boer, ML; Henze, G; Janka-Schaub, GE; Kazemier, KM; Pieters, R; Veerman, AJ2
Agaoglu, L; Anak, S; Aytepe, Z; Devecioglu, O; Gedikoglu, G; Guven, Y; Ozerkan, AG; Sepet, E; Yalman, N1
Bailey, C; Burrett, J; Chessells, J; Hann, I; Hill, F; Richards, S1
Black, P; Gutjahr, P; Stopfkuchen, H1
Bruserud, O1
Eden, OB; Hann, IM; Hill, FG; Richards, SM1
den Boer, ML; Durian, M; Janka, G; Kaspers, GJ; Pieters, R; Schmiegelow, K; van Wering, ER; Veerman, AJ1
Archimbaud, E; Fiere, D; Thomas, X1
Aricò, M; Basso, G; Biondi, A; Conter, V; De Rossi, G; Di Tullio, MT; Lo Nigro, L; Masera, G; Messina, C; Miniero, R; Mori, PG; Pession, A; Rizzari, C; Rondelli, R; Santoro, N; Silvestri, D; Tamaro, P; Testi, A; Valsecchi, MG1
Anami, K; Asami, K; Chin, M; Fujimoto, T; Hatae, Y; Hirota, T; Horikoshi, Y; Ito, M; Iwai, A; Kaneko, Y; Katano, N; Kataoka, S; Kikuchi, M; Koizumi, S; Miyawaki, T; Mugisima, H; Nakayama, M; Nishikawa, K; Osima, K; Suzumiya, J; Taga, T; Tanaka, A; Tsurusawa, M; Watanabe, A; Yanase, T1
Mauger, DC; Skeen, JE1
Cheung, AY; Chik, KW; Lai, HD; Lam, TK; Li, CK; Ng, MH; Shing, MM; Yuen, PM1
Bernacer Borja, M; Contra Gómez, T; Gil López, C; López Pérez, J; Martín Ramos, N; Melero Moreno, C; Palacios López, ME; Torres Valdivieso, MJ; Valverde Moreno, F; Vivanco Martínez, JL1
Kaleita, TA; MacLean, WE; Reaman, GH; Sather, HN; Whitt, JK1
Gadner, H; Gaiger, A; Haas, OA; Heinze, G; Linnerth, B; Lion, T; Mann, G; Schmid, D; Tisljar, K1
Den Boer, ML; Janka-Schaub, GE; Kapaun, P; Kazemier, KM; Pieters, R; Veerman, AJ1
Cortes, J; Estey, E; Giles, F; Kantarjian, H; Keating, M; O'Brien, S1
Mandelli, F; Montefusco, E1
Bueno, J; Julià, A; Villalba, T; Zuazu, J1
Fasching, K; Gadner, H; Panzer, S; Panzer-Grümayer, ER; Schneider, M1
Boyett, JM; Buchanan, GR; Chauvenet, AR; Crist, WM; Maybee, DA; Pinkel, D; Pollock, BH; Rivera, GK; Wagner, H1
Eden, OB; Gibson, B; Hann, I; Hill, F; Kinsey, S; Lilleyman, J; Mitchell, C; Richards, S; Vora, A1
Armata, J; Balcerska, A; Balwierz, W; Bogusławska-Jaworska, J; Bubała, H; Chybicka, A; Filiks-Litwin, B; Gorczyńska, E; Juszczak, K; Kowalczyk, J; Kołecki, P; Lukowska, K; Matysiak, M; Rokicka-Milewska, R; Rola-Kurc, E; Sońta-Jakimczyk, D; Stencel, D; Strojny, W; Wachowiak, J; Wieczorek, M; Wysocki, M; Zelenay, E1
Armata, J; Bogusławska-Jaworska, J; Bubała, H; Dłuzniewska, A; Kazanowska, B; Kowalczyk, J; Kołecki, P; Matysiak, M; Rokicka-Milewska, R; Sońta-Jakimczyk, D; Sopyło, B; Stańczak, E; Stefaniak, MJ; Stefańska, K; Wróbel, G1
Chen, J; Jiang, S; Li, J1
Berg, A; Bink-Boelkens, MT; Kamps, WA; Postma, A; Rammeloo, LA; Sobotka-Plojhar, MA; Veerman, AJ1
Jansen, P; Ludwig, WD; Mann, G; Neth, O; Reiter, A; Riehm, H; Seidemann, K; Tiemann, M1
Göbel, U; Junker, R; Mauz-Körholz, C; Nowak-Göttl, U1
Gao, H; Ren, X; Wang, S1
Diaz, MA; Garcia-Sanchez, F; Madero, L; Martinez, P; Ruano, D; Tutor, O1
Baranov, AE; Konchalovskiĭ, MV; Melkova, KN; Obukhova, EE; Tugova, SV1
Lange, B1
Behm, FG; Boyett, JM; Campana, D; Coustan-Smith, E; Hancock, ML; Pui, CH; Raimondi, SC; Ribeiro, RC; Rivera, GK; Rubnitz, JE; Sancho, J; Sandlund, JT1
Huismans, DR; Pieters, R; Schuurhuis, GJ; Styczynski, J; Veerman, AJ; Wysocki, M1
Blazek, B; Gajdos, P; Hak, J; Hrstkova, H; Jabali, Y; Mihál, V; Mydlil, J; Starý, J; Timr, P1
Baggio, G; Casolari, C; Castelli, M; Cermelli, C; Lupo, L; Malagoli, M; Riccomi, TR; Zanca, A1
Hirayama, Y; Honma, H; Kudo, T; Kuribayashi, K; Morii, K; Niitsu, Y; Nishihori, Y; Sakamaki, S; Sato, Y; Suzuki, N; Yamauchi, N1
Auvrignon, A; Baruchel, A; Bellenger, P; Bellott, R; Bertrand, Y; Gandemer, V; Leblanc, T; Leverger, G; Méchinaud, F; Pérel, Y; Robert, J; Vernois, J1
Bieri, S; Chapuis, B; Helg, C; Miralbell, R1
Anderson, JJ; Angus, B; Hall, AG; Horne, CH; Lodge, AJ; McIntosh, GG; Reid, MM; Steward, M1
Behard, C; Benoit, Y; Boutard, P; Dastugue, N; Dresse, MF; Ferster, A; Lutz, P; Marguerite, G; Mazingue, F; Mechinaud, F; Millot, F; Norton, L; Otten, J; Philippe, N; Philippet, P; Plantaz, D; Plouvier, E; Rialland, X; Robert, A; Suciu, S; Thyss, A; Uyttebroeck, A; Vilmer, E; Waterkeyn, C1
Eden, O; Gibson, B; Hann, I; Harrison, C; Harrison, G; Hill, F; Richards, S; Vora, A1
Akiyoshi, K; Eguchi, H; Hara, T; Inada, H; Ishii, E; Koga, H; Matsuzaki, A; Miyazaki, S; Nagatoshi, Y; Nakayama, H; Nibu, K; Okamura, J; Take, H; Tamai, Y; Yanai, F1
Kanda, Y; Mineishi, S; Murakami, J; Ogasawara, T; Saito, T; Seo, S; Shoji, N; Takaue, Y; Tanosaki, R; Tobinai, K1
Aricò, M; Basso, G; Conter, V; De Rossi, G; Favre, C; Indolfi, P; Lo Nigro, L; Madon, E; Miniero, R; Paolucci, G; Pession, A; Porta, F; Rondelli, R; Santoro, N; Vecchi, V1
Fletcher, BD; Harrison, PL; Kaste, SC; Kennedy, W; Neel, MD; Pui, CH; Razzouk, BI; Relling, MV; Ribeiro, RC; Rubnitz, JE; Sandlund, JT1
Bernard, M; Casassus, P; Delain, M; Desablens, B; Guilhot, F; Hunault-Berger, M; Ifrah, N; Jouet, JP; Milpied, N; Sadoun, A1
Eder, J; Heitger, A; Meister, B; Moritz, B1
Akiyoshi, K; Ayukawa, H; Eguchi, H; Ishii, E; Kamizono, J; Kawakami, K; Kinukawa, N; Koga, H; Kuroda, H; Matsuzaki, A; Okamura, J; Tamai, Y; Yanai, F1
Chen, X; Wang, J; Wang, Q1
Adachi, S; Akiyama, Y; Hamahata, K; Kubota, M; Lin, YW; Nakahata, T; Watanabe, K1
Han, M; He, H; Li, C1
Gadner, H; Grenzebach, J; Ludwig, WD; Parwaresch, R; Reiter, A; Riehm, H; Schrappe, M; Zimmermann, M1
Kopecna, L1
Bruggers, CS; Carroll, WL; Liu, T; Moos, PJ; Perkins, SL; Raetz, E; Smith, F1
Baccarani, M; Damiani, D; Ermacora, A; Fanin, R; Geromin, A; Masolini, P; Michelutti, A; Michieli, M; Russo, D; Stocchi, R1
Botsonis, A; Moschovi, M; Papadopoulou, AL; Tsangaris, GT; Tzortzatou-Stathopoulou, F1
Cortes, J; Estrov, Z; Faderl, S; Giles, FJ; Huh, YO; Kantarjian, HM; O'Brien, S; Pierce, S; Ravandi, F; Thomas, D1
Damon, L; Linker, C; Navarro, W; Ries, C1
Armata, J; Boguslawska-Jaworska, J; Derwich, K; Juszczak, K; Klus, K; Kolecki, P; Kowalczyk, J; Krauze, A; Matysiak, M; Pawelec, K; Pisarek, J; Rokicka-Milewska, R; Skoczen, S; Sońta-Jakimczyk, D; Styczyński, J; Tomaszewska, R; Wisniewska-Slusarz, H; Wysocki, M; Łuszczynska, A1
Armata, J; Balcerska, A; Balwierz, W; Bogusławska-Jaworska, J; Bubala, H; Chybicka, A; Filiks-Litwin, B; Gorczyńska, E; Kowalczyk, J; Kołecki, P; Matysiak, M; Rokicka-Milewska, R; Rola-Kurc, E; Sonta-Jakimczyk, D; Stencel, D; Strojny, W; Wachowiak, J; Wieczorek, M; Wysocki, M; Zelenay, E; Łukowska, K1
Jastrzebska, M; Lukowska, K; Pacholska, J; Paciorkiewicz, W; Rokicka-Milewska, R1
Bailly, F; Caillot, D; Carli, PM; Chavanet, P; Devilliers, E; Guy, H; Mugneret, F; Petrella, T; Solary, E; Waldner, A1
Broxterman, HJ; Hählen, K; Hongo, T; Huismans, DR; Loonen, AH; Pieters, R; Veerman, AJ1
Humphries, JE; Lee, JT1
Annino, L; Defazio, D; Gugliotta, L; Leone, G; Mandelli, F; Mattioli-Belmonte, M; Mazzucconi, MG; Tura, S1
Hählen, K; Huismans, DR; Loonen, AH; Peters, GJ; Pieters, R; van der Does-van den Berg, A; van Wering, ER; Veerman, AJ1
Bajko, G; Drozdowska, D; Hansz, J; Woźny, T1
Cotterill, S; Eden, OB; Gerrard, M; Hann, I; Imeson, J; Pinkerton, CR1
Armata, J; Balwierz, W; Skoczeń, S; Tacik, J1
Abakumov, EM; Isaev, VG; Kucher, RA; Parovichnikova, EN; Savchenko, VG1
Büchner, T; Hiddemann, W; Kewer, U; Reuter, C; Rolf, C; Schleyer, E; Uhrmeister, C; Unterhalt, M; Wörmann, B; Zühlsdorf, M1
Bloomfield, CD; Davey, F; Dodge, RK; Hooberman, AL; Larson, RA; Schiffer, C; Sobol, RE; Spino, C; Westbrook, CA; Wurster-Hill, DH1
Brugiatelli, M; Callea, V; Holowiecki, J; Kachel, L; Kardos, G; Koehler, M; Krzemien, S; Lutz, D; Rewesz, T; Zintl, Z1
Frisch, H; Schuster, E; Thun-Hohenstein, L1
Ciechanowska, U; Konopacka, M; Rytwiński, K; Sońta-Jakimczyk, D1
Sasaki, A; Tsukaguchi, M1
Kryzhanovskiĭ, OI; Maschan, AA; Samochatova, EV1
Di Mario, A; Etuk, B; Leone, G; Pagano, L; Salutari, P; Sica, S1
McCauley, DL1
Andrew, M; Barr, RD; Cairney, AE; DeVeber, LL; Halton, J; Pai, KM; Whitton, AC1
Batley, R; Cecalupo, AJ; Egorin, MJ; Lo, WD; Mortensen, ME1
Bancillon, A; Baruchel, A; Bergeron, C; Leblanc, T; Lejars, O; Lepage, E; Leverger, G; Perel, Y; Schaison, G; Sommelet, D1
Jiménez, E; Kohan, R; Pavlovsky, S; Rosso, A; Sackmann Muriel, F; Santarelli, MT; Svarch, E1
Annino, L; Camera, A; Ciolli, S; Deplano, W; Fabiano, F; Ferrara, F; Ladogana, S; Mandelli, F; Muti, G; Vegna, ML1
Andersen, JW; Bennett, JM; Cassileth, PA; Hoagland, HC; Mazza, JJ; O'Connell, MC; Paietta, E; Wiernik, P1
Ames, MM; Kuffel, MJ; Reid, JM1
Grimfors, G; Järnmark, M; Lerner, R; Ljungman, P; Lönnqvist, B; Nyström-Rosander, C; Oberg, G; Palmblad, J; Samuelsson, J1
Berman, E; McBride, M1
Armata, J; Balwierz, W; Bogusławska-Jaworska, J; Chybicka, A; Cyklis, R; Derulska, D; Duczmal, B; Jackowska, T; Jakowicka, M; Rokicka-Milewska, R1
Chojnowski, G; Kriegler, AB; Linsenmeyer, ME; Nink, V; Sawyer, WH; Webster, LK; Woodcock, DM1
Galbraith, A; Smith, PJ; Spink, J; Yeung, ST; Yoong, C1
Hählen, K; Huismans, DR; Loonen, AH; Pieters, R; van der Does-van den Berg, A; van Wering, ER; Veerman, AJ1
Cumber, PM; Hoy, T; Jacobs, A; Padua, RA; Tsuruo, T; Whittaker, JA1
Eguiguren, JM; Pui, CH1
Diedrich, H; Freund, M; Ganser, A; Gramatzki, M; Haas, R; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Kuse, R1
Bayle, C; Brugières, L; Caillaud, JM; Flamant, F; Hartmann, O; Kalifa, C; Lemerle, J; Patte, C; Valteau-Couanet, D1
Baum, E; Feig, SA; Harris, RE; Holcenberg, JS; Kaizer, H; Krailo, MD; Pendergrass, TW; Saunders, EF; Steinherz, L; Warkentin, PL1
Bancillon, A1
Bender-Götze, C; Dopfer, R; Ebell, W; Ehninger, G; Friedrich, W; Gadner, H; Henze, G; Klingebiel, T; Peters, C; Riehm, H1
Armata, J; Balwierz, W; Bogusławska-Jaworska, J; Chybicka, A; Cyklis, R; Darmal, B; Derulska, D; Jackowska, T; Jakowicka, M; Rokicka-Milewska, R1
Deforest, A; Ridgway, D; Wolff, LJ1
Hählen, K; Huismans, DR; Loonen, AH; Pieters, R; Veerman, AJ1
Cuttner, J; Davey, FR; Ellison, RR; Glicksman, AS; Henderson, ES; Mick, R; Royston, I; Schiffer, CA; Silver, RT; Woliver, T1
Budman, DR; Cuttner, J; Davey, F; Henderson, ES; Lee, EJ; Mayer, RJ; Mick, R; Paciucci, PA; Sobol, R; Weiss, RB1
Hellmann, A; Koberda, J1
Boyett, JM; Buchanan, GR; Crist, WM; Ghim, T; Johnson, W; Pollock, BH; Smith, SD; Vietti, TJ; Wharam, MD; Yanofsky, RA1
Eden, OB; Lilleyman, JS; Peto, J; Richards, S; Shaw, MP1
Kovrigina, TI; Mendeleev, IM; Polezhaev, IuN1
De Boben, M; Diedrich, H; Freund, M; Ganser, A; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Knauf, U; Koch, P1
Fengler, R; Henze, G; Reiter, A; Riehm, H; Ritter, J1
Goebel, U; Graubner, U; Haas, RJ; Janka-Schaub, GE; Juergens, H; Spaar, HJ; Winkler, K1
Andreeff, M; Haimi, J; Hegewisch, S; Jhanwar, S; Redner, A; Steinherz, P1
Nachman, J1
Belasco, JB; Luery, N; Scher, C1
Broekema, GJ; Dirven, MW; Hählen, K; Heyenbrok, MW; Huismans, DR; Loonen, AH; Pieters, R; Veerman, AJ1
Eden, OB; Micallef-Eynaud, P1
Bladé, J; Carreras, E; Cervantes, F; Grañena, A; Marín, P; Nomdedeu, B; Ribera, JM; Rozman, C; Sierra, J; Urbano-Ispizua, A1
Ekberg, M; Larsson, R; Nygren, P; Slater, L1
Bordessoule, D; Brière, J; David, B; Desablens, B; Fière, D; Gorin, NC; Harousseau, JL; Hayat, M; Marty, M; Solal-Celigny, P1
Bernard, P; Boiron, JM; Marit, G; Reiffers, J; Rice, A; Vezon, G1
Bell, DR; Davey, RA; Haber, M; Kavallaris, M; Norris, MD; Stewart, BW; White, L1
Hayashi, N; Inagaki, N; Matuzaki, T; Nakada, H; Nishimura, M; Nonaka, K; Osada, K; Sekito, N; Takahashi, I; Takeuchi, M1
Ikeda, Y; Ito, E; Ito, R; Miyano, T; Onodera, N; Saito, T; Sato, Y; Suto, Y; Tachibana, N; Tateoka, N1
Ihle, H; Ihle, R; Matthes, H1
Arlin, ZA1
de Koning, J; Rammeloo, JA; Solbu, G; Suciu, S; van 't Veer, MB; van der Does-van den Berg, A; van Wering, ER; van Zanen, GE1
Baba, Y; Fujieda, H; Hojo, H; Ohyashiki, JH; Ohyashiki, K; Toyama, K1
Alekseev, NA; Zil'berman, MV1
Castaman, G; Castronovo, S; Cortesi, S; Dini, E; Quaglio, R; Rodeghiero, F; Soffiati, G1
Hoffbrand, AV; O'Connor, NT; Prentice, HG1
Caro, J; Erslev, AJ; Piroso, E1
Chan, PK; Slater, LM; Sweet, P1
Mandelli, F; Petti, MC1
Benninger, C; Brandeis, WE; Lichter-Konecki, U; Matthis, P; Scheffner, D1
Amadori, S; Bagnulo, S; Carli, M; Dini, G; Guazzelli, C; Mandelli, F; Masera, G; Rossi, MR; Zanesco, L; Zurlo, MG1
Darbyshire, PJ; Mott, MG; Nesbit, ME; Pearson, AD1
Burnelli, R; Mancini, AF; Paolucci, G; Paolucci, P; Pession, A; Rosito, P; Serra, L; Vecchi, V; Vivarelli, F1
Boyett, JM; Buchanan, GR; Chauvenet, AR; Crist, WM; Rivera, GK; Vietti, TJ1
Gorin, NC; Isnard, F; Laporte, JP; Lemonnier, MP; Najman, A1
Javier, G; Olivé, T; Ortega, JJ1
Brugués, R; Grañena, A; Ribera, JM; Rozman, C; Sierra, J; Urbano-Ispizua, A1
Boyett, J; Buchanan, GR; Murphy, SB; Winick, N; Yu, A1

Reviews

23 review(s) available for daunorubicin and Acute Lymphoid Leukemia

ArticleYear
[Acute lymphoblastic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cyclophosphamide; Dasatinib; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Humans; Imatinib Mesylate; Methotrexate; Middle Aged; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Protein-Tyrosine Kinases; Pyrimidines; Thiazoles; Young Adult

2014
Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.
    Blood, 2017, 04-06, Volume: 129, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cyclophosphamide; Daunorubicin; Humans; Induction Chemotherapy; Male; Methotrexate; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine

2017
AML1 amplification in a child with acute lymphoblastic leukemia.
    Cancer genetics and cytogenetics, 2003, Jan-01, Volume: 140, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Chromosome Aberrations; Chromosome Painting; Chromosomes, Human, Pair 21; Core Binding Factor Alpha 2 Subunit; Cyclophosphamide; Daunorubicin; DNA-Binding Proteins; Female; Gene Amplification; Humans; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Proto-Oncogene Proteins; Remission Induction; Transcription Factors; Vincristine

2003
[Results and suggestion from comparing between world excellent protocols of childhood acute lymphoblastic leukemia].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2003, Volume: 41, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Cyclophosphamide; Daunorubicin; Humans; Internationality; Leucovorin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Survival Rate; Treatment Outcome; Vincristine

2003
A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.
    Blood, 1995, Apr-01, Volume: 85, Issue:7

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carboplatin; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 8; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Eosinophilia; Etoposide; Fatal Outcome; Female; Humans; Hydroxyurea; Hyperplasia; Ifosfamide; Leukemia, Myeloid; Lymph Nodes; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Syndrome; Translocation, Genetic; Vincristine

1995
[A heart transplant in a patient with doxorubicin-induced myocardiopathy as a complication of the treatment of a lymphoma].
    Revista espanola de cardiologia, 1994, Volume: 47, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathy, Dilated; Cyclophosphamide; Daunorubicin; Doxorubicin; Heart Transplantation; Humans; Male; Methotrexate; Myocardium; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Time Factors; Vincristine

1994
[Progress of chemotherapy in adult acute leukemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Disease-Free Survival; Humans; Leukemia, Myeloid, Acute; Mercaptopurine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Remission Induction; Survival Rate

1995
A review of idarubicin in acute leukemia.
    Oncology (Williston Park, N.Y.), 1993, Volume: 7, Issue:10

    Topics: Adult; Aged; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Daunorubicin; Europe; Humans; Idarubicin; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome; United States

1993
Therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: possible use of interferon on the basis of some novel concepts.
    Leukemia & lymphoma, 1993, Volume: 9, Issue:1-2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Female; Gene Rearrangement; Genes, abl; Humans; Immunologic Factors; Interferon-alpha; Male; Mercaptopurine; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine

1993
Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
    American journal of hematology, 1996, Volume: 51, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Bone Marrow; Chromosome Deletion; Chromosomes, Human, Pair 5; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Progression; Flow Cytometry; Humans; Immunophenotyping; Male; Mercaptopurine; Methotrexate; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Primary Myelofibrosis; Remission Induction; Vincristine

1996
Role of anthracyclines in the treatment of adult acute lymphoblastic leukemia.
    Acta haematologica, 1996, Volume: 95, Issue:3-4

    Topics: Adult; Antibiotics, Antineoplastic; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Humans; Idarubicin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction

1996
[Polycythemia vera progressing to acute lymphoblastic leukemia after 13 years].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Middle Aged; Polycythemia Vera; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Time Factors; Vincristine

1996
[Recent advances on the treatment of acute childhood leukemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Disease-Free Survival; Doxorubicin; Humans; Leukemia, Myeloid, Acute; Mercaptopurine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Remission Induction; Survival Rate; Treatment Outcome; Vincristine

1997
[Treatment of acute and chronic leukemias].
    Recenti progressi in medicina, 1999, Volume: 90, Issue:11

    Topics: Acute Disease; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosome Aberrations; Combined Modality Therapy; Daunorubicin; Humans; Idarubicin; Karyotyping; Leukemia; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Transplantation, Autologous; Transplantation, Homologous

1999
[Effects of chemotherapy on the changes of histology and function of the ovary].
    Zhonghua fu chan ke za zhi, 1998, Volume: 33, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Daunorubicin; Female; Fluorouracil; Humans; Methotrexate; Ovary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

1998
The management of neoplastic disorders of haematopoiesis in children with Down's syndrome.
    British journal of haematology, 2000, Volume: 110, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Down Syndrome; Female; Genetic Predisposition to Disease; Humans; Infant; Infant, Newborn; Leukemia; Leukemia, Myeloid; Male; Maternal Age; Myeloproliferative Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vincristine

2000
Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.
    International journal of hematology, 2001, Volume: 73, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Height; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Growth Disorders; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Infant; Japan; Male; Methotrexate; Myelodysplastic Syndromes; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Survivors; Treatment Outcome; Vincristine

2001
Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Daunorubicin; Disease-Free Survival; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Genes, Immunoglobulin; Humans; Immunoglobulin Heavy Chains; Infant; Leukemia-Lymphoma, Adult T-Cell; Life Tables; Male; Methotrexate; Neoplasm, Residual; Polymerase Chain Reaction; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Retrospective Studies; Risk; Survival Analysis; Survival Rate; Treatment Outcome; Vincristine

2001
Aggressive chemotherapy for acute leukemia relapsed after bone marrow transplantation: a second chance?
    Acta haematologica, 1992, Volume: 87, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chemotherapy, Adjuvant; Cytarabine; Daunorubicin; Humans; Idarubicin; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Time Factors; Vincristine

1992
Treatment of adult acute leukemia.
    Clinical pharmacy, 1992, Volume: 11, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prevalence; Prognosis; Remission Induction; United States

1992
Therapy for childhood non-Hodgkin's lymphomas, nonlymphoblastic type. Review of recent studies and current recommendations.
    The American journal of pediatric hematology/oncology, 1990,Fall, Volume: 12, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Brain Neoplasms; Cell Differentiation; Child; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Daunorubicin; Doxorubicin; France; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Multicenter Studies as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Rate; United States; Vincristine

1990
Mitoxantrone and amsacrine: two important agents for the treatment of acute myelogenous leukemia (AML) and acute lymphoblastic leukemia (ALL).
    Bone marrow transplantation, 1989, Volume: 4 Suppl 1

    Topics: Amsacrine; Daunorubicin; Drug Evaluation; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction

1989
[Transient hypofibrinogenemia induced by prednisolone in a case of acute lymphoblastic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:7

    Topics: Afibrinogenemia; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Mercaptopurine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine

1989

Trials

137 trial(s) available for daunorubicin and Acute Lymphoid Leukemia

ArticleYear
Characterizing Iranian Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia Through Gene Expression Profiling of Common ATP Binding Cassette Transporters Subfamily C.
    Journal of pediatric hematology/oncology, 2020, Volume: 42, Issue:1

    Topics: Adolescent; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Humans; Infant; Iran; Male; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence

2020
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.
    Leukemia, 2020, Volume: 34, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Time; Treatment Outcome; Vincristine

2020
Characteristics of Blood Transfusion During Induction Remission in Children With Acute Lymphoblastic Leukemia: A Single-Center Retrospective Investigation.
    Journal of pediatric hematology/oncology, 2020, Volume: 42, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Transfusion; Child; Child, Preschool; Combined Modality Therapy; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Risk Factors; Vincristine

2020
Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.
    Pediatric blood & cancer, 2017, Volume: 64, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Gene Expression Regulation, Leukemic; Gene Rearrangement; Humans; Ikaros Transcription Factor; Infant; Male; Oncogene Proteins, Fusion; PAX5 Transcription Factor; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Receptors, Cytokine; Receptors, Purinergic P2Y; Vincristine

2017
Role of ACE inhibitors in anthracycline-induced cardiotoxicity: A randomized, double-blind, placebo-controlled trial.
    Pediatric blood & cancer, 2018, Volume: 65, Issue:11

    Topics: Angiotensin-Converting Enzyme Inhibitors; Anthracyclines; Antibiotics, Antineoplastic; Cardiotoxicity; Child; Daunorubicin; Double-Blind Method; Doxorubicin; Enalapril; Female; Heart Failure; Humans; Lymphoma; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2018
High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
    Leukemia, 2013, Volume: 27, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Remission Induction; Risk Factors; Transplantation, Homologous; Treatment Outcome; Vincristine

2013
[Molecular genetic detection of minimal residual disease (MRD) in children with acute lymphoblastic leukemia].
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Genetic Markers; Humans; Mercaptopurine; Methotrexate; Neoplasm, Residual; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Prospective Studies; Vincristine

2013
Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Bone Marrow; Cell Lineage; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Patient Outcome Assessment; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Prospective Studies; Remission Induction; Risk Assessment; Vincristine

2013
Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004.
    Blood, 2013, Jul-04, Volume: 122, Issue:1

    Topics: Adolescent; Antibiotics, Antineoplastic; Bone Marrow; Child; Child, Preschool; Daunorubicin; Dose-Response Relationship, Drug; Female; Heart Diseases; Humans; Idarubicin; Leukemia, Myeloid, Acute; Liposomes; Male; Multivariate Analysis; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Risk Factors; Treatment Outcome

2013
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.
    Cytometry. Part B, Clinical cytometry, 2015, Volume: 88, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Daunorubicin; Female; Flow Cytometry; Follow-Up Studies; Humans; Immunophenotyping; Leukocytes, Mononuclear; Male; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Sensitivity and Specificity; Treatment Outcome; Vincristine

2015
[The prospects for children with acute lymphoblastic leukemia of being cured has increased in the Czech Republic in the 21st century to 90% - outcome of the ALL-IC BFM 2002 trial].
    Casopis lekaru ceskych, 2015, Volume: 154, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Czech Republic; Daunorubicin; Dexamethasone; Doxorubicin; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Rate; Thioguanine; Vincristine

2015
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
    Blood, 2015, Aug-06, Volume: 126, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Administration Schedule; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Pyrimidines; Recurrence; Remission Induction; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Vincristine

2015
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
    American journal of hematology, 2015, Volume: 90, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Induction Chemotherapy; Male; Methotrexate; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Survival Analysis; Transplantation, Homologous; Vincristine

2015
Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003.
    British journal of haematology, 2016, Volume: 172, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Dexamethasone; Female; Humans; Male; Mercaptopurine; Methotrexate; Neoplasm, Residual; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Assessment; Survival Analysis; Treatment Outcome; Vincristine; Young Adult

2016
High hyperdiploid acute lymphoblastic leukemia (ALL)-A 25-year population-based survey of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
    Pediatric blood & cancer, 2017, Volume: 64, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Chromosomes, Human, Pair 17; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Male; Mercaptopurine; Methotrexate; Mosaicism; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Survival Rate; Time Factors; Trisomy; Vincristine

2017
Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia.
    Leukemia, 2008, Volume: 22, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Prednisone; Prognosis; Prospective Studies; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine

2008
Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Humans; Infections; Middle Aged; Neurotoxicity Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome; Vincristine; Young Adult

2008
Treating childhood acute lymphoblastic leukemia without cranial irradiation.
    The New England journal of medicine, 2009, Jun-25, Volume: 360, Issue:26

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Daunorubicin; Dexamethasone; Hematopoietic Stem Cell Transplantation; Humans; Infant; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Risk Factors; Secondary Prevention; Survival Analysis; Treatment Outcome; Vincristine

2009
Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
    Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:6

    Topics: Administration, Oral; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine

2009
Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol.
    Pediatric blood & cancer, 2010, Volume: 54, Issue:3

    Topics: Adolescent; Age Factors; Antibiotics, Antineoplastic; Child; Child, Preschool; Daunorubicin; Female; Humans; Infant; Infant, Newborn; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2010
Randomized trial to compare LSA2L2-type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2010, Volume: 55, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Dexamethasone; Humans; Infant; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Assessment; Survival Analysis; Treatment Outcome; Vincristine

2010
Which steroids should we choose for the treatment of adult acute lymphoblastic leukemia?
    American journal of hematology, 2010, Volume: 85, Issue:10

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infections; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Risk; Treatment Outcome; Vincristine

2010
[Long-term observations of children with acute lymphoblastic leukemia and high leukocytosis treated according to modified "New York" protocols (1987-2003)].
    Przeglad lekarski, 2010, Volume: 67, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Comorbidity; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Leukocytosis; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Rate; Thioguanine; Vincristine

2010
Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906.
    Pediatric blood & cancer, 2011, Volume: 57, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Thioguanine; Treatment Outcome; Vincristine

2011
No advantage of a rotational continuation phase in acute lymphoblastic leukemia in childhood treated with a BFM back-bone therapy.
    Pediatric blood & cancer, 2011, Jul-15, Volume: 57, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Survival Rate; Vincristine

2011
Mitochondrial D-loop polymorphisms and mitochondrial DNA content in childhood acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control Studies; Child; Child, Preschool; Chromosome Aberrations; Daunorubicin; Dexamethasone; DNA, Mitochondrial; Female; Fetal Blood; Humans; Male; Mitochondria; Neoplasm, Residual; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Vincristine

2011
Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407.
    Pediatric blood & cancer, 2012, Volume: 59, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Dexamethasone; Disease-Free Survival; Female; Humans; Infant; Infant, Newborn; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Retrospective Studies; Survival Rate; Time Factors

2012
Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group.
    Pediatric blood & cancer, 2012, Dec-15, Volume: 59, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Disease-Free Survival; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Vincristine

2012
Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802.
    Cancer, 2013, Jan-01, Volume: 119, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Rate; Young Adult

2013
Treatment of young patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantation.
    British journal of haematology, 2012, Volume: 159, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Imatinib Mesylate; Male; Mercaptopurine; Methotrexate; Middle Aged; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Vincristine; Young Adult

2012
Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.
    The Lancet. Oncology, 2012, Volume: 13, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cohort Studies; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Incidence; Infant; Male; Methotrexate; Osteonecrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Sex Distribution; Sex Factors; Survival Rate; Treatment Outcome; Vincristine; Young Adult

2012
Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03.
    Pediatric blood & cancer, 2013, Volume: 60, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Doxorubicin; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2013
Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia.
    Annals of hematology, 2002, Volume: 81, Issue:8

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Disease-Free Survival; Drug Carriers; Drug Resistance, Multiple; Female; Humans; Leukemia, Myeloid, Acute; Liposomes; Male; Middle Aged; Patient Selection; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Risk Factors; Treatment Outcome

2002
[Results of the treatment of childhood acute lymphoblastic leukemia according to the Berlin-Moscow-91 protocol in 1991-2000].
    Voprosy onkologii, 2002, Volume: 48, Issue:3

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Data Interpretation, Statistical; Daunorubicin; Dexamethasone; Female; Follow-Up Studies; Humans; Infant; Male; Mercaptopurine; Methotrexate; Moscow; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Risk Factors; Russia; Survival Analysis; Time Factors; Vincristine

2002
Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration.
    Blood, 2003, Apr-01, Volume: 101, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Dexamethasone; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Thromboembolism; Vincristine

2003
The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:3

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Male; Methotrexate; Methylprednisolone; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine

2003
Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Apr-15, Volume: 21, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cross-Over Studies; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Infant; Male; Neutropenia; Neutrophils; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Risk Assessment; Survival Analysis; Treatment Outcome; Vincristine

2003
Long-term survival in acute lymphoblastic leukaemia in adults treated according to the LALA 87 protocol.
    Chemotherapy, 2003, Volume: 49, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Male; Mercaptopurine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Treatment Outcome; Vincristine

2003
[The assessment of plasma levels of insulin-like growth factor (IGF-I) and binding protein (IGFBP-3) during the maintenance therapy and after remissionof acute lymphoblastic leukemia (ALL)].
    Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych, 2003, Volume: 9, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Height; Body Mass Index; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Puberty; Radiotherapy, Adjuvant; Remission Induction; Vincristine

2003
[Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic].
    Casopis lekaru ceskych, 2003, Volume: 142, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Vincristine

2003
A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Grou
    Leukemia & lymphoma, 2003, Volume: 44, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Life Tables; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Remission Induction; Survival Analysis; Thioguanine; Treatment Outcome; Vincristine

2003
Does anthracycline administration by infusion in children affect late cardiotoxicity?
    British journal of haematology, 2004, Volume: 124, Issue:4

    Topics: Adolescent; Antibiotics, Antineoplastic; Child; Daunorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Heart Diseases; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ventricular Function, Left

2004
Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial.
    Blood, 2004, Nov-15, Volume: 104, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Combined Modality Therapy; Daunorubicin; Humans; Interferon-alpha; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Transplantation, Homologous; Treatment Outcome; Vincristine

2004
Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.
    Annals of hematology, 2004, Volume: 83, Issue:11

    Topics: Acute Disease; Adolescent; Adult; Aged; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk Factors; Survival Rate; Vidarabine

2004
Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.
    The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:5

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Drug Utilization; Female; Fever; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hospitalization; Humans; Idarubicin; Infection Control; Infections; Leukocyte Count; Male; Middle Aged; Neutropenia; Neutrophils; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Remission Induction; Salvage Therapy; Time Factors; Treatment Outcome; Vincristine

2004
Role of liposomal daunorubicin, fludarabine and cytarabine (FLAD) in the salvage therapy of adult acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:12

    Topics: Adult; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Liposomes; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Salvage Therapy; Treatment Outcome; Vidarabine

2004
Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL).
    Leukemia & lymphoma, 2005, Volume: 46, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Dexamethasone; Female; Humans; Infections; Liposomes; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Rate; Vincristine

2005
Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia.
    Leukemia, 2005, Volume: 19, Issue:4

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Fusion Proteins, bcr-abl; Humans; Male; Middle Aged; Neoplasm, Residual; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Vincristine

2005
Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial.
    British journal of haematology, 2005, Volume: 129, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Daunorubicin; Dexamethasone; Female; Humans; Infant; Leukocyte Count; Male; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Survival Analysis; Treatment Outcome

2005
Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jan-20, Volume: 24, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child; Cranial Irradiation; Daunorubicin; Disease-Free Survival; Female; Humans; Male; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Analysis; Treatment Outcome

2006
Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2006, Volume: 17, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Coagulation; Child; Child, Preschool; Daunorubicin; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Thrombosis; Vincristine

2006
Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies.
    Haematologica, 2006, Volume: 91, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Humans; Infant, Newborn; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vincristine

2006
Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.
    Blood, 2006, Aug-15, Volume: 108, Issue:4

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Dimerization; Female; Humans; Leukocyte Count; Male; Mutation; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Receptor, Notch1; Time Factors; Treatment Outcome; Vincristine

2006
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    European journal of haematology, 2007, Volume: 78, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comorbidity; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Severity of Illness Index; Survival Analysis; Teniposide; Treatment Outcome; Vincristine

2007
Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia.
    Blood, 2007, Apr-01, Volume: 109, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinical Protocols; Daunorubicin; Disease-Free Survival; Female; Humans; Male; Middle Aged; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Safety; Survival Rate; Vincristine

2007
[Auditory evoked potentials in patients after acute children's lymphoblastic leukemia treatment].
    Przeglad lekarski, 2006, Volume: 63, Issue:11

    Topics: Acoustic Stimulation; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Evoked Potentials, Auditory, Brain Stem; Female; Hearing Disorders; Hearing Tests; Humans; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Reaction Time; Thioguanine; Vincristine

2006
[Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asian People; Asparaginase; Child; Child, Preschool; China; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Treatment Outcome; Vincristine

2007
Outcome of adult acute lymphoblastic leukemia with BFM protocol in a resource-constrained setting.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Combined Modality Therapy; Daunorubicin; Female; Health Resources; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine

2007
Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia.
    Pediatric hematology and oncology, 2007, Volume: 24, Issue:4

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Kidney Diseases; Kidney Function Tests; Longitudinal Studies; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Turkey; Vincristine

2007
[The results of a multicenter trial of acute lymphoblastic leukemia treatment on ALL-MB 91/ALL-BFM 90m in children: analysis of efficacy and toxicity].
    Terapevticheskii arkhiv, 2007, Volume: 79, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Treatment Outcome; Vincristine

2007
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Jan-10, Volume: 26, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chi-Square Distribution; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; DNA, Neoplasm; Female; Humans; Infant; Italy; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Survival Rate; Treatment Outcome; Vincristine

2008
Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neoplasms; Child; Child, Preschool; China; Daunorubicin; Female; Health Care Costs; Humans; Idarubicin; Infant; Kaplan-Meier Estimate; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Risk Assessment; Treatment Outcome; Vincristine

2008
Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia.
    Leukemia, 2008, Volume: 22, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Feasibility Studies; Female; Humans; Infant; Infant, Newborn; Male; Methotrexate; Palliative Care; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Russia; Treatment Outcome; Vincristine

2008
Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Apr-10, Volume: 26, Issue:11

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Hematologic Diseases; Humans; Hydrocortisone; Infant; Infections; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Treatment Outcome; Vincristine

2008
Phase I trial of high-dose tamoxifen as a modulator of drug resistance in combination with daunorubicin in patients with relapsed or refractory acute leukemia.
    Leukemia, 1995, Volume: 9, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Administration Schedule; Drug Resistance, Multiple; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tamoxifen

1995
L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins.
    Leukemia, 1995, Volume: 9, Issue:10

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Synergism; Etoposide; Humans; Infant; Karyotyping; Leukemia, Myeloid; Mercaptopurine; Methotrexate; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone

1995
Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana d
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:10

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Injections, Spinal; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Regression Analysis; Remission Induction; Survival Analysis; Vincristine

1995
Outcome of treatment in adult acute lymphoblastic leukaemia in an Asian population: comparison with previous multicentre German study.
    Leukemia, 1995, Volume: 9, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asia; Asparaginase; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Ethnicity; Female; Follow-Up Studies; Germany; Humans; Malaysia; Male; Methotrexate; Methylprednisolone; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Probability; Racial Groups; Survival Rate; Time Factors; Treatment Outcome; Vincristine

1995
Hypercoagulability during induction therapy of acute lymphoblastic leukemia is of scarce clinical relevance. Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto.
    Blood, 1993, May-01, Volume: 81, Issue:9

    Topics: Adult; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Asparaginase; Blood Coagulation; Cyclophosphamide; Daunorubicin; Fibrinogen; Fibrinolysin; Fibrinopeptide A; Humans; Peptide Hydrolases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Prothrombin; Vincristine

1993
[Treatment for elderly patients with acute non-lymphocytic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:2

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Male; Mercaptopurine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Retrospective Studies; Survival Rate

1995
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Blood, 1995, Apr-15, Volume: 85, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Administration Schedule; Female; Humans; Immunophenotyping; Life Tables; Male; Mercaptopurine; Methotrexate; Middle Aged; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Remission Induction; Risk Factors; Survival Analysis; Thioguanine; Treatment Outcome; Vincristine

1995
Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma.
    Molecular aspects of medicine, 1994, Volume: 15 Suppl

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Child; Coenzymes; Daunorubicin; Echocardiography; Humans; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Treatment Outcome; Ubiquinone; Ventricular Function, Left

1994
Sequential induction chemotherapy with vincristine, daunorubicin, cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia.
    Annals of hematology, 1995, Volume: 70, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; Cyclophosphamide; Daunorubicin; Female; Humans; Hyperbilirubinemia; Male; Middle Aged; Nausea; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Salvage Therapy; Vincristine

1995
Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemia.
    British journal of cancer, 1994, Volume: 70, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Daunorubicin; Female; Humans; Leukemia, Myeloid; Male; Membrane Glycoproteins; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction

1994
High efficacy of the German multicenter ALL (GMALL) protocol for treatment of adult acute lymphoblastic leukemia (ALL)--a single-institution study.
    Annals of hematology, 1994, Volume: 69, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Austria; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Male; Mercaptopurine; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Remission Induction; Vincristine

1994
Adult acute lymphoblastic leukemia: results of an aggressive regimen in India.
    Leukemia & lymphoma, 1994, Volume: 14, Issue:3-4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine

1994
Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol.
    Cancer, 1993, Nov-15, Volume: 72, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Examination; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Heart; Humans; Infant; Male; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Risk; Survival Rate; Vincristine

1993
Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
    British journal of haematology, 1993, Volume: 85, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Male; Mercaptopurine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Sex Factors; Vincristine

1993
The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group.
    International journal of radiation oncology, biology, physics, 1993, Dec-01, Volume: 27, Issue:5

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Humans; Infant; Leukocyte Count; Lymphoma; Mediastinal Neoplasms; Meningeal Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Survival Rate; Thioguanine; Vincristine

1993
Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group.
    Leukemia, 1993, Volume: 7 Suppl 2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Administration Schedule; Follow-Up Studies; Humans; Mediastinum; Mercaptopurine; Methotrexate; Middle Aged; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Remission Induction; Survival Analysis; Teniposide; Vincristine

1993
Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and -85. ALL Brazilian Group.
    Leukemia, 1993, Volume: 7 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Drug Administration Schedule; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Teniposide; Vincristine

1993
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
    Blood, 1996, Apr-15, Volume: 87, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fever; Filgrastim; Gastrointestinal Diseases; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Infant; Infection Control; Life Tables; Male; Mercaptopurine; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Recombinant Proteins; Risk; Survival Analysis; Thioguanine; Vincristine; Vindesine

1996
Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Humans; Lymphocyte Count; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Vincristine

1996
Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia.
    Blood, 1996, Jun-15, Volume: 87, Issue:12

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Marrow Transplantation; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Humans; Mercaptopurine; Methotrexate; Middle Aged; Neoplasm, Residual; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Survival Analysis; Treatment Outcome; Vincristine

1996
Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
    Leukemia, 1996, Volume: 10, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Base Sequence; Child; Child, Preschool; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Fusion Proteins, bcr-abl; Germany; Humans; Incidence; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mercaptopurine; Methotrexate; Molecular Sequence Data; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Prospective Studies; Transcription, Genetic; Translocation, Genetic; Vincristine

1996
[Nephrotoxicity evaluation of cytostatic agents in children with acute lymphoblastic leukemia].
    Pediatria polska, 1995, Volume: 70, Issue:11

    Topics: Acetylglucosaminidase; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Isoenzymes; Kidney Tubules; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vincristine

1995
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group.
    Medical and pediatric oncology, 1996, Volume: 27, Issue:6

    Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Humans; Idarubicin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recurrence

1996
Acute lymphoblastic leukemia in children: nonrandomized comparison of conventional vs. intensive chemotherapy at the National Cancer Institute of Colombia.
    Medical and pediatric oncology, 1997, Volume: 28, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Treatment Outcome; Vincristine

1997
Addition of etoposide to initial therapy of adult acute lymphoblastic leukemia: a combined clinical and laboratory study.
    Leukemia & lymphoma, 1996, Volume: 23, Issue:1-2

    Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Prospective Studies; Remission Induction; Tumor Cells, Cultured

1996
Etoposide and mitoxantrone as a second cycle of consolidation therapy following high dose cytosine arabinoside and daunorubicin in patients with acute non-lymphocytic leukemia in remission: a pilot study.
    Leukemia & lymphoma, 1996, Volume: 23, Issue:1-2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mitoxantrone; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Remission Induction; Salvage Therapy

1996
Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Humans; Infant; Life Tables; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Time Factors; Treatment Outcome; Vincristine

1997
Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. The Medical Research Council's Working Party on Childhood Leukaemia.
    British journal of haematology, 1997, Volume: 97, Issue:3

    Topics: Antibiotics, Antineoplastic; Bone Marrow Diseases; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome

1997
Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study.
    Blood, 1997, Jul-15, Volume: 90, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Transfusion; Daunorubicin; Erythrocyte Count; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunophenotyping; Male; Middle Aged; Neutropenia; Neutrophils; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Rate; Vincristine

1997
Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients. French Group for Treatment of Adult Acute Lymphobl
    Leukemia, 1997, Volume: 11, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Female; Humans; Interferons; Male; Mercaptopurine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Steroids; Vincristine

1997
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin.
    Leukemia, 1998, Volume: 12, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Treatment Outcome; Vincristine

1998
Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia.
    Leukemia, 1998, Volume: 12, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Infant, Newborn; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Thioguanine; Vincristine

1998
Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
    Leukemia, 1998, Volume: 12, Issue:8

    Topics: Adolescent; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; CD13 Antigens; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Female; Humans; Immunophenotyping; Infant; Leukocyte Count; Male; Methotrexate; Neprilysin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Sialic Acid Binding Ig-like Lectin 3; Vincristine

1998
Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Haematologica, 1998, Volume: 83, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Aberrations; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Humans; Infant; Italy; Leucovorin; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Risk; Thioguanine; Treatment Outcome; Vincristine

1998
[Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:11

    Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine

1998
[The treatment results in children diagnosed with non-Hodgkin's lymphomas and acute B-cell lymphoblastic leukemias treated by the BFM protocols. The report of the POGM (Pediatric Oncology Group of Madrid)].
    Anales espanoles de pediatria, 1998, Volume: 49, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Time Factors; Vincristine

1998
Phase I study of liposomal daunorubicin in patients with acute leukemia.
    Investigational new drugs, 1999, Volume: 17, Issue:1

    Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Dose-Response Relationship, Drug; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Liposomes; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence

1999
Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
    Cancer, 2000, Mar-01, Volume: 88, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Teniposide; Vincristine

2000
Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
    Leukemia, 2000, Volume: 14, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infections; Male; Methotrexate; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Proportional Hazards Models; Remission Induction; Risk; Survival Analysis; Thioguanine; Treatment Outcome; Vincristine

2000
Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group.
    Medical and pediatric oncology, 2000, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Daunorubicin; Drug Administration Schedule; Echocardiography; Electrocardiography; Female; Heart Diseases; Heart Rate; Humans; Male; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survivors

2000
Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia.
    Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:1

    Topics: Adolescent; Antibiotics, Antineoplastic; Child; Child, Preschool; Daunorubicin; Drug Carriers; Female; Half-Life; Humans; Liposomes; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Time Factors

2001
Topoisomerase II alpha and II beta expression in childhood acute lymphoblastic leukaemia: relation to prognostic factors and clinical outcome.
    Journal of clinical pathology, 2001, Volume: 54, Issue:1

    Topics: Adolescent; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Daunorubicin; DNA Topoisomerases, Type II; DNA-Binding Proteins; Enzyme Inhibitors; Etoposide; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Infant; Infant, Newborn; Isoenzymes; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Survival Rate; Topoisomerase II Inhibitors; Treatment Outcome

2001
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Apr-01, Volume: 19, Issue:7

    Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Synergism; Europe; Female; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Injections, Spinal; Leukemic Infiltration; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Regression Analysis; Risk; Vincristine

2001
Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
    British journal of haematology, 2001, Volume: 113, Issue:1

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Humans; Infant; Leukocyte Count; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Remission Induction; Risk Factors; Sex Factors; Thioguanine; United Kingdom; Vincristine

2001
Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
    Haematologica, 2001, Volume: 86, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Humans; Infant; Longitudinal Studies; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Risk Factors; Treatment Outcome; Vincristine

2001
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study.
    Leukemia, 2001, Volume: 15, Issue:6

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infusions, Intravenous; Injections, Intravenous; Life Tables; Male; Methotrexate; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine

2001
Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
    Medical and pediatric oncology, 2001, Volume: 37, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Immunophenotyping; Infant; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Risk; Risk Factors; Severity of Illness Index; Sex Factors; Survival Analysis; Treatment Outcome; Vincristine

2001
Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
    Annals of hematology, 2001, Volume: 80 Suppl 3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Austria; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Germany; Humans; Immunophenotyping; Infant; Life Tables; Lymphoma, T-Cell; Male; Mercaptopurine; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Thioguanine; Treatment Outcome; Vincristine

2001
[Effectiveness of empirical antibiotic therapy in the control of infections in patients with acute leukemia during severe neutropenia].
    Polskie Archiwum Medycyny Wewnetrznej, 1992, Volume: 87, Issue:6

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cytarabine; Daunorubicin; Female; Humans; Immune Tolerance; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1992
Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503.
    British journal of haematology, 1992, Volume: 82, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Daunorubicin; Humans; Infant; Mercaptopurine; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine

1992
Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762).
    Blood, 1992, Dec-15, Volume: 80, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bone Marrow; Chromosome Banding; Daunorubicin; Female; Follow-Up Studies; Fusion Proteins, bcr-abl; Gene Rearrangement; Humans; Immunophenotyping; Karyotyping; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Survival Analysis; T-Lymphocytes; Time Factors

1992
Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Female; France; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Risk Factors; Vincristine; Vindesine

1992
An update of the results of intensive therapy in children with acute lymphoblastic leukemia.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cause of Death; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Administration Schedule; Humans; Infant; Infant, Newborn; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Survival Analysis

1992
GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukemia. Preliminary results.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Clinical Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Vincristine

1992
Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.
    Leukemia, 1992, Volume: 6 Suppl 2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Administration Schedule; Humans; Methotrexate; Middle Aged; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Thioguanine; Vincristine

1992
Ceftazidime as initial therapy in febrile patients with acute leukemia during induction chemotherapy. Leukemia Group of Middle Sweden.
    Scandinavian journal of infectious diseases, 1992, Volume: 24, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Ceftazidime; Cytarabine; Daunorubicin; Female; Fever; Fever of Unknown Origin; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Thioguanine

1992
[Second cessation of therapy in children with acute lymphoblastic leukemia].
    Acta haematologica Polonica, 1992, Volume: 23, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Time Factors; Vincristine

1992
Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the
    Medical and pediatric oncology, 1992, Volume: 20, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child, Preschool; Daunorubicin; Drug Administration Schedule; Female; Hematopoiesis; Humans; Idarubicin; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vincristine

1992
[Treatment of acute lymphoblastic leukemia in children. Results of the FRALLE 83 protocol].
    Archives francaises de pediatrie, 1991, Volume: 48, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Clinical Protocols; Cyclophosphamide; Daunorubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Vincristine

1991
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
    Blood, 1991, Nov-15, Volume: 78, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Daunorubicin; Etoposide; Follow-Up Studies; Graft vs Host Disease; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Time Factors; Transplantation, Homologous; Vincristine; Whole-Body Irradiation

1991
The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:11

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pregnancy; Remission Induction; Survival Analysis

1991
Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB Study.
    Leukemia, 1991, Volume: 5, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Injections, Spinal; Male; Methotrexate; Middle Aged; Mitoxantrone; Nervous System Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1991
Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study.
    Cancer, 1991, Jul-01, Volume: 68, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Risk Factors; Survival Rate; Teniposide; Testicular Neoplasms; Vincristine

1991
Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
    British journal of haematology, 1991, Volume: 78, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Daunorubicin; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Random Allocation; United Kingdom; Vincristine

1991
[Results of 16-year use of the 06-Paris-LA-66 program in the treatment of children with acute lymphoblastic leukemia].
    Gematologiia i transfuziologiia, 1991, Volume: 36, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Daunorubicin; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Time Factors; Vincristine

1991
Treatment of relapsed acute lymphocytic leukemia in adults.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Germany, West; Humans; Ifosfamide; Leucovorin; Life Tables; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spinal Cord Neoplasms; Teniposide; Testicular Neoplasms; Vindesine

1990
Impact of early intensive reinduction therapy on event-free survival in children with low-risk acute lymphoblastic leukemia.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Daunorubicin; Dexamethasone; Doxorubicin; Germany, West; Humans; Leucovorin; Life Tables; Mercaptopurine; Methotrexate; Multicenter Studies as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Randomized Controlled Trials as Topic; Risk; Survival Rate; Thioguanine; Vincristine

1990
Improved prognosis for childhood acute lymphocytic leukemia with very high white blood cell count (greater than 100/nl) with rotation of non-cross-resistant drug combinations.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Germany, West; Humans; Infant; Infant, Newborn; Leukocyte Count; Mercaptopurine; Methotrexate; Multicenter Studies as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Risk; Survival Rate; Teniposide; Thioguanine; Vincristine

1990
[Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
    Sangre, 1990, Volume: 35, Issue:1

    Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spain; Survival Rate; Teniposide; Thioguanine; Vincristine

1990
[Intensive induction and early consolidation of acute lymphoid leukemia in the adult. A pilot study of feasibility and long-term development].
    Presse medicale (Paris, France : 1983), 1989, Feb-11, Volume: 18, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Vincristine

1989
Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study
    The American journal of pediatric hematology/oncology, 1989,Summer, Volume: 11, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Male; Netherlands; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Random Allocation; Remission Induction; Vincristine

1989
Idarubicin in acute leukemias: experience of the Italian Cooperative Group GIMEMA.
    Seminars in oncology, 1989, Volume: 16, Issue:1 Suppl 2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Leukemia; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Random Allocation; Remission Induction

1989
Randomized multicentric Italian study on two treatment regimens for marrow relapse in childhood acute lymphoblastic leukemia.
    Pediatric hematology and oncology, 1986, Volume: 3, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Combinations; Humans; Italy; Life Tables; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Rate; Thioguanine; Vincristine

1986

Other Studies

347 other study(ies) available for daunorubicin and Acute Lymphoid Leukemia

ArticleYear
The incidence of symptomatic osteonecrosis is similar between Japanese children and children in Western countries with acute lymphoblastic leukaemia treated with a Berlin-Frankfurt-Münster (BFM)95-based protocol.
    British journal of haematology, 2022, Volume: 196, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Incidence; Infant; Japan; Male; Mercaptopurine; Osteonecrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Retrospective Studies; Vincristine

2022
Long-term results of the treatment of adolescents and adults with acute lymphoblastic leukemia with a pediatric-inspired regimen delivered on an outpatient basis: A single institution experience.
    Leukemia research, 2022, Volume: 121

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Humans; Mercaptopurine; Methotrexate; Outpatients; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

2022
DNMT3A low-expression is correlated to poor prognosis in childhood B-ALL and confers resistance to daunorubicin on leukemic cells.
    BMC cancer, 2023, Mar-18, Volume: 23, Issue:1

    Topics: Cell Line; Child; Daunorubicin; DNA Methyltransferase 3A; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction

2023
Invasive mucormycosis during treatment for acute lymphoblastic leukaemia-successful management of two life-threatening diseases.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020, Volume: 28, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Invasive Fungal Infections; Lung Diseases, Fungal; Male; Mercaptopurine; Methotrexate; Mucorales; Mucormycosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Triazoles; Vincristine

2020
Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress.
    Blood, 2019, 10-24, Volume: 134, Issue:17

    Topics: Adult; Aged; Animals; Antineoplastic Agents; Cell Line, Tumor; Cells, Cultured; Coculture Techniques; Cytarabine; Daunorubicin; Female; Humans; Male; Mesenchymal Stem Cells; Mice; Middle Aged; Mitochondria; Oxidative Stress; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Young Adult

2019
Determination of the DNA repair pathways utilised by acute lymphoblastic leukaemia cells following daunorubicin treatment.
    BMC research notes, 2019, Sep-24, Volume: 12, Issue:1

    Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Chromones; Daunorubicin; DNA; DNA Breaks, Double-Stranded; DNA End-Joining Repair; DNA Repair; Histones; Homologous Recombination; Humans; Maleimides; Morpholines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction

2019
T-Cell Lymphoblastic Lymphoma Presenting as Acute Clavicular Pain.
    South Dakota medicine : the journal of the South Dakota State Medical Association, 2019, Volume: 72, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Daunorubicin; Humans; Pain; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; T-Lymphocytes; Treatment Outcome

2019
Reduced-dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study.
    Blood, 2020, 04-23, Volume: 135, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infant; Male; Mercaptopurine; Methotrexate; Neoplasm, Residual; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Survival Rate; Vincristine

2020
Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia.
    Annals of hematology, 2020, Volume: 99, Issue:4

    Topics: Abnormal Karyotype; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comparative Genomic Hybridization; Cyclophosphamide; Cytarabine; Daunorubicin; Genes, Neoplasm; Humans; Ikaros Transcription Factor; In Situ Hybridization, Fluorescence; Mercaptopurine; Methotrexate; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Risk Factors; RNA, Messenger; RNA, Neoplasm; Sequence Analysis, RNA; Transcriptome; Vincristine; Workflow

2020
L-asparaginase-induced Parotitis in an Elderly Patient with Acute Lymphoblastic Leukemia.
    Internal medicine (Tokyo, Japan), 2020, Jul-15, Volume: 59, Issue:14

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Daunorubicin; Female; Humans; Parotitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Treatment Outcome; Vincristine

2020
Induction-remission response in peadiatric acute lymphoblastic leukaemia, Lahore protocol versus UKALL 2011 interim guidelines.
    JPMA. The Journal of the Pakistan Medical Association, 2020, Volume: 70, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Examination; Child; Daunorubicin; Female; Glucocorticoids; Humans; Leukocyte Count; Male; Pakistan; Practice Guidelines as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Risk Adjustment; Risk Factors; Treatment Outcome; Vincristine

2020
Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells.
    Molecular medicine reports, 2020, Volume: 22, Issue:4

    Topics: Antibiotics, Antineoplastic; Apoptosis Regulatory Proteins; Calcium-Binding Proteins; Cell Cycle Checkpoints; Cell Nucleus; Cell Proliferation; CREB-Binding Protein; Daunorubicin; Down-Regulation; Drug Resistance, Neoplasm; E2F3 Transcription Factor; Humans; Inhibitory Concentration 50; Jurkat Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA Interference; Signal Transduction; Transfection

2020
Comparison of myelosuppression using the D-index between children and adolescents/young adults with acute lymphoblastic leukemia during induction chemotherapy.
    Pediatric blood & cancer, 2021, Volume: 68, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacteremia; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Immunosuppression Therapy; Induction Chemotherapy; Infant; Injections, Spinal; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Retrospective Studies; Vincristine; Young Adult

2021
Salivary immunoglobulin A level during steroids and chemotherapy treatment administered in remission induction phase among pediatric patients with acute lymphoblastic leukemia.
    Medicine, 2020, Oct-16, Volume: 99, Issue:42

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Proteins; Child; Child, Preschool; Daunorubicin; Female; Glucocorticoids; Humans; Immunoglobulin A, Secretory; Lymphocyte Count; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proteins; Remission Induction; Saliva; Stomatitis; Vincristine

2020
Results of two consecutive treatment protocols in Polish children with acute lymphoblastic leukemia.
    Scientific reports, 2020, 11-19, Volume: 10, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Protocols; Asparaginase; Child; Child, Preschool; Clinical Protocols; Daunorubicin; Female; Fusion Proteins, bcr-abl; Humans; Incidence; Male; Neoplasm, Residual; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Progression-Free Survival; Retrospective Studies; Treatment Outcome; Vincristine

2020
Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.
    Annals of hematology, 2021, Volume: 100, Issue:3

    Topics: Adolescent; Adult; Age of Onset; Aged; Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Protocols; Child; Child, Preschool; Cohort Studies; Cytarabine; Daunorubicin; Egypt; Etoposide; Female; Humans; Incidence; Induction Chemotherapy; Infant; Leukemia, Biphenotypic, Acute; Maintenance Chemotherapy; Male; Middle Aged; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Treatment Outcome; Young Adult

2021
Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol.
    BMC cancer, 2021, Jan-13, Volume: 21, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Male; Mercaptopurine; Neoplasm Recurrence, Local; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Survival Rate

2021
Outcomes of pediatric mixed phenotype acute leukemia treated with lymphoid directed therapy: Analysis of an institutional series from India.
    Pediatric hematology and oncology, 2021, Volume: 38, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Female; Humans; India; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine

2021
Risk Factors of Daunorubicine Induced Early Cardiotoxicity in Childhood Acute Lymphoblastic Leukemia: A Retrospective Study.
    Asian Pacific journal of cancer prevention : APJCP, 2021, May-01, Volume: 22, Issue:5

    Topics: Adolescent; Antibiotics, Antineoplastic; Cardiotoxicity; Child; Child, Preschool; Daunorubicin; Female; Follow-Up Studies; Humans; Indonesia; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies; Risk Factors; ROC Curve

2021
Philadelphia chromosome-positive B-lymphoblastic lymphoma successfully treated with chemotherapy regimen containing imatinib: A rare case report and literature review.
    Medicine, 2021, Jun-11, Volume: 100, Issue:23

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Daunorubicin; Fusion Proteins, bcr-abl; Genetic Testing; Humans; Imatinib Mesylate; Male; Mutation; Pharmacogenomic Variants; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Protein Kinase Inhibitors; Remission Induction; Treatment Outcome; Vincristine; Young Adult

2021
Efficacy and safety of induction chemotherapy with daunorubicin or idarubicin in the treatment of an adult with acute lymphoblastic leukemia.
    Tumori, 2022, Volume: 108, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2022
Effects of cytochrome P450 family 3 subfamily A member 5 gene polymorphisms on daunorubicin metabolism and adverse reactions in patients with acute leukemia.
    Molecular medicine reports, 2017, Volume: 15, Issue:6

    Topics: Adolescent; Alleles; Child; Child, Preschool; Cytochrome P-450 CYP3A; Daunorubicin; Drug Monitoring; Enzyme Activation; Female; Gene Expression; Genotype; Humans; Inactivation, Metabolic; Male; Pharmacogenomic Variants; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome

2017
Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95.
    Leukemia, 2017, Volume: 31, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Gene Deletion; Humans; Ikaros Transcription Factor; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Treatment Outcome; Vincristine

2017
Faecal microbiota transplant: a novel biological approach to extensively drug-resistant organism-related non-relapse mortality.
    Bone marrow transplantation, 2017, Volume: 52, Issue:10

    Topics: Allografts; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacteria; Daunorubicin; Drug Resistance, Bacterial; Fatal Outcome; Fecal Microbiota Transplantation; Feces; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine

2017
miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment.
    British journal of cancer, 2017, Sep-05, Volume: 117, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Bone Marrow; Child; Child, Preschool; Daunorubicin; Disease Progression; DNA, Complementary; Down-Regulation; Drug Resistance, Neoplasm; Female; Humans; Infant; Kaplan-Meier Estimate; Male; MicroRNAs; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Real-Time Polymerase Chain Reaction; Regression Analysis; Treatment Outcome; Vincristine

2017
Adipocytes Sequester and Metabolize the Chemotherapeutic Daunorubicin.
    Molecular cancer research : MCR, 2017, Volume: 15, Issue:12

    Topics: 20-Hydroxysteroid Dehydrogenases; Adipocytes; Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductase Family 1 Member C3; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Humans; Hydroxysteroid Dehydrogenases; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Microenvironment

2017
Non-alcoholic steatohepatitis induced by induction chemotherapy for pediatric acute lymphoblastic leukemia.
    International journal of hematology, 2018, Volume: 107, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; Child; Daunorubicin; gamma-Glutamyltransferase; Humans; Induction Chemotherapy; Male; Non-alcoholic Fatty Liver Disease; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Tomography, X-Ray Computed; Vincristine

2018
DNA variants in DHFR gene and response to treatment in children with childhood B ALL: revisited in AIEOP-BFM protocol.
    Pharmacogenomics, 2018, Volume: 19, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Child; Daunorubicin; Disease-Free Survival; DNA; Female; Haplotypes; Humans; Male; Methotrexate; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Promoter Regions, Genetic; Tetrahydrofolate Dehydrogenase; Treatment Outcome; Vincristine

2018
A pilot study of daunorubicin-augmented hyper-CVAD induction chemotherapy for adults with acute lymphoblastic leukemia.
    Cancer chemotherapy and pharmacology, 2018, Volume: 81, Issue:2

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Cyclophosphamide; Daunorubicin; Dexamethasone; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Male; Middle Aged; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine; Young Adult

2018
Influence of thiopurine methyltransferase gene polymorphism on Egyptian children with acute lymphoblastic leukaemia.
    Journal of genetics, 2017, Volume: 96, Issue:6

    Topics: Adolescent; Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Drug-Related Side Effects and Adverse Reactions; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Infant; Male; Mercaptopurine; Methyltransferases; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

2017
Remission Rate of Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults (AYA).
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:2

    Topics: Adolescent; Adult; Asparaginase; Bone Marrow; Daunorubicin; Female; Humans; Immunophenotyping; Male; Pakistan; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Treatment Outcome; Vincristine; Young Adult

2018
Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
    Annals of hematology, 2018, Volume: 97, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Cells; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Gene Expression Profiling; Greece; Humans; Infant; Male; MicroRNAs; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Proportional Hazards Models; Real-Time Polymerase Chain Reaction; Remission Induction; Risk Assessment; RNA, Neoplasm; Treatment Outcome; Vincristine

2018
Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1.
    Experimental hematology, 2018, Volume: 63

    Topics: Butadienes; Cell Cycle; Chromones; Daunorubicin; Down-Regulation; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; Humans; Intercellular Signaling Peptides and Proteins; MAP Kinase Kinase Kinase 1; Morpholines; Neoplasm Proteins; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Receptor, IGF Type 1; RNA Interference; RNA, Small Interfering; Signal Transduction; STAT6 Transcription Factor; Tumor Cells, Cultured; Tyrphostins; Vincristine

2018
Incidence and Risk Factors for Hypertension During Childhood Acute Lymphoblastic Leukemia Therapy.
    Indian pediatrics, 2018, Oct-15, Volume: 55, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Humans; Hypertension; Incidence; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Risk Factors; Vincristine

2018
ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol.
    Italian journal of pediatrics, 2018, Aug-16, Volume: 44, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cohort Studies; Core Binding Factor Alpha 2 Subunit; Daunorubicin; Disease-Free Survival; ETS Translocation Variant 6 Protein; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Proto-Oncogene Proteins c-ets; Repressor Proteins; Retrospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; Treatment Outcome; Vincristine

2018
Paraneoplastic Demyelinating Sensorimotor Neuropathy Delaying the Diagnosis of an Underlying Acute Lymphoblastic Leukemia in a Child.
    Journal of oncology practice, 2018, Volume: 14, Issue:10

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain; Child; Daunorubicin; Demyelinating Diseases; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Male; Methotrexate; Paraneoplastic Syndromes, Nervous System; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Spine; Tomography, X-Ray Computed; Vincristine

2018
Improved Outcome of Newly Diagnosed Childhood Mature B-Cell Lymphoma/Leukemia With High Tumor Burden Treated With BFM95-based Protocol Combining Rituximab: A Report From Shanghai, China.
    Journal of pediatric hematology/oncology, 2019, Volume: 41, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control Studies; Child; China; Daunorubicin; Female; Humans; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Progression-Free Survival; Retrospective Studies; Rituximab; Treatment Outcome; Tumor Burden; Vincristine

2019
Evaluation of Insulin-mediated Regulation of AKT Signaling in Childhood Acute Lymphoblastic Leukemia.
    Journal of pediatric hematology/oncology, 2019, Volume: 41, Issue:2

    Topics: Antineoplastic Agents, Immunological; Apoptosis; Asparaginase; Child; Child, Preschool; Daunorubicin; Drug Resistance, Neoplasm; Female; Humans; Insulin; Jurkat Cells; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Receptors, Somatomedin; Signal Transduction; Vincristine

2019
Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia.
    BMC cancer, 2019, Feb-27, Volume: 19, Issue:1

    Topics: Antibiotics, Antineoplastic; Ataxia Telangiectasia Mutated Proteins; Cell Cycle; Cell Line, Tumor; Cell Survival; Daunorubicin; DNA Breaks, Double-Stranded; DNA Repair; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; Superoxide Dismutase; Tumor Suppressor Protein p53

2019
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.
    Pediatric blood & cancer, 2019, Volume: 66, Issue:6

    Topics: Antibiotics, Antineoplastic; Child; Cohort Studies; Daunorubicin; Female; Follow-Up Studies; Glucosephosphate Dehydrogenase; Humans; Induction Chemotherapy; Male; Neoadjuvant Therapy; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Risk Factors; Safety

2019
Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Experience of a single center using BFM protocols.
    Pediatric blood & cancer, 2019, Volume: 66, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Humans; Posterior Leukoencephalopathy Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Vincristine

2019
Visualization of Vertebral Body Deformities in Childhood by MRI in a Boy with ALL.
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2019, Volume: 191, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Density; Bone Marrow; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Fractures, Compression; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spinal Fractures; Spine; Vincristine

2019
Long-term outcomes of modified BFM-95 regimen in adults with newly diagnosed standard-risk acute lymphoblastic leukemia: a retrospective single-center study.
    International journal of hematology, 2019, Volume: 110, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asian People; Asparaginase; Cohort Studies; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Maintenance Chemotherapy; Male; Mercaptopurine; Methotrexate; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Retrospective Studies; Risk; Time Factors; Treatment Outcome; Vincristine

2019
Nasolacrimal system obstruction, ptosis and esotropia due to chemotherapy in acute lymphoblastic leukemia.
    Cutaneous and ocular toxicology, 2013, Volume: 32, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blepharoptosis; Child; Daunorubicin; Esotropia; Female; Humans; Lacrimal Duct Obstruction; Methotrexate; Nasolacrimal Duct; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine

2013
Outcome of patients with acute lymphoblastic leukemia (ALL) following induction therapy with a modified (pulsed dexamethasone rather than continuous prednisone) UKALL XII/ECOG E2993 protocol at Tawam Hospital, United Arab Emirates (UAE).
    Medical oncology (Northwood, London, England), 2013, Volume: 30, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cancer Care Facilities; Daunorubicin; Dexamethasone; Female; Humans; Induction Chemotherapy; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Pulse Therapy, Drug; Retrospective Studies; Treatment Outcome; United Arab Emirates; Vincristine; Young Adult

2013
Once upon a time--a personal view on episodes in leukemia research in Germany, and beyond.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomedical Research; Child; Daunorubicin; Faculty, Medical; Germany; History, 20th Century; History, 21st Century; Humans; Pediatrics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

2013
Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Europe; Germany; History, 20th Century; History, 21st Century; Humans; Medical Oncology; Mercaptopurine; Methotrexate; Pediatrics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Vincristine

2013
ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Europe; Hematopoietic Stem Cell Transplantation; Humans; Mercaptopurine; Methotrexate; Multicenter Studies as Topic; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Retreatment; Survival Rate; Vincristine

2013
Chemotherapy induces enhanced procoagulant activity through phosphatidylserine exposure in acute lymphoblastic leukemia.
    Thrombosis research, 2013, Volume: 132, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents; Asparaginase; Blood Coagulation; Blood Coagulation Tests; Cell Line, Tumor; Daunorubicin; Female; Humans; Male; Phosphatidylserines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thrombosis; Young Adult

2013
[Evaluation of the efficacy of two successive protocols on pediatric acute lymphoblastic leukemia with E2A-PBX1 fusion gene].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2013, Volume: 51, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Daunorubicin; Dexamethasone; Disease-Free Survival; Female; Homeodomain Proteins; Humans; Infant; Male; Neoplasm, Residual; Oncogene Proteins, Fusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Real-Time Polymerase Chain Reaction; Remission Induction; Retrospective Studies; Treatment Outcome

2013
Herpes simplex virus reactivation and disease during treatment for childhood acute lymphoblastic leukemia.
    Klinische Padiatrie, 2014, Volume: 226, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Encephalitis, Herpes Simplex; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Humans; Induction Chemotherapy; Infant; Male; Mercaptopurine; Methotrexate; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Simplexvirus; Stomatitis, Herpetic; Vincristine; Virus Activation

2014
[Clinical characteristics and efficacy analysis for patients over 55 years of age with acute lymphoblastic leukemia].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2013, Dec-18, Volume: 45, Issue:6

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Consolidation Chemotherapy; Cyclophosphamide; Daunorubicin; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Maintenance Chemotherapy; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Remission Induction; Retrospective Studies; Survival Rate; Vincristine; Vindesine

2013
Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma.
    Pediatric blood & cancer, 2014, Volume: 61, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Dexamethasone; Drug Substitution; Female; Follow-Up Studies; Humans; Male; Mitoxantrone; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Vincristine

2014
Drug targets for cell cycle dysregulators in leukemogenesis: in silico docking studies.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Antineoplastic Agents; Arabinonucleosides; Carcinogenesis; Catalytic Domain; Cell Cycle Checkpoints; Cell Cycle Proteins; Curcumin; Daunorubicin; Doxorubicin; Humans; Hydrogen Bonding; Molecular Docking Simulation; Molecular Targeted Therapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2014
Pneumatosis intestinalis and imatinib mesylate.
    Annals of hematology, 2014, Volume: 93, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Child, Preschool; Dasatinib; Daunorubicin; Dexamethasone; Drug Substitution; Female; Humans; Imatinib Mesylate; Parenteral Nutrition, Total; Piperazines; Pneumatosis Cystoides Intestinalis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Recurrence; Thiazoles; Vincristine

2014
Impact on survival and toxicity by duration of weight extremes during treatment for pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, May-01, Volume: 32, Issue:13

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cohort Studies; Daunorubicin; Disease-Free Survival; Female; Humans; Infant; Male; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Thinness; Time Factors; Vincristine; Young Adult

2014
Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia.
    Cancer science, 2014, Volume: 105, Issue:4

    Topics: Cell Line, Tumor; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Gene Expression Regulation, Leukemic; Humans; Male; MicroRNAs; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; ROC Curve; Treatment Outcome

2014
The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Annals of hematology, 2014, Volume: 93, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Evaluation; Follow-Up Studies; Humans; Immunophenotyping; Infant; Kaplan-Meier Estimate; Leukocyte Count; Mercaptopurine; Oncogene Proteins, Fusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Outcome; Turkey; Vincristine

2014
Leukemia propagating cells rebuild an evolving niche in response to therapy.
    Cancer cell, 2014, Jun-16, Volume: 25, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Cells; Cytarabine; Daunorubicin; Disease Models, Animal; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Niche; Tumor Microenvironment; Xenograft Model Antitumor Assays

2014
Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
    Annals of hematology, 2014, Volume: 93, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Combined Modality Therapy; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Diarrhea; Drug Administration Schedule; Drug Evaluation; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Liposomes; Male; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Remission Induction; Retrospective Studies; Salvage Therapy; Vidarabine; Young Adult

2014
Augmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL).
    Cancer, 2014, Dec-01, Volume: 120, Issue:23

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cohort Studies; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Female; Humans; Induction Chemotherapy; Maintenance Chemotherapy; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Thioguanine; Treatment Outcome; Vincristine; Young Adult

2014
A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia.
    Blood cancer journal, 2014, Aug-01, Volume: 4

    Topics: Adolescent; Animals; Anticholesteremic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cell Line, Tumor; Child; Child, Preschool; Cholesterol; Daunorubicin; Dexamethasone; Drug Resistance, Neoplasm; Female; Humans; Induction Chemotherapy; Infant; Male; Mice; Mice, Nude; Mice, SCID; Neoplasms, Experimental; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Simvastatin; Vincristine; Xenograft Model Antitumor Assays

2014
Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program.
    Pediatric blood & cancer, 2015, Volume: 62, Issue:1

    Topics: Adolescent; Animals; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Liposomes; Male; Maximum Tolerated Dose; Mice; Mice, Inbred NOD; Mice, SCID; Pediatrics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tissue Distribution; Treatment Outcome; Xenograft Model Antitumor Assays

2015
Cell-cycle disturbance and induction of programmed death by new formamidine analogs of daunorubicin.
    Anticancer research, 2014, Volume: 34, Issue:12

    Topics: Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Survival; Daunorubicin; DNA; DNA Fragmentation; Flow Cytometry; Humans; M Phase Cell Cycle Checkpoints; Necrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2014
The antileukemia roles of PP242 alone or in combination with daunorubicin in acute leukemia.
    Anti-cancer drugs, 2015, Volume: 26, Issue:4

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Drug Synergism; Eukaryotic Initiation Factor-4E; Humans; Indoles; Leukemia; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Lymphoma, Mantle-Cell; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Myeloid Cell Leukemia Sequence 1 Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Purines; Signal Transduction; TOR Serine-Threonine Kinases

2015
[SLCO1B1c. 521T>C gene polymorphisms are associated with high-dose methotrexate pharmacokinetics and clinical outcome of pediatric acute lymphoblastic leukemia].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2014, Volume: 52, Issue:10

    Topics: Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Disease-Free Survival; Genotype; Humans; Leucovorin; Liver-Specific Organic Anion Transporter 1; Methotrexate; Organic Anion Transporters; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Treatment Outcome; Vincristine

2014
[Outcomes of modified NHL-BFM-90 protocol for children and adolescents with lymphoblastic lymphoma].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2014, Volume: 35, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Treatment Outcome; Vincristine

2014
Clinical features and prognostic significance of TCF3-PBX1 fusion gene in Chinese children with acute lymphoblastic leukemia by using a modified ALL-BFM-95 protocol.
    Pediatric hematology and oncology, 2015, Volume: 32, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asian People; Asparaginase; Child; Child, Preschool; China; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Infant; Karyotyping; Male; Mercaptopurine; Oncogene Proteins, Fusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Retrospective Studies; Vincristine

2015
Infections during induction therapy of protocol CCLG-2008 in childhood acute lymphoblastic leukemia: a single-center experience with 256 cases in China.
    Chinese medical journal, 2015, Feb-20, Volume: 128, Issue:4

    Topics: Antineoplastic Agents; Child; Child, Preschool; China; Daunorubicin; Dexamethasone; Female; Humans; Infant; Male; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Vincristine

2015
Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers.
    Chemotherapy, 2014, Volume: 60, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Daunorubicin; Dexamethasone; Doxorubicin; Feasibility Studies; Female; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine; Young Adult

2014
Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse.
    Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; bcl-2-Associated X Protein; Biomarkers, Tumor; Bone Marrow; Bone Marrow Cells; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Female; Humans; Induction Chemotherapy; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proto-Oncogene Proteins c-bcl-2; Treatment Outcome; Up-Regulation; Vincristine

2015
Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
    Leukemia research, 2015, Volume: 39, Issue:8

    Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine; Young Adult

2015
Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells.
    Leukemia research, 2015, Volume: 39, Issue:9

    Topics: Animals; Antibiotics, Antineoplastic; B-Lymphocytes; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Daunorubicin; DNA-Binding Proteins; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Leukemic; Humans; Intracellular Signaling Peptides and Proteins; Jurkat Cells; Mice; Mice, Nude; Neoplasm Transplantation; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Cell Culture; RNA, Small Interfering; Signal Transduction; T-Lymphocytes; Tumor Burden; Tumor Necrosis Factor alpha-Induced Protein 3; Tumor Suppressor Protein p53

2015
Is a New Protocol for Acute Lymphoblastic Leukemia Research or Standard Therapy?
    Pediatrics, 2015, Volume: 136, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Clinical Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Evidence-Based Medicine; Humans; Leucovorin; Mercaptopurine; Methotrexate; Netherlands; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Assessment; Therapeutic Human Experimentation; United States; Vincristine

2015
Increased Th17 cells and IL-17A exist in patients with B cell acute lymphoblastic leukemia and promote proliferation and resistance to daunorubicin through activation of Akt signaling.
    Journal of translational medicine, 2016, 05-12, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Aged; Cell Proliferation; Cell Separation; Daunorubicin; Drug Resistance, Neoplasm; Enzyme Activation; Humans; Interleukin-17; Interleukins; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Signal Transduction; STAT3 Transcription Factor; Th1 Cells; Th17 Cells; Young Adult

2016
The Impact of Socioeconomic Factors on the Outcome of Childhood Acute Lymphoblastic Leukemia (ALL) Treatment in a Low/Middle Income Country (LMIC).
    Journal of pediatric hematology/oncology, 2016, Volume: 38, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Developing Countries; Female; Humans; Infant; Infections; Male; Malnutrition; Pakistan; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Socioeconomic Factors; Survival Rate; Vincristine

2016
Increased proapoptotic activity of electron beam irradiated doxorubicin and epirubicin in multidrug-resistant human leukemic cells.
    Chemico-biological interactions, 2016, Oct-25, Volume: 258

    Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Blotting, Western; Caspases; Cell Line, Tumor; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Electron Spin Resonance Spectroscopy; Electrons; Epirubicin; Free Radicals; Humans; NF-kappa B; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Suppressor Protein p53

2016
Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia.
    Oncotarget, 2016, 09-13, Volume: 7, Issue:37

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cell Line, Tumor; Child; Clonal Selection, Antigen-Mediated; Clone Cells; Daunorubicin; Dexamethasone; Drug Resistance, Neoplasm; Humans; Immunocompromised Host; Mice; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Antigen, T-Cell; T-Lymphocytes; Vincristine; Xenograft Model Antitumor Assays

2016
The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results.
    Cancer, 2017, 02-01, Volume: 123, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Female; Guatemala; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Risk Factors; Treatment Outcome; Vincristine

2017
Adipocytes cause leukemia cell resistance to daunorubicin via oxidative stress response.
    Oncotarget, 2016, Nov-08, Volume: 7, Issue:45

    Topics: 3T3-L1 Cells; Adipocytes; Animals; Antibiotics, Antineoplastic; Antioxidants; Cell Death; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Gene Expression Profiling; Glutathione; Humans; Leukemia; Mice; Oxidative Stress; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species

2016
Ikaros 6 protects acute lymphoblastic leukemia cells against daunorubicin-induced apoptosis by activating the Akt-FoxO1 pathway.
    Journal of leukocyte biology, 2017, Volume: 101, Issue:3

    Topics: Apoptosis; Cell Line, Tumor; Child; Cytoprotection; Daunorubicin; Enzyme Activation; Female; Forkhead Box Protein O1; Gene Silencing; Heterocyclic Compounds, 3-Ring; Humans; Ikaros Transcription Factor; Male; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Signal Transduction

2017
Lymphoblastic Lymphoma Presenting as Bilateral Ovarian Mass in an Adolescent Girl.
    Journal of pediatric and adolescent gynecology, 2017, Volume: 30, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Daunorubicin; Diagnosis, Differential; Female; Humans; Lymphoma, B-Cell; Ovarian Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vincristine

2017
Hyper-CVAD Compared With BFM-like Chemotherapy for the Treatment of Adult Acute Lymphoblastic Leukemia. A Retrospective Single-Center Analysis.
    Clinical lymphoma, myeloma & leukemia, 2017, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Daunorubicin; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Lebanon; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Retrospective Studies; Treatment Outcome; Vincristine; Young Adult

2017
CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation.
    Leukemia research, 2017, Volume: 53

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cytarabine; Daunorubicin; fms-Like Tyrosine Kinase 3; Humans; Inhibitory Concentration 50; Liposomes; Mutation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured

2017
Survival Outcome of Filipino Children With Acute Lymphoblastic Leukemia Treated With Modified Berlin-Frankfurt-Muenster/Hong Kong Acute Lymphoblastic Leukemia (BFM95/HKALL97) Protocol in a Tertiary General Hospital From January 2005 to December 2009: A Re
    Journal of pediatric hematology/oncology, 2017, Volume: 39, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cohort Studies; Consolidation Chemotherapy; Daunorubicin; Disease-Free Survival; Female; Humans; Infant; Infant, Newborn; Male; Methotrexate; Philippines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Survival Rate; Tertiary Care Centers; Treatment Outcome; Vincristine

2017
Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia.
    Annals of hematology, 2008, Volume: 87, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Child; Daunorubicin; Gene Expression Profiling; Humans; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Reverse Transcriptase Polymerase Chain Reaction; Vincristine

2008
Low-dose anthracyclines in childhood Acute Lymphoblastic Leukemia (ALL): no cardiac deterioration more than 20 years post-treatment.
    Journal of cancer survivorship : research and practice, 2007, Volume: 1, Issue:4

    Topics: Adolescent; Adult; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cross-Sectional Studies; Daunorubicin; Female; Follow-Up Studies; Heart Function Tests; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survivors; Time Factors

2007
Oral mucositis in acute lymphoblastic leukaemia: analysis of 169 paediatric patients.
    Oral diseases, 2008, Volume: 14, Issue:8

    Topics: Adolescent; Age Factors; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brazil; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Leukocyte Count; Male; Mercaptopurine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prevalence; Retrospective Studies; Risk Factors; Sex Factors; Stomatitis; Vincristine

2008
Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:7

    Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Charcot-Marie-Tooth Disease; Contraindications; Cytarabine; Daunorubicin; Etoposide; Gait Disorders, Neurologic; Humans; Male; Mercaptopurine; Methotrexate; Muscle Weakness; Neural Conduction; Peripheral Nervous System Diseases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine

2008
Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia.
    International journal of hematology, 2008, Volume: 88, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Female; Fibrinolytic Agents; Hepatic Veno-Occlusive Disease; Humans; Liver; Marfan Syndrome; Methotrexate; Middle Aged; Polydeoxyribonucleotides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine

2008
Vascular access for daunorubicin during childhood acute lymphoblastic leukaemia induction treatment: a UKCCSG supportive care group and MRC childhood leukaemia working party survey.
    European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2008, Volume: 12, Issue:5

    Topics: Antibiotics, Antineoplastic; Catheterization, Central Venous; Catheterization, Peripheral; Child; Daunorubicin; Extravasation of Diagnostic and Therapeutic Materials; Guideline Adherence; Health Care Surveys; Humans; Infusions, Intravenous; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Surveys and Questionnaires; Thromboembolism; Time Factors; United Kingdom

2008
Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.
    Blood, 2009, Feb-26, Volume: 113, Issue:9

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Deoxyglucose; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Glucocorticoids; Glucose; Glycolysis; Humans; Jurkat Cells; Oligonucleotide Array Sequence Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tumor Cells, Cultured; Vincristine

2009
Level of DNA topoisomerase IIalpha mRNA predicts the treatment response of relapsed acute leukemic patients.
    Leukemia research, 2009, Volume: 33, Issue:7

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antigens, Neoplasm; Blast Crisis; Cell Cycle; Daunorubicin; DNA Topoisomerases, Type II; DNA-Binding Proteins; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Treatment Outcome; Young Adult

2009
Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.
    Leukemia, 2009, Volume: 23, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Injections, Spinal; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; T-Lymphocytes; Treatment Outcome; Vincristine

2009
Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy.
    Annals of hematology, 2009, Volume: 88, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Pyrimidines; Salvage Therapy; Vincristine; Vindesine; Young Adult

2009
Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin.
    British journal of haematology, 2009, Volume: 145, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Asparaginase; Child, Preschool; Combined Modality Therapy; Daunorubicin; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Metapneumovirus; Methotrexate; Paramyxoviridae Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Ribavirin; Vincristine

2009
Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia.
    The Journal of pediatrics, 2009, Volume: 155, Issue:1

    Topics: Antineoplastic Agents; Asparaginase; Blood Glucose; Child; Child, Preschool; Daunorubicin; Dexamethasone; Escherichia coli; Female; Glucocorticoids; Humans; Hyperglycemia; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Severity of Illness Index; Vincristine

2009
DNA damage response as a biomarker in treatment of leukemias.
    Cell cycle (Georgetown, Tex.), 2009, Jun-01, Volume: 8, Issue:11

    Topics: Adolescent; Adult; Aged; Ataxia Telangiectasia Mutated Proteins; Biomarkers; Cell Cycle Proteins; Child; Daunorubicin; DNA Damage; DNA Topoisomerases; DNA-Binding Proteins; Enzyme Inhibitors; Histones; Humans; Idarubicin; Leukemia, Myeloid, Acute; Mitoxantrone; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Serine-Threonine Kinases; Topoisomerase Inhibitors; Tumor Suppressor Proteins

2009
Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols.
    Blood, 2009, Aug-13, Volume: 114, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child; Child, Preschool; Daunorubicin; Female; Follow-Up Studies; Germany; Heterozygote; Homozygote; Humans; Infant; Leukemia, Myeloid, Acute; Male; Methyltransferases; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Vincristine

2009
[Prophylaxis and treatment of modified BFM-90 regimen for lymphoblastic lymphoma in children and adolescents accompanied with infection].
    Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:7

    Topics: Adolescent; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Cross Infection; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Progression; Female; Humans; Itraconazole; Male; Mercaptopurine; Methotrexate; Mouth Diseases; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Respiratory Tract Infections; Vincristine

2009
Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961.
    Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Mass Index; Child; Child, Preschool; Cranial Irradiation; Cytarabine; Daunorubicin; Ethnicity; Female; Gastrointestinal Diseases; Glucose Intolerance; Humans; Incidence; Male; Methotrexate; Obesity; Pancreatitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Retrospective Studies; Risk; Vincristine; Weight Gain; Weight Loss; Young Adult

2009
Hyperammonemic encephalopathy after induction chemotherapy for acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Humans; Hyperammonemia; Infant; Male; Neurotoxicity Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Treatment Outcome; Vincristine

2009
Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2010, Volume: 21, Issue:1

    Topics: Alleles; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Egypt; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Mercaptopurine; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Neoplasm Proteins; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Stomatitis; Vincristine

2010
Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.
    American journal of hematology, 2010, Volume: 85, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Asparaginase; Case-Control Studies; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Fibrin Fibrinogen Degradation Products; Humans; Infant; Longitudinal Studies; Male; Mercaptopurine; Methotrexate; P-Selectin; Plasminogen Activator Inhibitor 1; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Risk Factors; Thrombin; Thrombophilia; Venous Thromboembolism; Vincristine; von Willebrand Factor

2010
Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution.
    Leukemia & lymphoma, 2010, Volume: 51, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System; Central Nervous System Diseases; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Electroencephalography; Female; Humans; Infant; Leukemic Infiltration; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Tomography, X-Ray Computed; Vincristine

2010
Schistocytic hemolytic anemia owing to central venous catheter in a child with acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:6

    Topics: Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Catheterization, Central Venous; Child, Preschool; Daunorubicin; Erythrocytes; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

2010
Anthracycline dose intensification in adult acute lymphoblastic leukemia: lack of benefit in the context of the fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen.
    Cancer, 2010, Oct-01, Volume: 116, Issue:19

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Humans; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Salvage Therapy; Treatment Outcome; Vincristine

2010
Childhood acute lymphoblastic leukemia in Turkey: factors influencing treatment and outcome: a single center experience.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Male; Mercaptopurine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Turkey; Vincristine

2010
Puffiness of the eyelids and lips with multiple subcutaneous masses in 2-month-old infant.
    Hematology/oncology and stem cell therapy, 2010, Volume: 3, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Common Cold; Daunorubicin; Eyelids; Female; Humans; Infant; Lip; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Subcutaneous Tissue; Tomography, X-Ray Computed; Vincristine

2010
Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2011, Volume: 77, Issue:2

    Topics: Antibiotics, Antineoplastic; Aptamers, Nucleotide; Cell Line, Tumor; Cell Survival; Daunorubicin; Delayed-Action Preparations; Drug Carriers; Humans; Hydrogen-Ion Concentration; Molecular Targeted Therapy; Nanotubes, Carbon; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors

2011
MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia.
    Haematologica, 2011, Volume: 96, Issue:5

    Topics: Antineoplastic Agents; Asparaginase; Child; Cluster Analysis; Daunorubicin; Drug Resistance, Neoplasm; Gene Expression Profiling; Genetic Variation; Humans; MicroRNAs; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Vincristine

2011
[Effects of bortezomib combined with daunorubicin on proliferation and apoptosis in primary adult acute leukemia].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2010, Volume: 41, Issue:5

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Daunorubicin; Drug Synergism; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrazines; Tumor Cells, Cultured; Young Adult

2010
[The anti-leukemic effects of imatinib, daunorubicin and bortezomib on two leukemia cell lines with Ph(+)].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2010, Volume: 41, Issue:5

    Topics: Antineoplastic Agents; Benzamides; Boronic Acids; Bortezomib; Cell Line, Tumor; Daunorubicin; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; K562 Cells; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrazines; Pyrimidines

2010
Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: low incidence of CNS tumours.
    Pediatric blood & cancer, 2011, Jul-15, Volume: 57, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Incidence; Infant; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Retrospective Studies; Survival Rate; Vincristine

2011
Prognostic impact of t(1;19)/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Münster-based protocols.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Basic Helix-Loop-Helix Transcription Factors; Child; Child, Preschool; Cytogenetic Analysis; Daunorubicin; Disease-Free Survival; DNA-Binding Proteins; Humans; Immunophenotyping; Infant; Pre-B-Cell Leukemia Transcription Factor 1; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Proto-Oncogene Proteins; Translocation, Genetic; Treatment Outcome; Vincristine

2011
Homozygosity for the rs9939609T allele of the FTO gene may have protective effect on becoming overweight in survivors of childhood acute lymphoblastic leukaemia.
    Journal of genetics, 2011, Volume: 90, Issue:2

    Topics: Adolescent; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Genetic Association Studies; Homozygote; Humans; Male; Methotrexate; Obesity; Odds Ratio; Overweight; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proteins; Radiotherapy; Risk Factors; Survivors; Thioguanine; Vincristine; Young Adult

2011
Antileukaemia effect of rapamycin alone or in combination with daunorubicin on Ph+ acute lymphoblastic leukaemia cell line.
    Hematological oncology, 2012, Volume: 30, Issue:3

    Topics: Adult; Autophagy; Cell Division; Cell Line, Tumor; Daunorubicin; Drug Synergism; Humans; K562 Cells; Neoplasm Proteins; Phagosomes; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Processing, Post-Translational; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tumor Stem Cell Assay

2012
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
    Blood, 2011, Nov-24, Volume: 118, Issue:22

    Topics: Adolescent; Adult; Antibodies; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Pharmacological; Chemotherapy, Adjuvant; Child; Child, Preschool; Daunorubicin; Drug Hypersensitivity; Drug Monitoring; Escherichia coli; Escherichia coli Proteins; Humans; Infant; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Recombinant Proteins; Retrospective Studies; Vincristine; Young Adult

2011
Isolation of human mAbs that directly modulate FMS-related tyrosine kinase 3 signaling.
    Cancer science, 2012, Volume: 103, Issue:2

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Cell Proliferation; Daunorubicin; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinases; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction

2012
Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy.
    International journal of hematology, 2012, Volume: 95, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Daunorubicin; Female; Humans; Posterior Leukoencephalopathy Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Radiography; Remission Induction; Vincristine

2012
Asparagine and aspartic acid concentrations in bone marrow versus peripheral blood during Berlin-Frankfurt-Münster-based induction therapy for childhood acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:9

    Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Asparagine; Aspartic Acid; Bone Marrow; Child; Child, Preschool; Daunorubicin; Drug Administration Schedule; Female; Glutamic Acid; Glutamine; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Time Factors; Treatment Outcome; Vincristine

2012
Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes.
    Diagnostic pathology, 2012, Feb-22, Volume: 7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Daunorubicin; Fatal Outcome; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Neoplasms, Multiple Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptor, Platelet-Derived Growth Factor beta; Stem Cell Transplantation

2012
Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells.
    Cell cycle (Georgetown, Tex.), 2012, Jun-15, Volume: 11, Issue:12

    Topics: Adolescent; Apoptosis; Cell Line, Tumor; Cell Proliferation; Child; Child, Preschool; Daunorubicin; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin Glargine; Insulin, Long-Acting; Male; Metformin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Rosiglitazone; Thiazolidinediones; TOR Serine-Threonine Kinases

2012
Substitution with doxorubicin for daunorubicin during induction for high risk pediatric acute lymphoblastic leukemia results in increased toxicity.
    Pediatric blood & cancer, 2013, Volume: 60, Issue:2

    Topics: Antineoplastic Agents; Child; Child, Preschool; Daunorubicin; Doxorubicin; Drug Substitution; Female; Humans; Induction Chemotherapy; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies

2013
Acute lymphoblastic leukemia presenting as bilateral serous macular detachment and lacrimal gland enlargement.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2012, Volume: 47, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Coloring Agents; Daunorubicin; Eye Neoplasms; Female; Fluorescein Angiography; Humans; Hypertrophy; Indocyanine Green; Lacrimal Apparatus; Lacrimal Apparatus Diseases; Leukocyte Count; Magnetic Resonance Imaging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retinal Detachment; Tomography, Optical Coherence; Vincristine; Visual Acuity

2012
Effects of structural modifications of daunorubicin on in vitro antileukemic activity.
    Anticancer research, 2012, Volume: 32, Issue:12

    Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Daunorubicin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Structure-Activity Relationship

2012
Comparison of prognostic value of in vitro drug resistance and bone marrow residual disease on day 15 of therapy in childhood acute lymphoblastic leukemia.
    Anticancer research, 2012, Volume: 32, Issue:12

    Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Infant; Male; Multivariate Analysis; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Vincristine

2012
Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy.
    Leukemia research, 2013, Volume: 37, Issue:5

    Topics: 3T3-L1 Cells; Adipose Tissue; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Daunorubicin; Drug Resistance, Neoplasm; Humans; Mice; Neoplasm Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Isogeneic; Tumor Microenvironment; Vincristine

2013
The evaluation of protein Z levels of children with acute lymphoblastic leukaemia during induction therapy.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Proteins; Case-Control Studies; Child; Child, Preschool; Daunorubicin; Female; Hemorrhage; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Thrombosis; Time Factors; Vincristine

2013
Successful treatment of a pregnant woman with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    International journal of hematology, 2013, Volume: 97, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Female; Humans; Induction Chemotherapy; Live Birth; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Vincristine

2013
A single-center experience of the nationwide daunorubicin shortage: substitution with doxorubicin in adult acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2013, Volume: 54, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Doxorubicin; Drug Substitution; Female; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult

2013
2D- and 3D-QSAR studies of a series of benzopyranes and benzopyrano[3,4b][1,4]-oxazines as inhibitors of the multidrug transporter P-glycoprotein.
    Journal of computer-aided molecular design, 2013, Volume: 27, Issue:2

    Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; Benzopyrans; Biological Transport; Daunorubicin; Drug Resistance, Multiple; Humans; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Molecular Structure; Oxazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quantitative Structure-Activity Relationship; Tumor Cells, Cultured

2013
Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.
    Medical and pediatric oncology, 2002, Volume: 39, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Glucose; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Hypoglycemia; Italy; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Purines; Retrospective Studies; Time Factors; Vincristine

2002
Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)?
    Medical and pediatric oncology, 2002, Volume: 39, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Cyclophosphamide; Cytarabine; Cytogenetic Analysis; Daunorubicin; DNA Primers; Female; Humans; Infant; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Translocation, Genetic; Vincristine

2002
Increased factor VIII activity and dural sinus thrombosis.
    Medical and pediatric oncology, 2002, Volume: 39, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Factor VIII; Humans; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Radiography; Risk Factors; Sagittal Sinus Thrombosis; Vincristine

2002
The influence of intracellular idarubicin and daunorubicin levels on drug cytotoxicity in childhood acute leukemia.
    Acta biochimica Polonica, 2002, Volume: 49, Issue:1

    Topics: Adolescent; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Child, Preschool; Daunorubicin; Flow Cytometry; Humans; Idarubicin; Infant; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tetrazolium Salts; Thiazoles

2002
CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
    Acta haematologica, 2002, Volume: 108, Issue:1

    Topics: Acute Disease; Aged; Antigens, CD; Antigens, CD7; Antigens, Differentiation, Myelomonocytic; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; CD56 Antigen; Cytarabine; Daunorubicin; Diagnosis, Differential; Etoposide; Fatal Outcome; Humans; Idarubicin; Killer Cells, Natural; Leukemia, Myeloid; Leukemic Infiltration; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Mitoxantrone; Myeloid Cells; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma, Myeloid; Sialic Acid Binding Ig-like Lectin 3

2002
Tuberculosis and immune thrombocytopenia.
    Haematologica, 2002, Volume: 87, Issue:8

    Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Asparaginase; Comorbidity; Daunorubicin; HIV Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Incidence; India; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Retrospective Studies; Rifampin; Thrombocytopenia; Tuberculosis; Vincristine

2002
A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT.
    American journal of hematology, 2002, Volume: 71, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azathioprine; Bone Marrow Transplantation; Cyclophosphamide; Daunorubicin; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Living Donors; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vincristine

2002
Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.
    Leukemia, 2002, Volume: 16, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; DNA, Neoplasm; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA-A Antigens; HLA-B Antigens; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Infant; Living Donors; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Registries; Remission Induction; Survival Rate; Time Factors; Transplantation, Homologous; Treatment Outcome; Vincristine

2002
Resistance of bcr-abl-positive acute lymphoblastic leukemia to daunorubicin is not mediated by mdr1 gene expression.
    American journal of hematology, 2002, Volume: 71, Issue:3

    Topics: Adolescent; Adult; Child; Child, Preschool; Daunorubicin; Drug Resistance, Neoplasm; Female; Gene Expression; Genes, abl; Genes, MDR; Humans; Infant; Lethal Dose 50; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis

2002
Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia.
    Bone marrow transplantation, 2002, Volume: 30, Issue:12

    Topics: Adult; Amsacrine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Betamethasone; Biomarkers, Tumor; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Female; Fusion Proteins, bcr-abl; Graft vs Host Disease; Humans; Imatinib Mesylate; Immunosuppressive Agents; Mitoxantrone; Neoplasm, Residual; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Homologous; Vincristine

2002
Benign intracranial hypertension in association with acute lymphoblastic leukemia.
    Pediatric hematology and oncology, 2003, Volume: 20, Issue:2

    Topics: Acetazolamide; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chlorthalidone; Cyclophosphamide; Cytarabine; Daunorubicin; Diagnosis, Differential; Headache; Humans; Intracranial Hypertension; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Sinus Thrombosis, Intracranial; Vincristine; Vomiting

2003
Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregnancies at 16 years.
    Leukemia research, 2003, Volume: 27, Issue:5

    Topics: Abortion, Spontaneous; Abortion, Therapeutic; Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Fatal Outcome; Female; Fetal Death; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Retrospective Studies; Turkey

2003
Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells.
    Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:2

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Cell Survival; Daunorubicin; Drug Resistance, Neoplasm; Humans; Oxides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured

2003
Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study.
    Cancer, 2003, Apr-15, Volume: 97, Issue:8

    Topics: Antibiotics, Antineoplastic; Child, Preschool; Cohort Studies; Daunorubicin; Echocardiography; Female; Heart; Heart Diseases; Humans; Kidney Neoplasms; Longitudinal Studies; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Wilms Tumor

2003
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias.
    Hematology (Amsterdam, Netherlands), 2003, Volume: 8, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Cytarabine; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Female; Fusion Proteins, bcr-abl; Hepatitis B; Humans; Imatinib Mesylate; Immunosuppressive Agents; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Neoplasm Proteins; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Remission Induction; Salvage Therapy; Vincristine

2003
[The influence of age, gender and modifications of therapeutic protocols on physical development of children and adolescents after completion of therapy for acute lymphoblastic leukemia].
    Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych, 2003, Volume: 9, Issue:1

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Mass Index; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Female; Growth; Humans; Longitudinal Studies; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Sex Factors; Thioguanine; Vincristine

2003
Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
    International journal of oncology, 2003, Volume: 23, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control Studies; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Genes, MDR; Humans; Hydroxyurea; Male; Mercaptopurine; Methotrexate; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tumor Cells, Cultured; Vincristine

2003
Disposition of liposomal daunorubicin during cotreatment with cytarabine in patients with leukaemia.
    Clinical pharmacokinetics, 2003, Volume: 42, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Liposomes; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2003
Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia.
    Blood, 2003, Dec-15, Volume: 102, Issue:13

    Topics: Antineoplastic Agents; Apoptosis; Asparaginase; Caspase 3; Caspases; Child; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Activation; Humans; Membrane Lipids; Mitochondria; Neoplastic Stem Cells; Phosphatidylserines; Poly(ADP-ribose) Polymerases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine

2003
Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Cancer, 2003, Sep-15, Volume: 98, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Radiotherapy Dosage; Survival Rate; Treatment Outcome; Vincristine

2003
Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.
    Haematologica, 2003, Volume: 88, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control Studies; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Leukemic; Humans; Male; Mercaptopurine; Methotrexate; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Protein Isoforms; Receptors, Glucocorticoid; Treatment Outcome; Vincristine

2003
Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy.
    European journal of haematology, 2004, Volume: 72, Issue:1

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Daunorubicin; Echocardiography; Humans; Male; Myocardial Ischemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome; Vincristine

2004
Chemotherapy-induced leukonychia.
    Haematologica, 2004, Volume: 89, Issue:7

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Female; Humans; Nail Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

2004
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.
    The New England journal of medicine, 2004, Aug-05, Volume: 351, Issue:6

    Topics: Antineoplastic Agents; Asparaginase; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Drug Resistance, Neoplasm; Gene Expression; Gene Expression Profiling; Humans; Infant; Multivariate Analysis; Oligonucleotide Array Sequence Analysis; Oncogenes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Proportional Hazards Models; Recurrence; RNA, Neoplasm; Vincristine

2004
The analysis of correlations between drug resistance and clinical/laboratory measures found in a group of children with all treated by ALL-BFM 90 protocol.
    Bulletin du cancer, 2004, Volume: 91, Issue:4

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Coloring Agents; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Female; Humans; In Vitro Techniques; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Prednisone; Remission Induction; Sex Factors; Tetrazolium Salts; Thiazoles; Vincristine

2004
Cerebrospinal fluid excitatory amino acids and tau protein in children with acute lymphoblastic leukemia treated according to the BFM protocol.
    Acta haematologica, 2004, Volume: 112, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Aspartic Acid; Child; Daunorubicin; Excitatory Amino Acids; Glutamic Acid; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; tau Proteins; Vincristine

2004
[Primary study of relationship between serum level of VEGF and non-Hodgkin's lymphoma in children and adolescent patients].
    Ai zheng = Aizheng = Chinese journal of cancer, 2004, Volume: 23, Issue:11 Suppl

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vascular Endothelial Growth Factor A; Vincristine

2004
An extra X chromosome as a sole abnormality in relapse of an adult acute lymphoblastic leukemia.
    Cancer genetics and cytogenetics, 2004, Volume: 155, Issue:2

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Bone Marrow; Chromosome Banding; Chromosomes, Human, X; Cyclophosphamide; Daunorubicin; Drug Therapy, Combination; Female; Genetic Markers; Humans; Karyotyping; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Secondary Prevention; Vincristine

2004
[Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases].
    Ai zheng = Aizheng = Chinese journal of cancer, 2004, Volume: 23, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Stem Cell Transplantation; Survival Rate; Treatment Outcome; Vincristine

2004
[Results of treatment of children with acute lymphoblastic leukemia with a modified BFM protocol].
    Srpski arhiv za celokupno lekarstvo, 2004, Volume: 132 Suppl 1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Humans; Infant; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Survival Rate; Vincristine

2004
[Immunologic monitoring in children with acute lymphoblastic leukemia during maintenance treatment with regard to co-existing infections].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2004, Volume: 57, Issue:7-8

    Topics: Adolescent; Antigens; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Flow Cytometry; Humans; Immunoglobulins; Lymphocyte Activation; Lymphocytes; Male; Methotrexate; Monitoring, Immunologic; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Risk Factors; Statistics, Nonparametric; Thioguanine; Time Factors; Vincristine

2004
[Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group].
    Przeglad lekarski, 2004, Volume: 61 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Neoplasms; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Infant, Newborn; Male; Mercaptopurine; Methotrexate; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Risk Factors; Secondary Prevention; Survival Analysis; Testicular Neoplasms; Time Factors; Treatment Outcome; Vincristine

2004
[Treatment results with ALL-BFM-95 protocol in children with acute lymphoblastic leukemia in Hungary].
    Orvosi hetilap, 2005, Jan-09, Volume: 146, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Male; Mercaptopurine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Risk Assessment; Survival Analysis; Treatment Outcome; Vincristine

2005
Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.
    Biochemistry, 2005, Mar-22, Volume: 44, Issue:11

    Topics: Adenosine Triphosphatases; Amino Acid Sequence; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line, Tumor; Cholesterol; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Membrane Lipids; Membrane Microdomains; Models, Chemical; Molecular Sequence Data; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteolipids; Vinblastine

2005
Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia.
    Cancer cell, 2005, Volume: 7, Issue:4

    Topics: Age Factors; Antineoplastic Agents; Asparaginase; Cell Survival; Child; Cluster Analysis; Core Binding Factor Alpha 2 Subunit; Daunorubicin; Disease-Free Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Mercaptopurine; Neoplasm Recurrence, Local; Oncogene Proteins, Fusion; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Prednisolone; Principal Component Analysis; Proportional Hazards Models; Translocation, Genetic; Treatment Outcome; Tumor Cells, Cultured; Vincristine

2005
Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens.
    The Journal of pediatrics, 2005, Volume: 146, Issue:5

    Topics: Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Communicable Diseases; Daunorubicin; Genotype; Humans; Infant; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

2005
In vitro activity of imatinib in cells from patients with adult acute lymphoblastic leukemia.
    Anti-cancer drugs, 2005, Volume: 16, Issue:6

    Topics: Adult; Antineoplastic Agents; Asparaginase; Benzamides; Cell Survival; Cytarabine; Daunorubicin; Drug Interactions; Drug Screening Assays, Antitumor; Fluorometry; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Immunosuppressive Agents; Mercaptopurine; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Pyrimidines; Tumor Cells, Cultured; Vincristine

2005
Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia.
    Leukemia & lymphoma, 2005, Volume: 46, Issue:6

    Topics: Apoptosis; Bone Marrow Cells; Child; Daunorubicin; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Immunophenotyping; Inhibitory Concentration 50; Leukemia, T-Cell; Medical Oncology; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reproducibility of Results; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles

2005
Decreased numbers of CD4+ T lymphocytes in peripheral blood after treatment of childhood acute lymphoblastic leukemia.
    Leukemia research, 2006, Volume: 30, Issue:1

    Topics: Adolescent; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Daunorubicin; Female; HLA-DR Antigens; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Receptors, Antigen, T-Cell; Recovery of Function; Retrospective Studies; Vincristine

2006
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature.
    Leukemia, 2005, Volume: 19, Issue:11

    Topics: Acyclovir; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Daunorubicin; Female; Herpes Simplex; Humans; Leukemia, B-Cell; Middle Aged; Pneumonia, Viral; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Simplexvirus; Vincristine

2005
Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study.
    Haematologica, 2005, Volume: 90, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Treatment Outcome; Vincristine

2005
Could Candida dubliniensis be involved in lung fungus balls?
    Revista iberoamericana de micologia, 2005, Volume: 22, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bronchoalveolar Lavage Fluid; Candida; Candidiasis; Cerebral Hemorrhage; Daunorubicin; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Species Specificity; Thrombocytopenia; Vincristine

2005
p16 inactivation associated with aggressive clinical course and fatal outcome in TEL/AML1-positive acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Chromosomes, Human, Pair 9; Combined Modality Therapy; Core Binding Factor Alpha 2 Subunit; Cyclin-Dependent Kinase Inhibitor p16; Cyclophosphamide; Cytarabine; Daunorubicin; Fatal Outcome; Gene Deletion; Genes, p16; Humans; Male; Mercaptopurine; Methotrexate; Neoplasm Proteins; Oncogene Proteins, Fusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Vincristine

2005
Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials.
    Pediatric blood & cancer, 2007, Volume: 48, Issue:3

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Male; Mercaptopurine; Methotrexate; Patient Selection; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Randomized Controlled Trials as Topic; Remission Induction; Research Design; Survival Analysis; Thioguanine; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Vincristine

2007
[Expression of survivin and its location in bone marrow cells of childhood acute leukemia: relationship to therapeutic efficacy].
    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2006, Volume: 8, Issue:2

    Topics: Adolescent; Apoptosis; Bone Marrow Cells; Child; Child, Preschool; Daunorubicin; Female; Humans; Immunohistochemistry; Infant; Inhibitor of Apoptosis Proteins; Leukemia, Myeloid, Acute; Male; Microtubule-Associated Proteins; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survivin

2006
Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark--secondary publication.
    Danish medical bulletin, 2006, Volume: 53, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Retrospective Studies; Stem Cell Transplantation; Treatment Outcome; Vincristine

2006
Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
    The Annals of thoracic surgery, 2006, Volume: 82, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Bone Marrow Transplantation; Cefepime; Cephalosporins; Combined Modality Therapy; Cunninghamella; Daunorubicin; Drug Resistance, Multiple, Fungal; Female; Humans; Imatinib Mesylate; Immunocompromised Host; Lung Diseases, Fungal; Middle Aged; Neutropenia; Piperazines; Pneumonectomy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Transplantation Conditioning; Triazoles; Vancomycin; Vincristine; Voriconazole; Zygomycosis

2006
[Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?].
    Ugeskrift for laeger, 2006, Jun-26, Volume: 168, Issue:26-32

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Stem Cell Transplantation; Treatment Outcome; Vincristine

2006
Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins.
    European journal of haematology, 2006, Volume: 77, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Liposomes; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence

2006
[Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Przeglad lekarski, 2006, Volume: 63, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Infant; Leukocyte Count; Leukocytosis; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Thioguanine; Treatment Outcome; Vincristine

2006
Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia.
    Acta bio-medica : Atenei Parmensis, 2006, Volume: 77 Suppl 2

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Brain Abscess; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Daunorubicin; Dexamethasone; Etoposide; Fatal Outcome; Female; Humans; Immunocompromised Host; Liposomes; Lung Diseases, Fungal; Mercaptopurine; Mitoxantrone; Mucormycosis; Pneumonia, Viral; Postoperative Complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Transplantation, Homologous; Vincristine

2006
[Twenty years of treating childhood acute lymphoblastic leukemia].
    Anales de pediatria (Barcelona, Spain : 2003), 2006, Volume: 65, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Prognosis; Recurrence; Risk Factors; Survival Rate; Time Factors; Vincristine

2006
Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
    Pediatric hematology and oncology, 2006, Volume: 23, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Osteonecrosis; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Retrospective Studies; Vincristine

2006
Chemotherapy exposure increases leukemia cell stiffness.
    Blood, 2007, Apr-15, Volume: 109, Issue:8

    Topics: Actins; Cytoskeleton; Daunorubicin; Dexamethasone; Humans; Jurkat Cells; Leukemia, Myeloid, Acute; Microfluidic Analytical Techniques; Microscopy, Atomic Force; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vascular Diseases

2007
[Reults of treatment with protocols BFM 90 and BFM 95].
    Medicinski arhiv, 2006, Volume: 60, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Survival Rate; Vincristine

2006
Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.
    Haematologica, 2007, Volume: 92, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Burkitt Lymphoma; CD13 Antigens; Cell Lineage; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Immunophenotyping; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Multicenter Studies as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Remission Induction; Sialic Acid Binding Ig-like Lectin 3

2007
Expression of multidrug resistance (MDR) proteins and in vitro drug resistance in acute leukemias.
    Hematology (Amsterdam, Netherlands), 2007, Volume: 12, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Survival; Child; Child, Preschool; Coloring Agents; Cytarabine; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Infant; Inhibitory Concentration 50; Leukemia; Leukemia, Myeloid; Male; Methylphenazonium Methosulfate; Middle Aged; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Staining and Labeling; Tetrazolium Salts; Thiazoles; Treatment Outcome; Tumor Cells, Cultured

2007
Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implicat
    Pediatric hematology and oncology, 2007, Volume: 24, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cognition Disorders; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Injections, Spinal; Intelligence Tests; Longitudinal Studies; Male; Mercaptopurine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Psychomotor Performance; Risk Factors; Vincristine

2007
Vincristine-induced acute neurotoxicity versus Guillain-Barré syndrome: a diagnostic dilemma.
    European journal of neurology, 2007, Volume: 14, Issue:7

    Topics: Action Potentials; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dexamethasone; Diagnosis, Differential; Erectile Dysfunction; Fatal Outcome; Guillain-Barre Syndrome; Humans; Hydrocortisone; Male; Methotrexate; Paraparesis; Paresthesia; Polyradiculoneuropathy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Urination Disorders; Vincristine

2007
Coenzyme Q10 concentration in the plasma of children suffering from acute lymphoblastic leukaemia before and during induction treatment.
    BioFactors (Oxford, England), 2007, Volume: 29, Issue:2-3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Asparaginase; Child; Child, Preschool; Coenzymes; Daunorubicin; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Ubiquinone; Vincristine

2007
[Exploratory study of novel leukemia bone marrow stromal cell adhesion mediated drug resistance model].
    Zhonghua yi xue za zhi, 2007, May-29, Volume: 87, Issue:20

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Bone Marrow Cells; Cell Adhesion; Cell Survival; Child; Child, Preschool; Daunorubicin; Drug Resistance, Neoplasm; Female; Humans; Inhibitory Concentration 50; Jurkat Cells; Male; Microscopy, Electron, Scanning; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stromal Cells; Tumor Cells, Cultured

2007
Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer.
    Pathology oncology research : POR, 2007, Volume: 13, Issue:3

    Topics: Acetylglucosaminidase; Adolescent; Adult; Albuminuria; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Child; Child, Preschool; Creatinine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Idarubicin; Infant; Kidney Diseases; Kidney Tubules, Proximal; Lymphoma, Non-Hodgkin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Razoxane; Retrospective Studies

2007
Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children.
    Haematologica, 2007, Volume: 92, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Austria; Basic Helix-Loop-Helix Transcription Factors; Child; Child, Preschool; Daunorubicin; DNA-Binding Proteins; Humans; Incidence; Infant; Pre-B-Cell Leukemia Transcription Factor 1; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proto-Oncogene Proteins; Survival Rate; Treatment Outcome; Vincristine

2007
The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group.
    Haematologica, 2007, Volume: 92, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Humans; Infant; Male; Matched-Pair Analysis; NAD(P)H Dehydrogenase (Quinone); Neoplasms, Second Primary; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

2007
Relationship between in vitro chemosensitivity assessed with MTT assay and clinical outcomes in 103 patients with acute leukemia.
    The Korean journal of laboratory medicine, 2007, Volume: 27, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Child; Child, Preschool; Coloring Agents; Cytarabine; Daunorubicin; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Female; Humans; Infant; Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tetrazolium Salts; Thiazoles; Treatment Outcome

2007
Outcomes of a modified CALGB 19802 regimen in adult acute lymphoblastic leukemia.
    Journal of Korean medical science, 2008, Volume: 23, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Female; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Treatment Outcome; Vincristine

2008
Granulocyte colony stimulating factor increases drug resistance of leukaemic blast cells to daunorubicin.
    Pathology oncology research : POR, 2008, Volume: 14, Issue:3

    Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Chemotherapy, Adjuvant; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Myeloid Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Granulocyte Colony-Stimulating Factor

2008
Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Medical and pediatric oncology, 1996, Volume: 26, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Remission Induction; Vincristine

1996
[The significance of preventive CNS irradiation during antineoplastic therapy in childhood with regard to late odontogenic and mandibulofacial injuries].
    Fortschritte der Kieferorthopadie, 1995, Volume: 56, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cephalometry; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Daunorubicin; Female; Humans; Infant; Male; Maxillofacial Development; Neoplasms; Odontogenesis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Radiation Injuries; Radiotherapy Dosage; Time Factors; Vincristine

1995
Acute lymphoblastic leukemia in the elderly: results of two different treatment approaches in 49 patients during a 25-year period.
    Leukemia, 1995, Volume: 9, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Retrospective Studies; Treatment Outcome; Vincristine

1995
Topoisomerase II alpha gene expression in childhood acute lymphoblastic leukemia.
    Leukemia, 1995, Volume: 9, Issue:10

    Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Daunorubicin; DNA Topoisomerases, Type II; DNA-Binding Proteins; Gene Expression; Humans; Isoenzymes; Lymphocytes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA, Messenger; Teniposide

1995
Pubertal growth in young adult survivors of childhood leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Height; Brain Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Daunorubicin; Female; Follow-Up Studies; Growth; Humans; Male; Menarche; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Puberty; Radiotherapy; Retrospective Studies; Sex Factors; Vincristine

1995
Prognosis and treatment of seizures in children with acute lymphoblastic leukemia.
    Epilepsia, 1995, Volume: 36, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Epilepsy; Female; Humans; Incidence; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Retrospective Studies; Seizures; Vincristine

1995
Evaluation of multidrug resistant phenotype by flow cytometry with monoclonal antibodies and functional tests.
    Bulletin du cancer, 1995, Volume: 82, Issue:3

    Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Daunorubicin; Drug Resistance, Multiple; Flow Cytometry; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Leukemia, Erythroblastic, Acute; Lymphoma, Non-Hodgkin; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhodamine 123; Rhodamines

1995
Granulocyte colony-stimulating factor (CSF), macrophage-CSF, granulocyte-macrophage CSF, interleukin-3, and interleukin-6 levels in sera from children undergoing blood stem cell autografts.
    Blood, 1993, Feb-01, Volume: 81, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Cytarabine; Daunorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-3; Interleukin-6; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphoma, Non-Hodgkin; Macrophage Colony-Stimulating Factor; Male; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Time Factors; Transplantation, Autologous

1993
The frequency of micronuclei in bone-marrow erythroblasts during the treatment of childhood acute lymphoblastic leukaemia.
    Mutation research, 1993, Volume: 303, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child, Preschool; Daunorubicin; Erythroblasts; Female; Humans; Infant; Male; Methotrexate; Micronucleus Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Vincristine

1993
Drug combination testing in acute lymphoblastic leukemia using the MTT assay.
    Leukemia research, 1995, Volume: 19, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Drug Interactions; Drug Resistance; Humans; In Vitro Techniques; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Vincristine

1995
[DNA index and proliferative activity of blastic cells in childhood ALL].
    Acta haematologica Polonica, 1995, Volume: 26, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Child; Child, Preschool; Daunorubicin; DNA; Female; Follow-Up Studies; Humans; Infant; Male; Ploidies; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; S Phase; Vincristine

1995
Changes in the oral health of children during treatment for acute lymphoblastic leukaemia.
    International journal of paediatric dentistry, 1994, Volume: 4, Issue:1

    Topics: Adolescent; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Chlorhexidine; Daunorubicin; Dental Plaque Index; DMF Index; Female; Gingivitis; Humans; Infant; Longitudinal Studies; Male; Methotrexate; Oral Hygiene Index; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Statistics, Nonparametric; Vincristine

1994
In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia.
    British journal of cancer, 1995, Volume: 71, Issue:6

    Topics: Aclarubicin; Antibiotics, Antineoplastic; Bone Marrow; Child; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Humans; Idarubicin; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence

1995
[Use of cyclosporin and verapamil in association with chemotherapy in the treatment of pediatric patients with advanced-stage neoplasms. A pilot study].
    Minerva pediatrica, 1994, Volume: 46, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cyclosporins; Daunorubicin; Doxorubicin; Drug Resistance; Female; Humans; Male; Medulloblastoma; Neoplasms; Neuroblastoma; Osteosarcoma; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Verapamil; Vincristine

1994
Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
    Leukemia, 1995, Volume: 9, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow; Bone Marrow Transplantation; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Resistance, Multiple; Female; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Rhodamine 123; Rhodamines; Survival Analysis

1995
Childhood acute lymphoblastic leukemia (ALL): sister chromatid exchange (SCE) frequency and lymphocyte subpopulations during therapy.
    Leukemia, 1995, Volume: 9, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Chromosomes, Human; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Immunophenotyping; Infant; Lymphocyte Count; Lymphocyte Subsets; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Sister Chromatid Exchange; Time Factors; Vincristine

1995
Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
    Cytometry, 1994, Sep-01, Volume: 17, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blast Crisis; Child; Child, Preschool; Daunorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy; Treatment Failure; Tumor Cells, Cultured; Verapamil; Vinblastine; Vincristine

1994
Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen.
    Indian journal of cancer, 1994, Volume: 31, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Daunorubicin; Female; Follow-Up Studies; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Rate; Vincristine

1994
Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
    Leukemia, 1994, Volume: 8, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Leucovorin; Male; Mercaptopurine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Teniposide; Vincristine

1994
The multiface morphology of acute leukemia.
    Haematologia, 1993, Volume: 25, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cytarabine; Daunorubicin; Fatal Outcome; Female; Hematopoietic Stem Cells; Humans; Immunophenotyping; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction

1993
Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia.
    Leukemia, 1994, Volume: 8, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Female; Follow-Up Studies; Humans; Leukocyte Count; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Treatment Outcome

1994
Successful treatment of acute lymphoblastic leukemia in a child with cystic fibrosis.
    Medical and pediatric oncology, 1994, Volume: 22, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cystic Fibrosis; Cytarabine; Daunorubicin; Female; Humans; Mercaptopurine; Methotrexate; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Teniposide; Vincristine

1994
Liver function studies in children with acute lymphocytic leukemia after cessation of therapy.
    Medical and pediatric oncology, 1994, Volume: 23, Issue:2

    Topics: Adolescent; Adult; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Child; Daunorubicin; Follow-Up Studies; Humans; Liver; Mercaptopurine; Methotrexate; Nervous System Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine

1994
Effects of macrophage colony-stimulating factor (M-CSF) on the mobilization of peripheral blood stem cells.
    Bone marrow transplantation, 1994, Volume: 13, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Blood Cells; Cell Movement; Cells, Cultured; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cells; Humans; Leukapheresis; Leukemia, Myeloid; Macrophage Colony-Stimulating Factor; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1994
Relapses after termination of therapy of acute lymphoblastic leukemia in children.
    Acta paediatrica Japonica : Overseas edition, 1993, Volume: 35, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Survival Rate; Vincristine

1993
In vitro cytotoxicity of mitoxantrone, daunorubicin and doxorubicin in untreated childhood acute leukemia.
    Leukemia, 1994, Volume: 8, Issue:1

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Daunorubicin; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Female; Humans; Infant; Male; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured

1994
Prediction of chemotherapy response in human leukemia using in vitro chemosensitivity test.
    Leukemia research, 1993, Volume: 17, Issue:8

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Coloring Agents; Cytarabine; Daunorubicin; Drug Screening Assays, Antitumor; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Tetrazolium Salts; Thiazoles

1993
Changes in the oral microflora during cytotoxic chemotherapy in children being treated for acute leukemia.
    Oral surgery, oral medicine, and oral pathology, 1993, Volume: 76, Issue:2

    Topics: Adolescent; Analysis of Variance; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Candida albicans; Candidiasis, Oral; Chi-Square Distribution; Child; Child, Preschool; Chlorhexidine; Colony Count, Microbial; Cytarabine; Daunorubicin; Etoposide; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methotrexate; Mouth; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Streptococcus mutans; Thioguanine; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine

1993
Late relapse after allogeneic bone marrow transplantation for Philadelphia-positive acute lymphoblastic leukaemia.
    Acta haematologica, 1993, Volume: 89, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Combined Modality Therapy; Daunorubicin; Humans; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Recurrence; Remission Induction; Time Factors; Transplantation, Homologous; Vincristine

1993
[Treatment and prognosis after late relapse in childhood acute lymphoblastic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1993, Volume: 34, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Administration Schedule; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Recurrence; Time Factors; Vincristine

1993
[Treatment of 71 adult acute lymphoblastic leukemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Female; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Remission Induction; Survival Rate; Vincristine

1993
Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

1993
Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia.
    Leukemia, 1993, Volume: 7, Issue:3

    Topics: Aging; Antineoplastic Agents; Child; Child, Preschool; Daunorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Immunophenotyping; Infant; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Prognosis; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Vincristine

1993
Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Cancer, 1993, May-01, Volume: 71, Issue:9

    Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Hydrocortisone; Infant; Injections, Intramuscular; Injections, Intravenous; Injections, Spinal; Leukemia-Lymphoma, Adult T-Cell; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide; Treatment Failure

1993
[Treatment of adult acute lymphoblastic leukemia with DCVP-l-asp protocol].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1993, Volume: 34, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Survival Rate; Vincristine

1993
Neutrophilic eccrine hidradenitis.
    Journal of the American Academy of Dermatology, 1993, Volume: 28, Issue:5 Pt 1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Facial Dermatoses; Female; Hidradenitis; Humans; Leukemia, Myeloid; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1993
Quantitation of the nucleophosmin/B23-translocation using imaging analysis.
    Cancer letters, 1996, Feb-27, Volume: 100, Issue:1-2

    Topics: Aclarubicin; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Nucleolus; Dactinomycin; Daunorubicin; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Humans; Image Processing, Computer-Assisted; Leukemia, Monocytic, Acute; Nuclear Proteins; Nucleophosmin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured

1996
Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity.
    Blood, 1996, Jun-01, Volume: 87, Issue:11

    Topics: Acute Disease; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cryopreservation; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Feasibility Studies; Fluorescent Dyes; Humans; Leukemia; Leukemia, Myeloid; Neoplasm Proteins; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reproducibility of Results; Rhodamine 123; Rhodamines; Sensitivity and Specificity; Verapamil; Vincristine

1996
True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
    Blood, 1996, Jun-15, Volume: 87, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Mercaptopurine; Methotrexate; Methylprednisolone; Neoplasms, Second Primary; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Remission Induction; Scapula; Spinal Neoplasms; Vincristine

1996
A T cell lymphoblastic lymphoma patient with two malignant cell populations carrying different 9p deletions including the p16INK4 and p15INK4B genes: Clinical response to interferon-alpha therapy in one of the subclones.
    Leukemia, 1996, Volume: 10, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carrier Proteins; Cell Cycle Proteins; Chromosome Deletion; Chromosomes, Human, Pair 9; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Gene Deletion; Humans; Immunologic Factors; Interferon-alpha; Male; Neoplasm Proteins; Neoplastic Stem Cells; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; RNA, Messenger; RNA, Neoplasm; Salvage Therapy; Tumor Suppressor Proteins; Vincristine

1996
Childhood acute lymphoblastic leukemia relapse in the uterine cervix.
    Journal of pediatric hematology/oncology, 1996, Volume: 18, Issue:3

    Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Child; Cyclophosphamide; Daunorubicin; Female; Follow-Up Studies; Humans; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Ultrasonography; Uterine Cervical Neoplasms; Vaginal Smears; Vincristine

1996
Pyomyositis during induction chemotherapy for acute lymphocytic leukemia.
    Journal of pediatric hematology/oncology, 1996, Volume: 18, Issue:3

    Topics: Abscess; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Child; Daunorubicin; Drug Therapy, Combination; Humans; Male; Muscular Diseases; Oxacillin; Pain; Penicillins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Staphylococcal Infections; Vincristine

1996
Induction toxicity of a modified Memorial Sloan-Kettering-New York II Protocol in children with relapsed acute lymphoblastic leukemia: a single institution study.
    Medical and pediatric oncology, 1996, Volume: 27, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Daunorubicin; Female; Humans; Male; Methotrexate; Neutropenia; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Vincristine

1996
Expression and prognostic value of the retinoblastoma tumour suppressor gene (RB-1) in childhood acute lymphoblastic leukaemia.
    British journal of haematology, 1996, Volume: 94, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Base Sequence; beta 2-Microglobulin; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Female; Gene Expression; Genes, Retinoblastoma; Humans; Infant; Male; Molecular Sequence Data; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Retrospective Studies; RNA, Messenger; Vincristine

1996
Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia.
    European journal of pediatrics, 1996, Volume: 155, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cell Division; Child; Child, Preschool; Daunorubicin; Humans; Infant; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

1996
Modified BFM protocol for childhood acute lymphoblastic leukemia: a retrospective analysis.
    Medical and pediatric oncology, 1997, Volume: 28, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Survival; Vincristine

1997
Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Child; Child, Preschool; Daunorubicin; Female; Heart; Heart Ventricles; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survivors

1997
Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-glycoprotein expression.
    Annals of hematology, 1997, Volume: 74, Issue:2

    Topics: Antigens, CD34; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Fluorescent Dyes; Humans; Idarubicin; Leukemia, Myeloid, Acute; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhodamines

1997
In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
    Blood, 1997, Apr-15, Volume: 89, Issue:8

    Topics: Aclarubicin; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Bone Marrow; Cell Survival; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Follow-Up Studies; Humans; Infant; Infant, Newborn; Life Tables; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Recurrence; Remission Induction; Tumor Cells, Cultured; Vincristine

1997
Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia.
    Anti-cancer drugs, 1997, Volume: 8, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cells, Cultured; Child; Daunorubicin; Deoxycytidine Kinase; Humans; Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; RNA, Messenger; Vincristine

1997
Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:8

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cranial Irradiation; Daunorubicin; Female; Humans; Infant; Injections, Spinal; Leukemia-Lymphoma, Adult T-Cell; Leukocyte Count; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Survival Rate; Vincristine

1997
Neurophysiological findings in long-term survivors of acute lymphoblastic leukaemia in childhood treated with the BFM protocol 81 SR-A/B.
    European journal of pediatrics, 1997, Volume: 156, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cerebral Cortex; Child; Child, Preschool; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Electroencephalography; Evoked Potentials, Visual; Female; Follow-Up Studies; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Reaction Time; Vincristine

1997
Non-transferrin-bound iron induced by myeloablative chemotherapy.
    British journal of haematology, 1997, Volume: 99, Issue:2

    Topics: Adolescent; Adult; Blood Transfusion; Daunorubicin; Female; Hematopoiesis; Hodgkin Disease; Humans; Iron; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Transferrin; Transferrin; Transplantation Conditioning

1997
[Retrospective analysis of elderly patients > or = 60 years of age with acute leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:3

    Topics: Aclarubicin; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; DNA; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Retrospective Studies; Vincristine

1998
[Detection of multidrug resistance in patients with leukemia by using flow cytometry and RNA in situ hybridization].
    Zhonghua nei ke za zhi, 1996, Volume: 35, Issue:9

    Topics: Adult; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gene Expression; Genes, MDR; Humans; Immunosuppressive Agents; In Situ Hybridization; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured

1996
The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia.
    Leukemia, 1998, Volume: 12, Issue:6

    Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cell Survival; Cyclosporine; Cyclosporins; Daunorubicin; Drug Resistance, Neoplasm; Genistein; Humans; In Vitro Techniques; Multidrug Resistance-Associated Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Verapamil

1998
Acute lymphoblastic leukemia: dental health of children in maintenance therapy.
    The Journal of clinical pediatric dentistry, 1998,Spring, Volume: 22, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control Studies; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dental Care for Chronically Ill; Dental Caries; DMF Index; Female; Humans; Male; Mercaptopurine; Methotrexate; Oral Hygiene; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vincristine

1998
Physical performance in long-term survivors of acute leukaemia in childhood.
    European journal of pediatrics, 1998, Volume: 157, Issue:6

    Topics: Adolescent; Antibiotics, Antineoplastic; Child; Child, Preschool; Daunorubicin; Doxorubicin; Echocardiography; Electrocardiography; Female; Heart Rate; Humans; Infant; Leukemia, Myeloid, Acute; Male; Oxygen Consumption; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quality of Life; Spirometry; Time Factors

1998
Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia; characterization of the cytokine repertoire of clonogenic T cells.
    Cancer immunology, immunotherapy : CII, 1998, Volume: 46, Issue:4

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Clone Cells; Cytarabine; Cytokines; Daunorubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-10; Interleukin-2; Leukemia, Myeloid; Leukopenia; Lymphopenia; Male; Middle Aged; Phytohemagglutinins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stimulation, Chemical

1998
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.
    Leukemia, 1998, Volume: 12, Issue:9

    Topics: Adolescent; Adult; Age Distribution; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Immunophenotyping; Infant; Infant, Newborn; Lymphoma, B-Cell; Lymphoma, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone

1998
Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia.
    Leukemia, 1998, Volume: 12, Issue:9

    Topics: Adult; Aged; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Cytarabine; Daunorubicin; Female; Heart; Heart Failure; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Tretinoin

1998
Childhood acute lymphoblastic leukaemia: outcomes of 54 consecutive patients treated in Auckland 1985-1991.
    The New Zealand medical journal, 1998, Nov-27, Volume: 111, Issue:1078

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Infant; Mercaptopurine; Methotrexate; New Zealand; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proportional Hazards Models; Prospective Studies; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vincristine

1998
Outcomes and prognostic factors of Chinese children with acute lymphoblastic leukemia in Hong Kong: preliminary results.
    Medical and pediatric oncology, 1999, Volume: 32, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asian People; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Follow-Up Studies; Hong Kong; Humans; Infant; Injections, Spinal; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Survival Rate; Treatment Outcome; Vincristine

1999
Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
    Cancer, 1999, Apr-15, Volume: 85, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Damage, Chronic; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Developmental Disabilities; Female; Follow-Up Studies; Humans; Infant; Injections, Spinal; Leucovorin; Leukemic Infiltration; Male; Mercaptopurine; Methotrexate; Movement Disorders; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Psychomotor Performance; Remission Induction; Risk; Socioeconomic Factors; Survivors; Vincristine

1999
Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol.
    European journal of haematology, 1999, Volume: 63, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; DNA-Binding Proteins; Female; Gene Expression Regulation, Leukemic; Genes, Wilms Tumor; Humans; Life Tables; Male; Mercaptopurine; Methotrexate; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Transcription Factors; Vincristine; WT1 Proteins

1999
Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance.
    British journal of haematology, 1999, Volume: 105, Issue:4

    Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; CD13 Antigens; Daunorubicin; Drug Resistance, Neoplasm; Humans; Multidrug Resistance-Associated Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sialic Acid Binding Ig-like Lectin 3; Tumor Cells, Cultured

1999
Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia.
    Leukemia, 1999, Volume: 13, Issue:12

    Topics: Antibiotics, Antineoplastic; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Vault Ribonucleoprotein Particles

1999
[Acute leukemia in Jehovah's Witnesses].
    Sangre, 1999, Volume: 44, Issue:5

    Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Transfusion; Christianity; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Fatal Outcome; Female; Humans; Male; Mercaptopurine; Methotrexate; Personnel, Hospital; Physician-Patient Relations; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Refusal to Treat; Remission Induction; Right to Die; Treatment Refusal; Vincristine

1999
Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia.
    Blood, 2000, Feb-01, Volume: 95, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Gene Rearrangement; Humans; Infant; Male; Mercaptopurine; Methotrexate; Neoplasm, Residual; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Risk; Time Factors; Treatment Outcome; Vincristine

2000
[The efficacy of BFM-90 program in the treatment of acute lymphoblastic leukemia in children in the studies of Polish pediatric leukemia/lymphoma group].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1998, Volume: 51 Suppl 4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine

1998
[The analysis of failures in the treatment of children with non-B non-Hodgkin's lymphoma. Polish pediatric leukemia/lymphoma study group report].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1998, Volume: 51 Suppl 4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasm Staging; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Survival Rate; Treatment Failure; Vincristine

1998
Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90.
    Medical and pediatric oncology, 2000, Volume: 35, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Austria; B-Lymphocytes; Child; Child, Preschool; Cohort Studies; Daunorubicin; Disease-Free Survival; Female; Germany; Humans; Infant; Male; Multicenter Studies as Topic; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Registries; Survival Analysis; Vincristine

2000
Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
    Thrombosis and haemostasis, 2000, Volume: 83, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cohort Studies; Daunorubicin; Escherichia coli; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prevalence; Risk Factors; Thromboembolism; Thrombophilia; Venous Thrombosis; Vincristine

2000
[A study on apoptotic cell death during chemotherapy of patients with acute leukemia].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1998, Volume: 20, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Tretinoin; Vincristine

1998
Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
    Haematologica, 2000, Volume: 85, Issue:8

    Topics: Adolescent; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Bone Marrow; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Genes, Immunoglobulin; Humans; Immunoglobulin Heavy Chains; Immunophenotyping; Infant; Leukocyte Count; Male; Neoplasm Proteins; Neoplasm, Residual; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Treatment Outcome; Vincristine

2000
[A second allogeneic transplantation with a mild conditioning regimen in a patient with a posttransplantation relapse of lymphoblastic lymphoma after achieving aplasia with Daunoxome and alkeran].
    Terapevticheskii arkhiv, 2000, Volume: 72, Issue:7

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Combined Modality Therapy; Daunorubicin; Humans; Liposomes; Male; Melphalan; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retreatment; Time Factors; Transplantation Conditioning; Transplantation, Homologous

2000
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.
    Blood, 2000, Oct-15, Volume: 96, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Etoposide; Female; Flow Cytometry; Humans; Hydrocortisone; Immunophenotyping; Infant; Male; Mercaptopurine; Methotrexate; Neoplasm, Residual; Neoplastic Cells, Circulating; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Prospective Studies; Remission Induction; Treatment Outcome; Vincristine

2000
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
    British journal of haematology, 2000, Volume: 110, Issue:4

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Asparaginase; Bone Marrow Cells; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Statistics, Nonparametric; Teniposide; Thioguanine; Vincristine

2000
Acute lymphoblastic leukemia in infants: a decade of experience in the Czech Republic.
    Medical and pediatric oncology, 2000, Volume: 35, Issue:5

    Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chromosomes, Human, Pair 11; Czech Republic; Daunorubicin; Diploidy; Disease-Free Survival; DNA-Binding Proteins; Female; Genetic Predisposition to Disease; Histone-Lysine N-Methyltransferase; Humans; Infant; Infant, Newborn; Male; Myeloid-Lymphoid Leukemia Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Proto-Oncogenes; Risk Factors; Transcription Factors; Translocation, Genetic; Vincristine

2000
Antiviral and antiproliferative activity in vitro of some new benzimidazole derivatives.
    Pharmacology & toxicology, 2001, Volume: 88, Issue:2

    Topics: Animals; Antineoplastic Agents; Antiviral Agents; Benzimidazoles; Burkitt Lymphoma; Cell Division; Chlorocebus aethiops; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterovirus B, Human; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Vero Cells; Viruses

2001
[Severe hemolysis and SIADH-like symptoms induced by vincristine in an ALL patient with liver cirrhosis].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2000, Volume: 41, Issue:11

    Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Hemolysis; Hepatitis C; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine

2000
Total body irradiation before allogeneic bone marrow transplantation: is more dose better?
    International journal of radiation oncology, biology, physics, 2001, Mar-15, Volume: 49, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation-Sensitizing Agents; Radiotherapy Dosage; Retrospective Studies; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation

2001
Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation.
    American journal of hematology, 2001, Volume: 67, Issue:3

    Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immune System; Immunocompromised Host; Male; Methotrexate; Middle Aged; Opportunistic Infections; Pneumonia, Pneumocystis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Respiratory Insufficiency; Transplantation Conditioning; Transplantation, Autologous; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine; Whole-Body Irradiation

2001
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma.
    Leukemia, 2001, Volume: 15, Issue:6

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Arthroplasty, Replacement, Hip; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Femur Head Necrosis; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Osteonecrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Treatment Outcome; Vincristine

2001
Intact T-cell regenerative capacity in childhood acute lymphoblastic leukemia after remission induction therapy.
    Medical and pediatric oncology, 2001, Volume: 36, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Humans; Infant; Leukocyte Common Antigens; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Regeneration; T-Lymphocytes; Vincristine

2001
[Study on the sensitization of acute myeloid leukemia cell to daunorubicin by recombinant human interleukin-3].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 1999, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Cell Division; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Interleukin-3; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Tumor Cells, Cultured

1999
Repetitious appearance and disappearance of different kinds of clonal cytogenetic abnormalities after allogeneic bone marrow transplantation.
    International journal of hematology, 2001, Volume: 74, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Clone Cells; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; DNA Damage; Female; Follow-Up Studies; Humans; In Situ Hybridization, Fluorescence; Karyotyping; Mercaptopurine; Methotrexate; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Vincristine

2001
[Acute lymphoblastic leukemia complicated with tumor lysis syndrome--four cases report].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 1999, Volume: 20, Issue:6

    Topics: Adult; Allopurinol; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Female; Humans; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Tumor Lysis Syndrome; Vincristine

1999
Late effects of anticancer therapy on kidney function in children with acute lymphoblastic leukemia.
    Bratislavske lekarske listy, 2001, Volume: 102, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Kidney; Kidney Function Tests; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

2001
Diversity of the apoptotic response to chemotherapy in childhood leukemia.
    Leukemia, 2002, Volume: 16, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caspase 3; Caspases; Child; Child, Preschool; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Daunorubicin; Dexamethasone; Enzyme Induction; Etoposide; Female; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Genes, bcl-2; Genes, p53; Humans; Idarubicin; Infant; Male; Neoplasm Proteins; Neoplastic Stem Cells; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-mdm2; Thioguanine; Tumor Suppressor Protein p53; Vincristine

2002
P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia.
    British journal of haematology, 2002, Volume: 116, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Biomarkers, Tumor; Daunorubicin; Disease-Free Survival; Female; Humans; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Treatment Outcome; Vault Ribonucleoprotein Particles

2002
CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia.
    Leukemia research, 2002, Volume: 26, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Cells; CD56 Antigen; Cell Adhesion; Central Nervous System; Chemotaxis, Leukocyte; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Gene Expression; Humans; Incidence; Leukemic Infiltration; Life Tables; Male; Mercaptopurine; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Neurons; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Prednisone; Risk; Survival Analysis; Treatment Outcome; Vincristine

2002
Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, May-15, Volume: 20, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Immunophenotyping; Male; Mercaptopurine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Risk Factors; Treatment Outcome; Vincristine

2002
[High risk acute lymphoblastic leukaemia in children. Preliminary report after introducing a new version of New York (1997) protocol adjusted to the age of the patients. Report of the Polish Paediatric Leukaemia/Lymphoma Study Group].
    Medycyna wieku rozwojowego, 2000, Volume: 4, Issue:1 Suppl 2

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Infant, Newborn; Male; Methotrexate; Multicenter Studies as Topic; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Retrospective Studies; Risk Factors; Thioguanine; Time Factors; Treatment Outcome; Vincristine

2000
[Preliminary results of BFM 96 protocol in treatment of childhood ALL relapse in the experience of the Polish Paediatric Leukaemia /Lymphoma Study Group].
    Medycyna wieku rozwojowego, 2000, Volume: 4, Issue:1 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Male; Neoplasm Recurrence, Local; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine

2000
Cytomegalovirus infection in children with blood diseases.
    Acta haematologica Polonica, 1992, Volume: 23, Issue:3

    Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Daunorubicin; Female; gamma-Globulins; Humans; Immune Tolerance; Immunization, Passive; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Thioguanine; Vincristine

1992
Bone marrow necrosis and human parvovirus associated infection preceding an Ph1+ acute lymphoblastic leukemia.
    Leukemia & lymphoma, 1992, Volume: 8, Issue:4-5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Daunorubicin; Erythema Infectiosum; Female; Humans; Karyotyping; Methotrexate; Pancytopenia; Parvovirus B19, Human; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Steroids; Vincristine

1992
Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.
    British journal of cancer, 1992, Volume: 65, Issue:5

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Death; Child; Daunorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Membrane Glycoproteins; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Verapamil; Vincristine

1992
Acute bilateral parotitis during chemotherapy for acute lymphoblastic leukemia.
    Acta haematologica, 1992, Volume: 88, Issue:1

    Topics: Acute Disease; Adult; Ancitabine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Humans; Male; Parotitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1992
[Treatment of various types of acute leukemia in adult. An analysis of 98 cases. The Leukemia Cooperation Group of Beijing City].
    Zhonghua nei ke za zhi, 1992, Volume: 31, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

1992
Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group.
    European journal of haematology, 1992, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Asparaginase; Child; Cyclophosphamide; Daunorubicin; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Thrombin; Thrombosis; Vincristine

1992
Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.
    Leukemia research, 1992, Volume: 16, Issue:9

    Topics: 5'-Nucleotidase; Acid Phosphatase; Adolescent; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Drug Resistance; Female; Humans; Immunophenotyping; Infant; Leukemia, B-Cell; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Vincristine

1992
[Disparity of the bone marrow involvement in a 5-year-old boy with primary non-Hodgkin's malignant lymphoma of the bone].
    Przeglad lekarski, 1992, Volume: 49, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Neoplasms; Child, Preschool; Daunorubicin; Humans; Lymphoma, Non-Hodgkin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Radius; Vincristine

1992
[The programmed therapy of acute lymphoblastic leukemia in adults].
    Terapevticheskii arkhiv, 1992, Volume: 64, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Evaluation; Humans; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Vincristine

1992
Differences in the intracellular pharmacokinetics of cytosine arabinoside (AraC) between circulating leukemic blasts and normal mononuclear blood cells.
    Leukemia, 1992, Volume: 6, Issue:12

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Cytarabine; Daunorubicin; Drug Administration Schedule; Humans; Leukemia, Myeloid; Leukocytes, Mononuclear; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thioguanine

1992
Childhood acute lymphoblastic leukemia immunophenotypes and their prognostic significance: experience of the IGCI-study in 389 children. International Society for Chemo-immunotherapy (IGCI-Vienna) Cooperative Group.
    Leukemia & lymphoma, 1992, Volume: 7, Issue:3

    Topics: Adolescent; Age Factors; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Histocompatibility Antigens Class II; Humans; Immunophenotyping; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Probability; Prognosis; Remission Induction; Survival Analysis; Vincristine

1992
Growth after radiotherapy and chemotherapy in children with leukemia or lymphoma.
    Hormone research, 1992, Volume: 37, Issue:3

    Topics: Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Height; Body Weight; Child; Child, Preschool; Daunorubicin; Dose-Response Relationship, Radiation; Female; Growth; Humans; Lymphoma, Non-Hodgkin; Male; Multivariate Analysis; Pituitary Gland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Somatomedins; Vincristine

1992
[Anemia and recurrences in acute lymphoblastic leukemia in children after the treatment and the frequency of the erythroblasts with micronuclei].
    Acta haematologica Polonica, 1992, Volume: 23, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; beta-Thalassemia; Bone Marrow; Child; Child, Preschool; Daunorubicin; Erythrocytes; Hematopoietic Stem Cells; Humans; Infant; Micronuclei, Chromosome-Defective; Micronucleus Tests; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

1992
[Evaluation of 58 patients with acute leukemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome

1992
[Tactics of adjuvant therapy in the treatment of acute lymphoblastic leukemia according to the BFM program].
    Pediatriia, 1992, Issue:2

    Topics: Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Humans; Infusions, Parenteral; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

1992
Management of children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols. An update of the Ontario experience.
    The American journal of pediatric hematology/oncology, 1992, Volume: 14, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cohort Studies; Cranial Irradiation; Cytarabine; Daunorubicin; Doxorubicin; Humans; Infant; Life Tables; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Remission Induction; Risk; Survival Analysis; Survival Rate; Treatment Outcome; Vincristine

1992
Inadvertent intrathecal injection of daunorubicin with fatal outcome.
    Medical and pediatric oncology, 1992, Volume: 20, Issue:3

    Topics: Central Nervous System Diseases; Child, Preschool; Daunorubicin; Female; Humans; Injections, Spinal; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1992
Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture.
    Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:1

    Topics: Antibiotics, Antineoplastic; Cell Division; Daunorubicin; DNA Damage; DNA, Neoplasm; Doxorubicin; Epirubicin; Glioma; Humans; Idarubicin; Leukemia, Myeloid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured

1992
Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells.
    Blood, 1992, Jun-15, Volume: 79, Issue:12

    Topics: Cell Division; Daunorubicin; Drug Resistance; Humans; Idarubicin; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Verapamil

1992
Reversal of multidrug resistance by surfactants.
    British journal of cancer, 1992, Volume: 66, Issue:1

    Topics: Animals; Biological Transport; Bone Marrow; Cell Line; Cell Survival; Daunorubicin; Doxorubicin; Drug Resistance; Glycerol; Humans; Leukemia P388; Membrane Fluidity; Mice; Mice, Inbred DBA; Mice, Inbred Strains; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Surface-Active Agents; Tumor Cells, Cultured

1992
Functional myocardial impairment in children treated with anthracyclines for cancer.
    Lancet (London, England), 1991, Apr-06, Volume: 337, Issue:8745

    Topics: Adolescent; Blood Pressure; Child; Child, Preschool; Daunorubicin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Exercise Test; Female; Heart Rate; Humans; Male; Myocardial Contraction; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ventricular Function

1991
Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.
    Lancet (London, England), 1991, Aug-17, Volume: 338, Issue:8764

    Topics: Antineoplastic Agents; Asparaginase; Chi-Square Distribution; Child; Coloring Agents; Daunorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Remission Induction; Tetrazolium Salts; Thiazoles; Thioguanine; Tumor Cells, Cultured; Vincristine

1991
Increased drug accumulation ex vivo with cyclosporin in chronic lymphatic leukemia and its relationship to epitope masking of P-glycoprotein.
    Leukemia, 1991, Volume: 5, Issue:12

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Chlorambucil; Cyclosporine; Daunorubicin; Drug Resistance; Humans; In Vitro Techniques; Membrane Glycoproteins; Neuraminidase; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured

1991
Bone marrow necrosis and thrombotic complications in childhood acute lymphoblastic leukemia.
    Medical and pediatric oncology, 1992, Volume: 20, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Proteins; Bone Marrow; Child; Child, Preschool; Daunorubicin; Hemoglobins; Humans; Intracranial Embolism and Thrombosis; Leukocyte Count; Male; Necrosis; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vincristine

1992
Treatment of relapsed or refractory adult acute lymphocytic leukemia.
    Cancer, 1992, Feb-01, Volume: 69, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Vindesine

1992
Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma.
    Medical and pediatric oncology, 1992, Volume: 20, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Female; Humans; Infant; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Analysis; Vincristine

1992
[The fate of children after discontinuation of treatment for acute lymphoblastic leukemia].
    Acta haematologica Polonica, 1991, Volume: 22, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Sex Factors; Time Factors; Vincristine

1991
Immunization response varies with intensity of acute lymphoblastic leukemia therapy.
    American journal of diseases of children (1960), 1991, Volume: 145, Issue:8

    Topics: Antibodies, Bacterial; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Capsules; Bacterial Vaccines; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Diphtheria Antitoxin; Diphtheria Toxoid; Diphtheria-Tetanus Vaccine; Drug Combinations; Female; Haemophilus influenzae; Haemophilus Vaccines; Humans; Immunization; Immunization, Secondary; Male; Methotrexate; Polysaccharides, Bacterial; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Tetanus Antitoxin; Tetanus Toxoid; Vincristine

1991
Cytotoxic effects of vitamin A in combination with vincristine, daunorubicin and 6-thioguanine upon cells from lymphoblastic leukemic patients.
    Japanese journal of cancer research : Gann, 1991, Volume: 82, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Dose-Response Relationship, Drug; Drug Synergism; Humans; Isotretinoin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thioguanine; Tumor Cells, Cultured; Vincristine; Vitamin A

1991
Glutathione S-transferase activity of leukemic cells as a prognostic factor for response to chemotherapy in acute leukemias.
    Medical oncology and tumor pharmacotherapy, 1991, Volume: 8, Issue:1

    Topics: Bone Marrow; Daunorubicin; Doxorubicin; Glutathione Transferase; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis

1991
A study of multidrug resistance and cell kinetics in a child with near-haploid acute lymphoblastic leukemia.
    Leukemia research, 1990, Volume: 14, Issue:9

    Topics: Cell Cycle; Chromosome Aberrations; Daunorubicin; Drug Resistance; Haplotypes; Humans; Membrane Glycoproteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Verapamil

1990
Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children.
    Cancer, 1990, Dec-15, Volume: 66, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Hydrocortisone; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Teniposide; Vincristine

1990
In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions.
    Blood, 1990, Dec-01, Volume: 76, Issue:11

    Topics: Asparaginase; Cells, Cultured; Child; Coloring Agents; Culture Media; Cyclophosphamide; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Mechlorethamine; Mercaptopurine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tetrazolium Salts; Thiazoles; Thioguanine; Vincristine

1990
Intussusception in acute childhood lymphoblastic leukemia: an unusual complication.
    Pediatric hematology and oncology, 1990, Volume: 7, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cecal Diseases; Child; Daunorubicin; Female; Humans; Intussusception; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vincristine

1990
Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay.
    Leukemia, 1990, Volume: 4, Issue:8

    Topics: Cell Count; Cell Survival; Daunorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Fluoresceins; Fluorometry; Humans; Leukemia; Leukemia, Myeloid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Vincristine

1990
The role of peripheral blood stem cells as rescue after myeloablative therapy.
    Bone marrow transplantation, 1989, Volume: 4 Suppl 1

    Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Combined Modality Therapy; Cytarabine; Daunorubicin; Evaluation Studies as Topic; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Leukemia, Myeloid, Acute; Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Transplantation, Autologous

1989
Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
    Cancer research, 1989, Oct-01, Volume: 49, Issue:19

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Drug Resistance; Gene Amplification; Humans; Membrane Glycoproteins; Mice; Mice, Nude; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Tumor Cells, Cultured; Vinca Alkaloids; Vincristine

1989
[Treatment of acute lymphocytic leukemia in adult].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Mercaptopurine; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Survival Rate; Vincristine

1989
[Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child, Preschool; Daunorubicin; Drug Evaluation; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Vincristine

1989
Phenotype switch in acute leukemia patients after intensive chemotherapy.
    Haematology and blood transfusion, 1989, Volume: 32

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1989
[Diagnosis and treatment of rubomycin-induced heart lesions in children with leukemia].
    Gematologiia i transfuziologiia, 1989, Volume: 34, Issue:9

    Topics: Adolescent; Cardiotonic Agents; Child; Child, Preschool; Daunorubicin; Electrocardiography; Female; Heart Diseases; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ultrasonography

1989
Clinical significance of fibrinopeptide A in acute lymphocytic and non-lymphocytic leukaemia.
    Blut, 1989, Volume: 59, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinopeptide A; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Longitudinal Studies; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radioimmunoassay; Thioguanine; Time Factors

1989
Prevention of urate nephropathy in the tumour lysis syndrome.
    Clinical and laboratory haematology, 1989, Volume: 11, Issue:2

    Topics: Adolescent; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Diuresis; Humans; Hydrogen-Ion Concentration; Kidney Diseases; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tumor Lysis Syndrome; Uric Acid; Vincristine

1989
Inappropriate increase in erythropoietin titers during chemotherapy.
    American journal of hematology, 1989, Volume: 32, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Erythropoietin; Female; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

1989
Cyclosporin A and verapamil enhancement of daunorubicin-produced nucleolar protein B23 translocation in daunorubicin-resistant and -sensitive human and murine tumor cells.
    Cancer research, 1989, Feb-01, Volume: 49, Issue:3

    Topics: Animals; Cell Line; Cyclosporins; Daunorubicin; Drug Resistance; Humans; Liver Neoplasms, Experimental; Mice; Nuclear Proteins; Nucleophosmin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Verapamil

1989
Changes in the EEG background activity of children with acute lymphoblastic leukemia during cytotoxic therapy.
    Pediatric hematology and oncology, 1987, Volume: 4, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Diseases; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Daunorubicin; Doxorubicin; Electroencephalography; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine

1987
Fungal pneumonias masquerading as thromboses during induction therapy of acute lymphoblastic leukemia.
    Pediatric hematology and oncology, 1986, Volume: 3, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Aspergillosis; Child, Preschool; Daunorubicin; Diagnostic Errors; Encephalomalacia; Humans; Lung Diseases; Lung Diseases, Fungal; Male; Mucormycosis; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Thrombosis; Vincristine

1986
Childhood non-Hodgkin's lymphoma and "leukemia-lymphoma syndrome": long-term results with the modified LSA2-L2 protocol.
    Pediatric hematology and oncology, 1986, Volume: 3, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Daunorubicin; Diagnosis, Differential; Evaluation Studies as Topic; Humans; Italy; Life Tables; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Survival Rate; Syndrome; Vincristine

1986
Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group Study.
    Blood, 1988, Volume: 72, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Daunorubicin; Female; Hematopoiesis; Humans; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Vincristine

1988
A new combination of two intercalating agents (mitoxantrone + daunomycin) in adult refractory acute leukemia: the DON protocol.
    Cancer chemotherapy and pharmacology, 1988, Volume: 22, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Female; Humans; Intercalating Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Vincristine

1988
Treatment of high-risk acute lymphoblastic leukemia with protocols PETHEMA LAL 7/78 and LAL 17/84.
    Anales espanoles de pediatria, 1988, Volume: 29 Suppl 34

    Topics: Adolescent; Antineoplastic Agents; Asparaginase; Child; Child, Preschool; Clinical Protocols; Cytarabine; Daunorubicin; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine

1988
[Acute lymphoblastic leukemia in adults: results of the DATOP-79 protocol].
    Medicina clinica, 1988, Nov-19, Volume: 91, Issue:17

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Evaluation; Female; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Thioguanine; Time Factors; Vincristine

1988
Deoxycoformycin treatment for childhood T-cell acute lymphoblastic leukemia early in second remission: a Pediatric Oncology Group Study.
    Medical and pediatric oncology, 1988, Volume: 16, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Coformycin; Cytarabine; Daunorubicin; Humans; Pentostatin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Ribonucleosides; T-Lymphocytes; Teniposide; Vincristine

1988